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Abstract 
Cardiovascular diseases (CVDs) – including stroke and heart failure – are the leading cause 
of death worldwide. More people die from CVDs each year than any other cause. Magnetic 
resonance imaging (MRI) is a powerful technique which is now routinely used for imaging 
these diseases as it offers high-resolution anatomical detail, exquisite soft-tissue contrast and 
assessment of function such as tissue water content, oxygenation, metabolism, vascular 
blood flow and microvascular perfusion. This thesis focuses on the development of MRI 
techniques for use in pre-clinical animal models of cardiovascular diseases, with a focus on 
stroke and heart disease.  
Firstly, in chapter 3, the continued development of an in-house MRI sequence known as 
extravascular convectography (EVAC) for measuring the flow of interstitial fluid is 
described. A series of phantom experiments were conducted to assess the sensitivity of the 
sequence to slow flowing fluid. Next, an in vivo repeatability and reproducibility study was 
conducted before finally the technique was applied to a rat model of stroke.  
In chapter 4, a pair of studies was carried out using recently established, advanced cardiac 
imaging techniques. In the first study, CINE and late gadolinium-enhanced inversion 
recovery (LGE IR) imaging were used to assess cardiac structure and function in a Prox1-
deficient genetic mouse model of dilated cardiomyopathy. In the second part of the chapter, 
a multi-parametric MRI study – incorporating CINE, LGE IR, arterial spin labeling and T2-
mapping – was conducted in a mouse model of reperfused myocardial infarction to assess 
the extent of area-at-risk and compare with gold-standard histological staining. 
Finally, in chapter 5, the development of a retrospective high-temporal resolution (HTR) 
CINE MRI sequence for assessing cardiac diastolic function is described and compared with 
pulsed wave Doppler ultrasound, which is the currently-accepted standard for measuring 
diastolic function. The HTR-CINE sequence was established, validated and optimised in 
phantoms and naïve mouse hearts. Repeatability studies were then carried out to ensure the 
robustness of the technique before application to a mouse model of myocardial infarction. 
The overall aim of the research in this thesis is the development of MRI techniques for 
application to experimental models of cardiovascular disease.  
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CHAPTER 1: AN OVERVIEW OF CARDIOVASCULAR 
DISEASES 
 
The cardiovascular diseases (CVDs) of myocardial infarction and stroke are the two most 
deadly diseases in the world, costing hundreds of billions of dollars each year. Imaging is 
playing an increasingly prevalent role in the diagnosis, management, treatment and 
understanding of CVDs. In this chapter, myocardial infarction and stroke are briefly 
discussed including the aetiologies and pathological processes involved in these diseases, 
how they are commonly imaged in the clinic and how the diseases are recreated in pre-
clinical animal models, for use in the studies contained in the rest of this thesis. 
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1.1 Introduction 
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. In 
2012, 17.5 million people died from CVDs according to statistics from the World Health 
Organization [1], equivalent to 30% of all deaths. By 2030, this figure is projected to rise to 
more than 23.3 million people [2]. While typically considered a disease of the developed 
world, CVD is becoming increasingly prevalent in developing countries as well [3]. 
The economic burden of CVD is enormous. In 2010, the total cost of CVDs in the United 
States was estimated to be $273 billion [4]. In Europe, expenditure is similarly high: recent 
estimates from 2012 put the cost of CVD to the European Union at €196 billion ($257 
billion) [5]. In the United States, these costs have increased at an annual rate of 
approximately 6% per year [6], and they are set to continue rising. By 2030, CVD 
expenditure in the United States is projected to triple, reaching $818 billion [7]. 
CVDs are a broad group of diseases that includes diseases of the heart, vascular diseases of 
the brain and diseases of blood vessels. Atherosclerosis, which is the formation of plaques 
inside blood vessels due to the build-up of fat, cholesterol and calcium, underlies many 
ischaemic CVDs such as coronary artery disease, cerebrovascular disease and peripheral 
vascular diseases. Other CVDs include rheumatic heart disease where the heart valves are 
damaged by inflammation following rheumatic fever; congenital heart disease caused by 
malformations present at birth; cardiomyopathies which cause thickening of the 
myocardium; and vascular diseases such as deep vein thrombosis and pulmonary embolism. 
Inevitably, as the global burden of CVDs continues to increase, the need to assess and treat 
these diseases grows as well. In response, the role of non-invasive imaging has become 
increasingly important for diagnosis, assessment of prognosis and the understanding of the 
basic mechanisms of disease. This thesis is focussed on magnetic resonance imaging (MRI) 
of CVDs, in particular pre-clinical studies using mouse and rat models of human disease. 
Owing to its excellent soft tissue contrast and use of non-ionising radiation to generate 
images, MRI has emerged as a versatile technique for assessing structure, function, tissue 
status and the effects of therapeutic drugs. Pre-clinical animal models of CVD are extremely 
valuable because they permit in-depth, repeatable studies. This allows for the thorough 
development of experimental therapies, imaging biomarkers and improvements in our 
understanding of basic mechanisms of disease, which can then inform or be translated into 
human medical research. 
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For the rest of this chapter, two of the most prevalent forms of CVD will be described in 
greater detail, specifically stroke and myocardial infarction, which are central to the MRI 
studies in this thesis. 
 
1.2 Stroke and myocardial infarction 
Myocardial infarction, also known as heart attack, and stroke, also known as brain attack, 
are the two most deadly forms of CVD, both frequently caused by blood vessel ischaemia 
following atherosclerosis, which is a pathological process characterised by the formation of 
fatty, atherosclerotic plaques (or thrombi) that restrict, and potentially block, the flow of 
blood through arteries [8-12].  
Myocardial infarction is the leading cause of death worldwide causing 7.4 million deaths in 
2012 [1]. This is closely followed by stroke, the second leading cause of death worldwide, 
which resulted in 6.7 million deaths in 2012 [1]. The costs of these two diseases to the 
United States in 2010 were $109 billion and $54 billion [7], respectively, while in the 
European Union in 2012 the costs were €60 billion ($79 billion) and €38 billion ($50 
billion), respectively [5]. 
 
1.2.1 Aetiology of stroke 
The primary cause of stroke is ischaemia where the blood supply to the brain becomes 
blocked following thrombus formation. Ischaemia accounts for 85% of stroke cases, while 
the remaining 15% of cases are caused by haemorrhagic stroke following blood vessel 
rupture [13]. The animal model of stroke studied in this thesis is an ischaemic injury model, 
therefore only ischaemic stroke will be described in the rest of this chapter. 
 
1.2.2 Pathophysiology of ischaemic stroke 
A series of cellular and molecular processes follows the blockage of a blood vessel, known 
as the ischaemic cascade [14]. In stroke, this cascade leads to neuronal death and ultimately 
brain damage. In the central region of the tissue normally perfused by the blocked vessel, 
known as the ischaemic core, the primary mechanism of cell death is energy failure. In the 
absence of oxygen and glucose, the neurons cannot generate the adenosine triphosphate 
(ATP) required by the sodium-potassium pumps to maintain neuronal membrane 
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homeostasis. As a result, cytoplasmic accumulation of sodium and calcium ions leads to 
neuronal swelling, loss of membrane integrity and cell dissolution.  
Surrounding the ischaemic core is the ischaemic penumbra. In this region perfusion is 
reduced and tissue is hypoxic, but not to the extent that ATP generation is completely 
inhibited. Neurons in the penumbra may remain viable for extended periods (hours) 
following ischaemic injury, but become vulnerable to numerous pathogenic events which 
may disrupt their weak metabolic balance, described at length by Lo et al (2003) and 
Moskowitz et al. (2010) [15, 16]. One major factor contributing to penumbra cell death is 
excitotoxicity where an overabundance of glutamate accumulates in the extracellular space 
over stimulating α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-
methyl-D-aspartate (NMDA) receptors, thus enhancing the influx of sodium, calcium and 
water. Without intervention, the ischaemic core will gradually increase in size and become 
irreversibly infarcted as the neurons in the ischaemic penumbra succumb to the effects of 
reduced perfusion. 
 
1.2.3 Stroke in the clinical setting – imaging and treatment 
Rapid diagnosis and treatment of acute stroke is crucial for patient outcome. The National 
Institute for Health and Care Excellence (NICE) guidelines state that a patient with acute 
stroke should be imaged immediately [17]. Stroke is routinely imaged using magnetic 
resonance imaging (MRI) and X-ray computed tomography (CT). CT is the more widely 
used modality for immediate diagnosis owing to faster scan times [18], however, MRI is the 
most widely used for assessment of the ischaemic penumbra [19]. The dual use of diffusion 
weighted imaging (DWI) and perfusion weighted imaging (PWI) in MRI of stroke patients 
has led to the creation of the so called ‘mismatch’ concept for identifying tissue at risk of 
infarction [20]. PWI is a marker for tissue with reduced blood flow [21], while DWI detects 
the restricted motion of water molecules [22], which approximately correlates with infarct 
tissue (although DWI lesions can also contain regions of benign oligemia [23]). Both scans 
are run in series and the spatial difference between the two scans, known as the diffusion-
perfusion mismatch, corresponds to the ischaemic penumbra (Figure 1.1). 
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Figure 1.1: Imaging the ischaemic penumbra in acute stroke with MRI (image adapted from [19]). (a) 
DWI hyperintensity (red arrow) corresponds to the infarct core. (b) PWI shows regions of reduced 
blood flow (red region). (c) Subtracting the DWI infarct region (blue) from the PWI produces a 
diffusion-perfusion mismatch image, showing ischaemic penumbra. The red region now corresponds 
to potentially salvageable tissue. 
 
Treatment of acute stroke aims to restore blood flow to the ischaemic region. The primary 
method of intervention is thrombolysis, using tissue plasminogen activator (t-PA) drugs to 
remove the occluding embolism. NICE recommends that t-PA must be administered within 
4.5 hours of the onset of stroke symptoms for effective treatment, otherwise the benefits are 
limited. The majority of patients reach hospital 12-24 hours following a stroke and as a 
result less than 5% receive thrombolytic treatment [24]. Treatment for patients who miss the 
opportunity of thrombolysis includes administration of aspirin and, if appropriate, 
anticoagulants to reduce the possibility of further blood clot formation. 
 
1.2.4 Rat models of stroke – middle cerebral artery occlusion surgery 
The experiments in this thesis are all conducted on a pre-clinical 9.4T MRI scanner, often 
involving imaging of rodents. Animal models of stroke are used to provide a better 
understanding of the pathological mechanisms underlying the disease and for the 
development of treatments which can be translated into patients.  
In this thesis, a rat model of ischaemic stroke is used. In this model, surgery is performed – 
by Mrs Valerie Taylor, typically 24-48 hours prior to imaging – with the aim of generating a 
reproducible infarct and ischaemic region. Surgery is conducted in a controlled, sterile 
surgical suite with aseptic operating practices. Anaesthesia is induced and then maintained in 
the rats using 4% and 2% isoflurane in 1.5 l/min oxygen, respectively. Neck and throat 
regions are shaved and skin is disinfected using Betadine. The animal is placed supine on a 
heating mat to maintain physiological body temperature, which is monitored via rectal 
probe. Using a microscope, a ventral midline incision is performed and superficial tissue is 
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dissected. Further careful dissection is performed to expose the common carotid artery 
(CCA), external carotid artery (ECA) and internal carotid artery (ICA). 
Figure 1.2 shows a schematic of the arterial vasculature supplying a rat brain illustrating 
how the middle cerebral artery (MCA) is occluded to induce a stroke. Two loops of suture 
are tied around the CCA. One loop is tightened to prevent unwanted blood flow during 
surgery, while the second loop is left loose before tightening later on. After a small incision 
in the CCA, a 2.2-3.0 cm length of silicone rubber-coated monofilament (4-0 Doccol) is 
inserted into the CCA and pushed to the origin of the MCA. As visualisation of the 
monofilament inside the vasculature is not possible, a small mark on the monofilament 
indicates insertion depth, which is used to determine successful middle cerebral artery 
occlusion (MCAO). Then the second loop of suture is tied to maintain monofilament 
position. After successful implantation of the monofilament, a microvascular clip is placed 
on the contralateral CCA to ensure ischaemia. For a 60 minute MCAO, the vascular clip is 
removed after 30 minutes, while the monofilament is left in place for the full 60 minutes. 
Finally, the monofilament is removed, all surgical openings are closed and the rat is 
recovered. 
 
Figure 1.2: Schematic of middle cerebral artery (MCA) occlusion in a rat brain to induce a stroke. A 
silicon monofilament (blue) attached to a thin wire is inserted into the common carotid artery (CCA) 
and pushed to the origin of the MCA. The monofilament is kept in place for 60 minutes. At the same 
time, a microvascular clip (grey) is placed on the contralateral CCA for 30 minutes. 
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1.2.5 Aetiology of myocardial infarction 
Myocardial infarction is the end result of coronary heart disease (CHD). Atherosclerosis 
within the coronary arteries can cause plaques to develop which rupture and form a 
thrombus, consequently blocking blood flow and causing myocyte cell death if the thrombus 
is not removed. Following ischaemia, myocyte cell death can take as little as 20 minutes, 
while extensive necrosis within the myocardium takes at least 2-4 hours, or longer [25]. The 
pathophysiology of myocardial infarction is described in greater detail in section 1.2.7, but 
first a knowledge of normal heart physiology is required to understand how heart disease 
affects cardiac function. 
 
1.2.6 The physiology of a normal heart 
The purpose of the heart is to pump blood through the circulatory system – a vast network of 
blood vessels linked to the heart and separated into two distinct circuits. The pulmonary 
circulatory system is responsible for transporting blood to the lungs for oxygenation before 
returning to the heart. The systemic circulatory system carries blood around the body, 
delivering oxygen and nutrients before returning deoxygenated blood to the heart. 
 
Figure 1.3: Illustration of the heart showing the direction of blood flow through the four chambers 
(image adapted from Wikipedia.org). Red shading represents oxygenated blood. Blue shading 
represents deoxygenated blood. 
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The heart itself is a muscular pump comprising four chambers, surrounded by muscular 
walls known as the myocardium. The chambers are two atria, responsible for collecting 
blood, and two ventricles, responsible for pumping blood (Figure 1.3). The right ventricle 
(RV) pumps deoxygenated blood to the lungs for oxygenation, which is returned to the heart 
via the left atrium (LA). The left ventricle (LV) then pumps the oxygenated blood around 
the systemic circulatory system before it is returned to the heart via the right atrium (RA). 
The LA and LV are separated by the mitral valve, while the RA and RV are separated by the 
tricuspid valve. The LV and aorta are separated by the aortic valve, while the RV and 
pulmonary artery are separated by the pulmonary valve. The valves function to prevent 
retrograde blood flow. 
Pumping of the heart is initiated by an electrical impulse which propagates through the heart 
causing a series of contractions, first in the atrial myocardium and then the ventricular 
myocardium. The contraction phase of the cardiac cycle is known as systole, where blood is 
pumped out of the heart. The filling phase of the heart is known as diastole, where blood 
enters the heart. The extremes of these phases are known as end systole (ES) and end 
diastole (ED), where the volume of blood in the ventricles is at its minimum and maximum, 
respectively. A schematic of changing blood volume throughout the cardiac cycle is 
illustrated in Figure 1.4. The performance of the heart can be assessed by imaging during the 
systolic and diastolic phases of the cardiac cycle for the diagnosis of heart failure, which will 
be discussed further in section 2.7.1. 
 
Figure 1.4: Schematic blood pool volume curve generated using standard CINE MRI (see section 2.7) 
in a normal mouse heart showing the systolic and diastolic filling phases of the cardiac cycle. 
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The electrical activity of the heart can be detected and recorded by electrocardiography 
(ECG), typically using electrodes attached to the surface of the skin. Electrical activity is 
measured as the changing voltage between the electrodes, which represents ionic exchange 
across the membranes of cardiomyocytes. A normal heart will demonstrate an ECG pattern 
similar to the schematic pictured in Figure 1.5. The P-wave represents atrial depolarization 
where the atria contract, the QRS-complex corresponds to ventricular depolarization where 
the ventricles contract (systole begins) and the T-wave represents repolarization of the 
ventricles causing them to relax (diastole begins). The QRS-complex has the largest change 
in voltage throughout the cardiac cycle, hence it is exploited and used for triggering in 
cardiac MRI (see section 2.6). 
The duration of time between consecutive QRS-complexes is known as the R-R interval, 
measured from R-wave to R-wave. The human heart rate is 50-100 beats per minute (bpm), 
whereas the mouse heart can be 10 times faster, between 450-700 beats per minute. Hence, 
the typical R-R interval duration for a mouse is approximately 90-130ms. 
 
 
Figure 1.5: Schematic of a QRS complex from an ECG trace of a normal heart. The P-wave 
represents atrial depolarisation which leads to atrial contraction. Together, the Q-, R- and S-waves 
form the QRS-complex, which represents the depolarisation of the ventricles and leads to ventricular 
contraction (systole). The T-wave represents repolarisation of the ventricles, leading to ventricular 
relaxation (diastole). 
 
1.2.7 Pathophysiology of myocardial infarction 
The mechanisms of cell death in myocardial infarction are similar to those in ischaemic 
stroke. Hypoxia causes myocytes to generate insufficient ATP for normal cellular 
homeostasis, which results in gradual cell death if blood flow is not restored quickly and 
cessation of contractile function [26]. On a macroscopic scale, ischaemia leads to what is 
known as the “wavefront phenomenon” of myocardial infarction [27]. This concept is 
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similar to the ischaemic penumbra in stroke, as it describes the evolution of an infarct region 
with time. Following the onset of ischaemia, the region of tissue distal to the occluded 
coronary artery suffers greatly reduced perfusion, or none at all. This region is now termed 
the area-at-risk (AAR), as shown in Figure 1.6. Here, cardiomyocytes begin to die within 20 
minutes, however, at such a short duration the damage is reversible. After a few hours, a 
necrotic core begins to form where cell damage cannot be reversed. Throughout this process, 
the non-infarcted tissue undergoing ischaemia can be salvaged if the occluded coronary 
artery is reperfused. However, without reperfusion the infarct region typically progresses 
from the endocardium towards the epicardium as the wavefront of necrosis gradually 
spreads through viable tissue within the AAR. 
 
Figure 1.6: Schematic illustrating the concept of area-at-risk (AAR) following myocardial infarction. 
(a) Coronary artery blockage (×) leads to myocardial hypoxia. The region of myocardium previously 
perfused by the occluded artery is defined as the AAR (orange + grey). Gradually, the AAR risk turns 
into infarcted tissue (grey). (b) If the occlusion remains, the entire AAR eventually becomes infarcted, 
however, (c) if the coronary artery is unblocked, the myocardium becomes reperfused, limiting the 
size of the infarct region. 
 
1.2.8 Myocardial infarction in the clinical setting – treatment and imaging 
Diagnosis of suspected myocardial infarction in the clinic is most often carried out by 
immediate assessment of ECG [25]. If a coronary artery is blocked, the ECG will often 
present with an elevated signal between the S- and T-waves of the recorded trace. This is 
known as STEMI: ST segment elevation in myocardial infarction [28]. Partial blockage of 
the coronary artery often results in an NSTEMI, non-ST segment elevation in myocardial 
infarction, ECG waveform. If acute STEMI is diagnosed, the patient is admitted for 
coronary reperfusion therapy as quickly as possible. 
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The majority of myocardial infarction imaging in an acute setting is carried out using 
ultrasound owing to its availability and real-time imaging capabilities. Cardiac MRI has 
excellent spatial resolution, it is the gold-standard technique for evaluating myocardial 
function and it offers strong temporal resolution, however, it is less commonly used for 
assessment of acute myocardial infarction because of its cost and cumbersome form [25]. 
Nonetheless, MRI offers a wealth of information about contractile performance (systolic and 
diastolic function – see section 2.7.1), myocardium morphology, myocardial tissue status, 
perfusion, metabolism, great vessel blood flow, and more [29], particularly in the healing 
phase following myocardial infarction. 
 
1.2.9 Mouse models of myocardial infarction 
Animal models of myocardial infarction play an important role in the prevention, diagnosis 
and development of therapeutics for human myocardial infarction [30]. In this thesis, two 
surgical models of myocardial infarction were used. The first model was a reperfused mouse 
model of myocardial infarction, where the left anterior descending (LAD) coronary artery 
was occluded for a fixed period of time (typically 15 to 90 minutes) before the ligature was 
released and the vessel was reperfused. The duration of occlusion ultimately determined the 
sizes of the infarct and salvageable tissue regions within the AAR. The second model was a 
permanent occlusion model of myocardial infarction. In this case, the ligature used to 
occlude the LAD was not released, therefore reperfusion was prevented. 
All reperfused surgeries in this thesis were carried out by Dr. Rachel Dongworth, while all 
permanent occlusion surgeries were conducted by Ms. Valerie Taylor. Surgery was 
conducted in a controlled, sterile surgical suite with aseptic operating practices. Anaesthesia 
was induced and maintained in the mice using isoflurane anaesthetic at 4% and 1.5%, 
respectively, in 1.5l/min. Analgesia was provided using a 0.1mg/kg intramuscular injection 
of buprenorphine at the beginning of surgery, and both 6- and 24-hours post-surgery. Mice 
were positioned supine on a heated operating table to maintain physiological body 
temperature, which was monitored using a rectal thermometer. ECG was recorded with 
subcutaneous electrodes (Powerlab coupled to Chart7 software, AD Instruments, USA). 
Artificial respiration was provided by a ventilator (MiniVent Type 845, Hugo Sachs 
Electronik, Germany) via oral intubation with a stroke volume of 200µL. Open-chest 
surgery was performed to gain access to the heart. The LAD was identified and a suture was 
placed under the vessel approximately 2mm below the tip of the left atrium. A custom-made 
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snare system, created using plastic tubing, was used to occlude the LAD, which was 
confirmed by ST-elevation on the ECG recording.  
At this point in the permanent occlusion model, the ligature was left in place, all surgical 
openings were closed and the animal was recovered. In the reperfused model, after 30 
minutes of occlusion the snare was released to allow for reperfusion of the myocardium. 
Reperfusion was confirmed by a return to baseline of the ECG signal. Then, the snare 
system was removed, but the suture was left in place for re-occlusion later on during 
histology. All surgical openings were closed and the animal was recovered. 
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1.3 Summary 
This chapter has discussed the medical implications and pertinent biology of the CVDs 
which will be studied in the rest of this thesis, namely stroke and myocardial infarction. The 
methodologies for creating animal models of these diseases were also described. In the next 
chapter, the theory behind MRI will be described, with particular reference to the physics 
and pulse sequences that will be used in the experimental chapters. 
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CHAPTER 2: MRI THEORY, BACKGROUND, PULSE 
SEQUENCES AND HARDWARE 
 
This chapter is intended to provide an overview of the physics behind the research presented 
in the rest of the thesis. The fundamental principles underlying the MRI signal and how an 
image is generated are outlined. Pulse sequence design is discussed with particular reference 
to the sequences used in the rest of the thesis, and finally, the hardware used for the studies 
in the following three experimental chapters is described.  
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2.1 Fundamental physics of MRI 
To understand the contents of this thesis, a working understanding of the physical principles 
underlying MRI is required. Many of the concepts in this chapter have been written about 
extensively in the past [1-4], so the present chapter will be only a brief discussion. This 
section (2.1) will start by describing the magnetic field generated by spinning charged 
nuclei. This will be followed by a discussion of magnetic spin states and how the spin 
density of a sample is changed when placed in a magnetic field. Next spin relaxation will be 
covered and finally image generation will be described. 
 
2.1.1 Nuclear spin and the Larmor frequency 
All subatomic particles, such as electrons, protons and neutrons can be visualised as 
spinning on an axis. They possess an intrinsic form of angular momentum known as spin. 
Atomic nuclei, behave as a single entity with collective nuclear spin, I. In 1924, Otto Stern 
and Walther Gerlach demonstrated that nuclear spin is quantised, rather than having a 
continuous distribution of possible momenta [5]. By passing silver atoms through a non-
uniform magnetic field, they observed that the atoms were deflected along one of two paths, 
implying that the atoms had two possible angular momentum states. 
MRI is primarily concerned with the hydrogen nucleus (a single proton) which is found 
abundantly throughout the body in water and fat. Quantum theory dictates that the angular 
momentum of atomic nuclei is constrained to 2I + 1 possible spin states. A single proton has 
spin = ½, therefore the hydrogen nucleus has two possible spin states (2.(½) + 1). In the 
presence of a magnetic field, the spin states correspond to alignment or anti-alignment of the 
protons with the magnetic field (Figure 2.1). The two spin states have different energy 
levels, separated by an energy difference ΔE = ħω. 
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Figure 2.1: Nuclei in the absence of a magnetic field (a) are randomly orientated and there is no net 
magnetisation. In the presence of a magnetic field (b), the nuclei occupy one of two possible spin 
states (c). The nuclei are either aligned or anti-aligned with the magnetic field. Overall there is an 
excess of nuclei which align with the magnetic field as it is energetically favourable. 
 
The magnetic field also causes the nuclei to precess around the direction of the magnetic 
field. This phenomenon was first described by Sir Joseph Larmor in the early 1900s [6]. He 
stated that nuclei with non-zero spin placed within a magnetic field will possess a magnetic 
moment and therefore experience a torque. The rate, or frequency (ω0), with which the 
nuclei precess around the magnetic field is determined by the nuclear gyromagnetic ratio (γ) 
and the strength of the magnetic field (B0), as described by the now ubiquitous Larmor 
equation: 
 𝜔 = 𝛾𝐵0 EQ 2.1 
For hydrogen protons γ(H) = 42.6 MHz/T. In a typical clinical 1.5T MRI scanner the 
precessional frequency, ω, of hydrogen protons is therefore approximately 64 MHz. In a 
9.4T pre-clinical scanner this increases to 400 MHz. Both values fall within the 
radiofrequency (RF) range of the electromagnetic spectrum, which is crucial for signal 
generation in MRI and will be discussed further in the next section. 
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2.1.2 Resonance, Excitation and Relaxation 
When nuclei are placed in a magnetic field, they either align or anti-align with the direction 
of the magnetic field. The population of these spin states is governed by the Boltzmann 
distribution: 
𝑁𝑢
𝑁𝑑
= 𝑒−
∆𝐸
𝑘𝑇  EQ 2.2 
where Nu and Nd represent the number of nuclei in the upper and lower spin states, 
respectively, ΔE is the energy difference between the two spin states, k is Boltzmann’s 
constant and T is temperature. As it is energetically favourable for the nuclei to occupy the 
lower energy state, a small excess align with the magnetic field. This imbalance in 
populations results in a small net magnetisation vector, M0, in the direction of B0 (Figure 
2.1b).  
In 1946, Felix Bloch and Edward Purcell discovered the phenomenon of nuclear magnetic 
resonance (NMR), whereby nuclei placed in a magnetic field absorb and re-emit RF energy 
at the resonance (Larmor) frequency of the nuclei when they transition between spin states. 
The pair measured – independently of each other – the precessional signals from water and 
paraffin molecules in a magnetic field [7, 8]. 
 
Figure 2.2: The excitation and relaxation of magnetisation in a reference frame rotating at the 
Larmor frequency. At equilibrium the spins (blue) are aligned or anti-aligned with the magnetic field. 
A 90° RF pulse excites the spins, causing them to gain phase coherence and the net magnetisation 
vector (red) to point in the transverse plane. During relaxation, the spins dephase and the net 
magnetisation vector recovers to the align with the magnetic field. 
 
In the absence of an RF pulse, the nuclei possess no phase coherence and the individual 
protons rotate out of phase with each other. The application of an RF pulse causes two 
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important phenomena to occur: firstly, phase coherence is induced between the nuclei 
causing them to rotate in synchrony, and secondly, the nuclei are excited to transition 
between the two spin states. Following the RF pulse, relaxation occurs where the nuclei 
simultaneously lose phase coherence (dephase) and transition between energy levels, 
returning to their original spin states and re-emitting RF pulses in the process. 
Diagrammatically, this process is most commonly conceptualised using a coordinate system 
which rotates at the Larmor frequency (Figure 2.2). Effectively, the observer sees an arc of 
motion as the net magnetisation is flipped into the x-y plane. After excitation, the nuclei both 
dephase and relax back to their original spin states. During this period, the transverse 
component of the magnetisation vector rotating in the x-y plane is detected by Faraday 
induction in the RF receiver coil of the MRI scanner. 
 
2.1.3 Mechanisms of Relaxation 
As mentioned in the previous section (2.1.2), the NMR phenomenon involves two forms of 
energetic relaxation following excitation of nuclei in a magnetic field. There are two main 
types known as T1 and T2 relaxation, which represent time constants inherent to different 
types of media or tissue type. 
T1, or spin-lattice relaxation, refers to the time taken for energised nuclei to return to their 
equilibrium state. T1 is also known as the longitudinal relaxation time because 
diagrammatically it represents the time taken for the net magnetisation vector, M0, to return 
to the B0 direction following excitation. The mechanism underlying T1 relaxation is thermal 
transferral of energy from the spins to their surrounding lattice. Nuclei residing within a 
sample are held in a lattice. The nuclei in the lattice are subject to vibrational and rotational 
motion, which creates a separate, complex, magnetic field. This magnetic field can share 
frequency and phase equal to the Larmor frequency of the nuclei, causing the nuclei to lose 
energy and return to the lower spin state. This is a thermal process because every transferral 
of energy causes a very small temperature rise in the sample. 
T2, or spin-spin relaxation, is a much more rapid process which refers to the time taken for 
coherent nuclei to dephase. T2 is also known as transverse relaxation because 
diagrammatically it represents the time for the transverse magnetisation vector Mxy to reduce 
to zero. The mechanism underlying T2 relaxation is the interaction of magnetic fields 
between neighbouring nuclei. For example, a proton aligned with B0 exerts a slightly higher 
magnetic field on its neighbour (B0 + ΔB) than an anti-aligned proton which exerts a 
magnetic field on its neighbour slightly weaker (B0 - ΔB) than the B0 field. As a result of the 
35 
 
Larmor equation (equation 2.1), nuclei residing closest to the aligned proton will have a 
faster precessional frequency. Similarly, nuclei in the vicinity of the anti-aligned proton will 
have a slower precessional frequency. Thus, the sample is no longer perfectly coherent and 
on a macroscopic scale the sample dephases. 
The rapidity of T2 relaxation is further increased by inhomogeneities which are present in all 
magnetic fields. Fluctuations in the magnetic field at different locations cause nuclei within 
a sample to precess at different frequencies, causing increased dephasing. This is also known 
as T2* relaxation, to distinguish it from T2 relaxation which is caused purely by spin-spin 
interactions. 
 
2.1.4 Spatial Encoding 
The signal received by an RF receiver originates from the entire sample. To construct an 
image, spatial information must be encoded into the signal. Spatial encoding is carried out 
by an additional set of resistive magnets within the MRI scanner known as the gradients. 
Three gradients (Gx, Gy, Gz) are used to encode spatial information in each Cartesian 
direction. Depending on the orientation of the desired imaging plane, the gradients perform 
one of three functions: slice selection, frequency encoding or phase encoding. 
For slice selection, a linear gradient (typically Gz) is applied to create a linear distribution of 
Larmor frequencies through the sample (B0 – Gz < ω0 < B0 + Gz). As resonance only occurs 
when the frequency of the incident RF pulse matches the Larmor frequency, the frequency 
of the RF pulse is specified to correspond to a slice of interest. By adjusting the centre 
frequency of the RF pulse different slices can be spatially encoded. The thickness of the 
slice can be controlled either by adjusting the bandwidth of the RF pulse, or by changing the 
strength of the slice selection gradient. 
In a similar manner, frequency encoding uses another linear gradient (typically Gx) so that 
the nuclei possess a Larmor frequency dependency in the direction of the frequency 
encoding gradient. Combined with the slice selection gradient, frequency encoding 
effectively enables spatial encoding of columns within the plane of interest. 
Finally, a phase encoding gradient (typically Gy) is required to spatially encode pixels. A 
third linear magnetic field is momentarily applied generating a linear phase dependency in 
the direction of the phase encode gradient. Nuclei either increase or decrease in phase 
depending on their location in the sample. After a series of phase encoding steps, typically of 
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incremental gradient strength, the multiple signals collected are spatially decoded to produce 
an image. 
 
2.1.5 Basic Pulse Sequences 
The ordering and timing of the RF pulses and gradients collectively forms a pulse sequence. 
‘Gradient echo’ and ‘spin echo’ are the main types of pulse sequence in MRI (Figure 2.3 and 
Figure 2.4). Many more complicated pulse sequences are built upon these basic sequences. 
The term ‘echo’ refers to the emission of energy generated following excitation and 
refocussing of a sample, which is measured by the RF receiver. 
 
Figure 2.3: Gradient echo pulse sequence timing diagram in the rotating frame showing the ordering 
of RF pulses and gradient waveforms and the corresponding effects on net spin magnetisation (red) 
and individual spins (blue). (1) Equilibrium: the net magnetisation aligns with the B0 field. (2) Spins 
excited by arbitrary α° RF pulse. (3) Spins dephased by gradients. (4) Spins rephased by readout 
gradient, Gx. (5) Signal echo coincides with centre of readout gradient. (6) Spins continue to dephase. 
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Figure 2.4: Spin echo pulse sequence timing diagram in the rotating frame showing the ordering of 
RF pulses and gradient waveforms and the corresponding effects on spin magnetisation (red) and 
individual spins (blue). (1) Equilibrium. (2) Following excitation (omitted), spins dephased by 
gradients. (3) Spin phase reversed by 180° refocusing pulse. (4) Spins rephased by readout gradient, 
Gx. (5) Signal echo coincides with centre of readout gradient. (6) Spins continue to dephase. 
 
Both sequences share common features, such as slice selection, frequency encoding and 
phase encoding gradients as well as a slice select RF pulse. The two pulse sequences are 
distinguished by different methods of echo formation. In a gradient echo sequence, the echo 
is formed by rephasing the spins with a gradient waveform of negative polarity. In a spin 
echo sequence, a second (180°) RF pulse is used to rephase the spins and form an echo. 
Waveform-by-waveform descriptions of both pulse sequences are given in Figure 2.3 and 
Figure 2.4. Both sequences are advantageous for different purposes. Gradient echo 
sequences are generally faster whereas spin echo sequences often have higher a signal-to-
noise ratio because the refocusing RF pulse rephases spins, lessening the T2* effect. 
 
2.1.6 k-space and image generation 
k-space is a 2D or 3D mathematical matrix in the spatial frequency domain which contains 
the digitised signals received during an MRI scan (Figure 2.5). In 2D k-space, each row of k-
space represents the time course of one digitally sampled echo at a single phase encode 
value. Typically, there may be 64-256 echoes, each acquired with a unique phase encoding 
value. Performing a two-dimensional fast Fourier transform (2D FFT) of k-space converts 
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the spatial frequency data into image data of complex type. The signal detected by the 
receiver during an MRI scan is an oscillating circularly polarised magnetic field which can 
be decomposed into real and imaginary components. Two different images can be generated: 
magnitude images are generated by taking the modulus of the real and imaginary data, 
according to equation 2.3, and phase images are generated by taking the complex argument 
of the data, according to equation 2.4. 
𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒 = √𝑅𝑒𝑎𝑙2 + 𝐼𝑚𝑎𝑔2 EQ 2.3 
𝑃ℎ𝑎𝑠𝑒 = 𝑎𝑟𝑐𝑡𝑎𝑛 (
𝐼𝑚𝑎𝑔
𝑅𝑒𝑎𝑙
) EQ 2.4 
Both image types have a different utility. Magnitude images are often used for structural 
visualisation, while phase images can contain information about magnetic field homogeneity 
or fluid flow. 
 
Figure 2.5: Converting echoes into images. Echoes are acquired at incremented phase encode 
gradient values. Echoes are stored in k-space following analogue to digital conversion. Magnitude 
and phase images are generated by manipulation of the real and imaginary parts of the signal. 
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2.2 Velocity-encoded MRI 
MRI is a versatile imaging modality because – in addition to its excellent soft tissue contrast 
and high resolution structural imaging capabilities – pulse sequences can be programmed to 
enable sensitivity to the direction of motion. Erwin Hahn was the first person to suggest 
using MRI to detect the motion of water in 1960 [9]. One decade later, the first measurement 
of blood velocity in humans was carried out [10]. Since then, velocity-encoded MRI has 
found many applications, primarily in vascular flow studies [11], but also cerebrospinal fluid 
flow studies [12] and myocardial tissue tracking [13]. 
MRI velocity-encoding is based on the principle that a sample (blood flow, contracting 
myocardium, etc.) gains phase proportional to its velocity when moving during a gradient 
waveform. The phase, ϕ, of nuclei in a magnetic field is the time integral of the Larmor 
frequency: 
𝜙 = ∫ 𝜔0 𝑑𝑡 EQ 2.5 
In the presence of an additional magnetic field gradient, Gx, this phase shift becomes: 
𝜙 = 𝛾 ∫(𝐵0 + 𝐺𝑥𝑥) 𝑑𝑡 EQ 2.6 
For moving nuclei with constant velocity, v, traveling in the x direction, this phase shift can 
be recast as: 
𝜙 = 𝛾 ∫(𝐵0 + 𝐺𝑥(𝑥 + 𝑣𝑡)) 𝑑𝑡 EQ 2.7 
Expanding this equation gives: 
𝜙 = 𝜙0 + 𝛾𝑥 ∫ 𝐺𝑥 𝑑𝑡 + 𝛾𝑣 ∫ 𝐺𝑥𝑡 𝑑𝑡 EQ 2.8 
where the first term corresponds to background phase from the main magnetic field, the 
second term corresponds to the zeroth magnetic moment, M0, or phase due to static spins, 
and the third term corresponds to the first magnetic moment, M1, or phase shift due to 
moving nuclei. 
There are various MR velocity-encoding strategies [14], but the most common methods use 
bipolar gradients pulses to encode phase into the moving spins. Figure 2.6 shows a typical 
40 
 
velocity-encoded gradient echo sequence. The sequence is run twice. For the second 
acquisition, the polarity of the bipolar gradients is reversed. Thus, the phase difference, Δϕ, 
between the two acquisitions can be calculated according to: 
∆𝜙 = 𝜙1 − 𝜙2 EQ 2.9 
As the background magnetic field and static nuclei contribute the same phase during both 
orientations of the bipolar gradients, it follows that the first two terms in equation 2.8 
contribute zero to the phase difference. Therefore, the phase shift due to moving nuclei with 
a positive bipolar gradient of duration, T, and amplitude, G, gives a phase shift: 
𝜙 = 𝛾 ∫ 𝐺𝑣𝑡 𝑑𝑡 =  
1
2
𝛾𝑣𝐺𝑇2
𝑇
0
 EQ 2.10 
For the repeat acquisition, the bipolar gradient amplitude is reversed to –G. Therefore, 
combining equations 2.9 and 2.10 gives: 
∆𝜙 = 𝛾𝑣∆𝑀1 EQ 2.11 
where ΔM1 = ½GT
2
 – (– ½GT2). Finally, the velocity encoding parameter, VENC, is defined 
as the velocity of a moving spin that produces a phase shift of π radians: 
𝜋 = 𝛾. 𝑉𝐸𝑁𝐶. ∆𝑀1 EQ 2.12 
In practice, VENC is a tuneable parameter on the MRI scanner chosen by the operator, 
therefore equation 2.12 is recast as: 
𝑉𝐸𝑁𝐶 =
𝜋
𝛾∆𝑀1
 EQ 2.13 
The VENC represents the maximum encodable velocity before aliasing occurs; speeds 
greater than VENC cause phase wrapping [2, 15]. 
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Figure 2.6: Velocity-encoded gradient echo pulse sequence. Flowing nuclei are sensitised by the 
bipolar gradients. The pulse sequence is run twice with the polarity of the velocity encoding gradients 
reversed (dashed lines) during the second acquisition. By calculating the phase difference between 
the two acquisitions, a velocity-encoded image can be generated. 
 
2.3 Inversion recovery MRI 
For many MRI studies, it can be advantageous to null the signal from specific regions of the 
image. Inversion recovery (IR) pulse sequences enable the suppression of signal from tissues 
of a specific T1, thus making the tissue appear hypointense in the final image. This can 
reveal and facilitate the delineation of certain tissues or structures that would otherwise be 
masked in conventional T1- or T2-weighted images. 
IR pulse sequences (Figure 2.7a) typically involve applying a 180° RF pulse before waiting 
a period of time – known as the inversion time, TI – when a 90° RF pulse is applied and the 
magnetisation is measured.  If the duration of TI is chosen appropriately, it is possible to 
suppress the signal from a specific tissue. Normally, the choice of TI requires some a priori 
knowledge of the tissue relaxation times within the sample. 
42 
 
 
Figure 2.7: (a) Inversion recovery pulse sequence diagram. A 180° RF pulse is added before the 
gradient echo readout to (b) invert the sample magnetisation which subsequently recovers according 
to T1 relaxation, passing through a null point corresponding to zero magnetisation at time, TI. 
 
Figure 2.7b shows a relaxation curve during an IR pulse sequence. The 180° RF pulse causes 
the sample magnetisation to flip along the z-axis so that the initial magnetisation is equal to 
–M0, equivalent to all the nuclei within a sample swapping spin states from aligned to anti-
aligned, and vice versa. Following this, the sample recovers according to T1 relaxation and 
grows exponentially according the equation: 
𝑀𝑧 = 𝑀0(1 − 2𝑒
−𝑇𝐼
𝑇𝑅 ) EQ 2.14 
In the heart, it is often necessary to null the myocardial signal to facilitate the delineation of 
infarcted regions (see section 2.7.3). In this case, TI is chosen so that the recovery curve of 
the myocardium passes through zero magnetisation (M0 = 0), at which point the 90° RF 
pulse and subsequent gradients play out. As blood has a longer T1 duration it recovers more 
slowly and has non-zero magnetisation at t = TI, resulting in a hyperintense blood pool 
surrounded by hypointense myocardium. 
 
2.4 Double inversion recovery MRI 
Double inversion recovery (DIR) MRI pulse sequences extend the concepts underlying IR 
sequences, discussed in the previous section. In a standard IR sequence, the 180° RF pulse is 
a global pulse which inverts the spins of the entire sample including those external to the 
imaging plane. In a DIR sequence, this global inversion pulse is immediately followed by a 
second, slice-selective 180° RF pulse (Figure 2.8), which returns the nuclei within the slice 
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back to equilibrium magnetisation. Following the double inversion, the magnetisation of the 
slice is allowed to recover according to T1 relaxation. 
DIR sequences exploit the fact that during T1 recovery the nulled blood external to the 
imaging slice flows into the slice, while simultaneously, any blood which experienced both 
inversion pulses exits the slice. In an ideal scenario, this exchange of equilibrated blood and 
recovering blood means that any signal remaining in the slice must be due to static tissue, 
which experienced both 180° RF pulses. For this reason, DIR sequences are often referred to 
as ‘black blood’ sequences because the blood has little or no signal. 
 
Figure 2.8: Double inversion recovery pulse sequence diagram and illustrations showing the effects 
of the inversion pulses on spin magnetisation in a flowing blood vessel surrounded by static tissue. (1) 
Global 180° RF pulse: the magnetisation of all spins is inverted. (2) Slice-selective 180° RF pulse 
(dashed line): spins within the slice are returned to equilibrium. (3) Blood null point, TI: equilibrated 
blood flows out of the slice and is replaced by inverted blood undergoing T1 recovery. TI is chosen to 
coincide with the null point of blood, so that there is no contribution to the signal from blood.  
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2.5 The challenges of cardiac MRI 
Cardiac imaging is a particularly challenging part of MRI due to various types of 
physiological motion which must be compensated for to produce artefact-free images. MRI 
sequences must be adjusted to account for respiratory and cardiac motion, as well as high 
velocity blood flow. These issues are exacerbated in pre-clinical imaging studies because 
rats, and mice in particular, have very fast heart rates of 330-480 and 450-700 beats per 
minute, respectively, compared to the human heart rate of 50-100 beats per minute. In mice 
these values translate to an RR-interval range of 90-150ms. Acquiring a static image of the 
heart within a single heartbeat is very difficult unless the number of phase encode lines is 
greatly reduced, therefore most cardiac sequences must be run over multiple heartbeats, 
often while accounting for respiratory motion at the same time. The following sections 
describe the theory underlying the basic cardiac MRI techniques used in the rest of the 
thesis. 
 
2.6 Physiological monitoring and gating in rodent cardiac MRI 
For artefact-free cardiac images, animal physiology must be monitored and MRI pulse 
sequences must be ‘gated’ or ‘triggered’ according to the recorded physiological traces. A 
gated acquisition is one in which specific components of a pulse sequence, such as an RF 
pulse or gradient waveform, are synchronised to occur in time with a particular 
physiological event, such as the QRS complex of an ECG trace. 
Commonly in pre-clinical imaging, ECG is measured using subcutaneously-inserted 
electrodes, which translate the electrical impulses of the heart into a continuous voltage 
waveform. Simultaneously, respiration motion is measured using a small pressure sensitive 
balloon placed underneath or on the abdomen of the mouse. In addition, body temperature 
and anaesthesia dose should also be monitored to keep the animal physiologically stable 
throughout the duration of the imaging session. Moreover, body temperature affects heart 
rate and parameters of cardiac function, and in turn gating, therefore it should be maintained 
at between 36.5-37°C for a consistent heart rate. Similarly, anaesthetic has a large impact on 
respiratory rate and even myocardial perfusion [16], therefore a constant dosage should be 
maintained as far as possible. 
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2.7 Cardiac CINE pulse sequences 
The most commonly used cardiac MRI sequence is a CINE sequence, shorthand for 
cinematic, which generates a succession of images – known as frames – throughout the 
cardiac cycle. The first in vivo CINE scan was carried out in rabbits in 1986 [17]. Since then, 
CINE imaging has become widely used in clinical settings for non-invasively assessing 
cardiac structure and function. In mice, standard CINE sequences generate in the region of 
15-30 frames per cardiac cycle. This gives a 4-8 millisecond temporal resolution, which is 
sufficient to quantify a host of systolic parameters, detailed further in section 2.7.2. 
A number of CINE pulse sequences exist based on different readout strategies including 
fast-spin echo, gradient echo and steady-state free precession. For pre-clinical imaging, 
CINE pulse sequences are commonly based on a spoiled gradient echo preparation, also 
known as a FLASH (fast low-angle shot) sequence. Two gating strategies are possible with 
CINE methods: either prospective or retrospective, which will be discussed in the rest of this 
section.  
 
Figure 2.9: Prospectively-gated spoiled gradient echo CINE pulse sequence diagram. The sequence 
is double-gated to the respiration and ECG traces. Dummy pulses occur during respiration breaths. 
During the quiescent respiration phases, the sequence is triggered by the R-wave. NF frames, 
typically 20, are acquired in a single scan. A single line of k-space per frame is acquired with each 
heartbeat. 
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Figure 2.9 shows a prospectively-gated spoiled gradient echo CINE pulse sequence diagram. 
Following R-wave detection, the sequence is repeated NF times (NF = number of frames, 
variable depending on the heart rate of the animal). Due to the high heart rate of mice, 
typically NF = 15-30 frames meaning that the repetition time is usually very short (TR = 5 
ms). In a single heartbeat, one line of k-space is acquired for each frame, therefore it takes 
128 or 256 heartbeats to acquire a single slice CINE, depending on resolution. The sequence 
is simultaneously respiration-gated such that data acquisition is disabled during breaths: the 
pulse sequence plays-out, however, no lines of k-space are acquired. Such repetitions of the 
sequence are referred to as dummy pulses and are used to maintain steady state 
magnetisation. Generally, CINE sequences are run with low flip-angle, slice-selective RF 
pulses (typically < 30° at 9.4T), which produces bright-blood contrast surrounded by darker 
myocardium. The RF pulse saturates the in-plane myocardium, whereas inflowing blood is 
unsaturated because it is unaffected by the RF pulse. The level of contrast between the blood 
pool and myocardium can be altered by changing the flip angle [18]. Higher flip angles 
cause greater saturation of the myocardium increasing the contrast, whereas very low flip 
angles (~5°) homogenise the signals of the blood pool and myocardium. 
 
 
Figure 2.10: Retrospectively-gated spoiled gradient echo CINE pulse sequence diagram. The 
sequence is run continuously without any gating. Typically, respiration, ECG and RF pulse 
timestamps are recorded and k-space is reconstructed offline by binning the RF pulses into the 
appropriate cardiac frames. 
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Figure 2.10 shows a retrospectively-gated spoiled gradient echo CINE pulse sequence 
diagram. In this case, the CINE pulse sequence is played continually. Cardiac and 
respiratory gating are performed offline after completion of data acquisition. Retrospective 
gating has a number of advantages. The entire cardiac cycle can be imaged including late 
diastole, which is not possible using a standard prospectively-gated method because the 
sequence must be stopped during diastole to prevent running into the next heartbeat. 
Furthermore, retrospective gating is useful in patients and animals with cardiac arrhythmias 
because lines of k-space can be accepted or rejected depending on the irregularity of certain 
heartbeats. 
In recent years, a variety of retrospective sorting strategies have emerged. Conventionally, 
cardiac and respiratory traces are recorded using ECG electrodes and respiratory bellows, as 
in prospective imaging, in parallel with recordings of the signal echo timestamps [19]. Once 
the acquisition is complete, k-space is sorted based on the timing of these events. This is the 
method illustrated by the pulse sequence in Figure 2.10. Alternatively, self-gated 
retrospective pulse sequences [20-22] acquire a 1-dimensional ‘navigator’ signal from a 
region which intersects different tissues experiencing both respiratory and cardiac motion. k-
space lines are then accepted or rejected, and sorted, based entirely on this signal which is 
modulated by cardiac and respiratory movement. The advantage of self-gating is that there is 
no requirement for ECG or respiratory monitoring. In a similar method, cardiac and 
respiratory motion can be extracted from the echo peak MR signal of an ungated radial 
acquisition [23] for retrospective reconstruction. Each strategy also has limitations. 
Retrospective-gating using ECG electrodes suffers from magnetic gradient interference [24], 
which can make the ECG signal very noisy, and electrode positioning can also be an issue. 
Self-gating strategies are also imperfect, as in pathological mouse models turbulent blood 
flow can cause poor periodicity in the navigator signal [25]. 
 
2.7.1 Images generated by a standard CINE protocol 
A routine CINE protocol will image the heart in three different orientations, as shown in 
Figure 2.11. When a patient or animal is placed in an MRI scanner, the heart lies obliquely 
in the chest relative to the imaging gradients. Therefore, cardiac imaging initially requires 
the acquisition of pilot scans to accurately determine the cardiac axes. After this, two long-
axis views of the heart are acquired with a CINE sequence. From this pair of images, a short-
axis CINE stack is acquired from the apex to the base of the heart. In a mouse heart, with 
1mm slice thickness, this typically corresponds to 9-12 slices for full heart coverage. 
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The 4-chamber CINE depicts the two ventricles, the two atria and the aorta. Chamber valves 
can also be observed depending on resolution. The 2-chamber CINE shows the left ventricle 
and left atrium. The short axis view shows the left ventricle and right ventricle, as well as the 
atria and great vessels in the higher slices. Standard spoiled gradient echo CINE scans have 
bright blood (hyperintense) which allows easy delineation of the blood pool against the 
darker, grey, myocardium. However, all views are affected by fast inflow artefacts to some 
extent, which cause signal dropout. 
 
Figure 2.11: CINE frames from a mouse heart in the three cardiac axes. Top row shows views at end 
diastole (ED). Bottom row shows views at end systole (ES). The 4-chamber long axis views show the 
left atria (LA), right atria (RA), left ventricle (LV) and right ventricle (RV). The 2-chamber long axis 
view shows the LA and LV. The 2-chamber short axis images show a mid-ventricle slice. 
 
2.7.2 CINE image analysis 
CINE images contain a wealth of information. Structural assessment of the great vessels, 
myocardial thickness and contractility can all be observed at a glance. However, more 
thorough, quantitative analysis of CINE images enables the assessment of a host of 
functional parameters, which help determine cardiac performance and health. 
Systolic cardiac parameters – which indicate the performance of the heart during the 
contracting phase of the cardiac cycle – are assessed by segmentation of the left ventricle 
endocardium and epicardium at two time points in the cardiac cycle: end diastole and end 
systole. In this thesis, semi-automatic segmentation was carried out using the software 
package Segment (Medviso, Sweden), unless stated otherwise. Figure 2.12 shows an 
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example of a segmented CINE stack. The software package applies an automatic 
segmentation algorithm to the images. If the automated segmentation is inaccurate, the user 
can correct the regions manually. Segmentation of the left ventricle endocardium in all ED 
slices gives end diastolic volume (EDV). Similarly, endocardial segmentation in all ES 
slices gives end systolic volume (ESV). From these two sets of measurements, various 
systolic parameters can be calculated, as detailed in Table 2.1. Additional segmentation of 
the epicardium enables calculation of left ventricular mass (LVM). The average of two 
epicardial measures at ED and ES, matched to within 2% error of each other, gives a final 
measure of LVM. 
 
Figure 2.12: Short-axis CINE stack segmentation of the left ventricle blood pool (red) and left 
ventricle epicardium (green) at end diastole for calculating systolic functional parameters. In the 
most basal slice (9), the segmentation intersects the ventricular and atrial tissue and blood. For 
analysis of functional parameters, the CINE stack is also segmented at end systole. 
 
Parameter Method of calculation Functional relevance 
Stroke volume (SV) ESV – EDV 
Volume of blood ejected from 
the LV within a heartbeat 
Ejection fraction (EF) SV/EDV × 100% 
Percentage of blood ejected from 
the LV within a heart beat 
Left ventricular mass (LVM) 
myocardial volume × 
1.05 g/ml [26] 
Mass of the left ventricular tissue 
Table 2.1: Cardiac systolic functional and morphological parameters, which can be determined by 
segmentation of standard CINE images. 
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2.7.3 Late gadolinium enhanced MRI 
Assessment of scar tissue size following myocardial infarction is widely visualised both 
clinically and pre-clinically using gadolinium-based contrast agents during MRI scans, such 
as gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA). Gadolinium contrast agents 
are non-targeted and therefore distribute passively throughout the blood and extracellular 
space [27]. In an infarcted region of myocardium, gadolinium contrast agent exhibits 
delayed accumulation and longer retention [28] due to decreased tissue perfusion and 
increased extracellular volume compared to healthy myocardium, as well as an increase in 
total accumulation due to tissue necrosis. This mismatch in kinetics between healthy and 
infarcted tissue is exploited for the purposes of late gadolinium enhancement (LGE) MRI. 
Gadolinium is a T1 shortening contrast agent, therefore the increased presence of contrast 
agent in regions of infarcted tissue causes a signal difference between healthy and infarcted 
tissue, allowing delineation of scar tissue and quantification of infarct volume.  
 
Figure 2.13: T1 relaxation of healthy and scar tissue in an IR late-gadolinium enhanced experiment. 
(a) 2-chamber short axis slice in a mouse heart showing nulled myocardium and hyperintense infarct 
tissue. (b) The gadolinium contrast agent preferentially accumulates in the infarct region, causing 
faster relaxation in the scar tissue. Images are generated at the null point of the healthy myocardium 
when the scar tissue has higher signal. 
 
In this thesis, all gadolinium-based myocardial infarction imaging is carried out using a 
multi-slice, IR late-gadolinium enhanced protocol, originally developed in CABI by Dr 
Anthony Price [29]. Firstly, Gd-DTPA is injected intraperitoneally 10 minutes prior to 
imaging. The imaging protocol consists of two pulse sequences. The first sequence is an 
inversion time sweep to determine the optimum value of TI required for nulling of the 
healthy myocardium and hyperintense signal in scar tissue (Figure 2.13). In mice at 9.4T, 
generally, TI = 300-400 ms. Following this, a multi-slice IR sequence with optimised TI is 
used to generate long-axis and short-axis images of the heart.  
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2.8 Experimental Hardware in CABI 
2.8.1 Pre-clinical MRI hardware 
All MRI experiments in this thesis were carried out on the Agilent 9.4T horizontal bore 
scanner (Agilent Technologies, Santa Clara, USA) in CABI (Figure 2.14) using either 
1000mT/m or 400mT/m gradient inserts, with internal diameters of 60mm and 120mm, 
respectively. The scanner software VNMRJ (versions 2.3A and 3.1) were used for data 
acquisition. Various different volume RF coils were used throughout the experiments with 
inner diameters of 26mm, 35mm, 39mm and 72mm (RAPID biomed, Ripmar, Germany). 
For most rat imaging studies, the 72mm volume RF coil was used for transmission with a 4-
channel phased array coil used in receive mode. 
 
Figure 2.14: (a) The Agilent 9.4T scanner in CABI and (b) a screenshot of the software, VNMRJ, used 
to control the scanner. 
 
Mice and rats were placed in a cradle which could be positioned in the centre of the MRI 
scanner bore (Figure 2.15). Generally, mice were positioned supine whereas rats were 
positioned prone. Animal body temperature was measured using a rectal probe. Temperature 
was regulated using a hot water system which pumped the water through tubes placed 
underneath and on top of the animal. Respiration was monitored using a neonatal apnoea pad 
taped to the abdomen of the animal. For some experiments, a three-lead electrode set was 
used for monitoring animal ECG. For gadolinium contrast agent-based experiments, an 
additional infusion line was placed in the cradle. 
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Figure 2.15: Animal cradles used for imaging (a) mice and (b) rats in the MRI scanner. A: 
anaesthetic nose cone, B: heated water tubes, C: respiration pad, D: rectal temperature probe, E: 
infusion line, F: three-lead subcutaneous ECG electrodes, G: ear bar holders, H: 4-channel phased 
array coil. 
 
Software designed by SA Instruments (Stony Brook, NY) was used to monitor animal 
temperature, respiration and ECG (Figure 2.16a). For most scans the software was also used 
to control respiration- and ECG-gating. For the retrospective CINE studies in Chapter 5, a 
Power1401 data logger (Cambridge Electronic Design, Cambridge, UK) was used in 
conjunction with Spike2 software (Cambridge Electronic Design, Cambridge, UK) for 
recording respiration, ECG and RF events during the scans (Figure 2.16b). More specific 
detail on Spike2 will be given in Chapter 5. 
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Figure 2.16: (a) SA Instruments animal monitoring software and (b) Spike2 software for recording 
physiological traces for retrospective image reconstruction. 
 
2.8.2 Pre-clinical ultrasound hardware 
All ultrasound imaging in this thesis (see Chapter 5) was carried out on a VisualSonics Vevo 
2100 (CA, USA) system (Figure 2.17) using a VisualSonics 550D 30 MHz transducer. 
Ultrasound was conducted by Dr Daniel Stuckey, a highly experienced ultrasound operator. 
Mice were positioned supine on a physiological monitoring platform which simultaneously 
regulated body temperature and measured respiration and ECG traces. Prior to imaging, hair 
removal cream (Veet, UK) was applied to the chest to reduce attenuation of ultrasound 
signal. 
 
Figure 2.17: The VisualSonics Vevo 2100 ultrasound scanner in CABI showing the animal platform 
(green), ultrasound probe and hardware to control the system. 
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2.8.3 Syringe pump 
A syringe pump (PHD 2000 Syringe Pump, Harvard Apparatus, Kent, UK) was used for a 
number experiments (Chapter 3) to drive water through a phantom for the purposes of 
measuring flow in the MRI scanner (Figure 2.18). The syringe pump console was positioned 
on a benchtop outside of the MRI scanner room. The syringe driver was positioned on a 
small platform inside the MRI scanner room. A 50ml syringe was filled with distilled water 
and connected to the flow phantom inside the scanner bore via plastic tubing. The console 
allowed the input of precise flow rates down to a minimum of 0.0001µL/hr. 
 
Figure 2.18: The syringe pump used to pass water through a flow phantom within the bore of the MRI 
scanner. 
.  
55 
 
2.9 Summary 
In this chapter, the MRI theory and physics underlying the rest of this thesis was described. 
This included discussion of the basic principles of nuclear magnetic resonance, spatial 
encoding, data acquisition and fundamental pulse sequence design. Finally, the experimental 
equipment used in the CABI laboratory was described. The following chapters contain the 
results of the research performed in this thesis. 
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CHAPTER 3: IMAGING EXTRACELLULAR AND 
INTERSTITIAL FLUID FLOW IN EXPERIMENTAL ANIMAL 
MODELS OF DISEASE WITH EXTRAVASCULAR 
CONVECTOGRAPHY MRI 
 
Extravascular convectography (EVAC) MRI is a novel imaging sequence designed to image 
the flow of extracellular fluid, including interstitial and cerebrospinal fluid. Following 
stroke, intracranial pressure rises causing changes in the extracellular fluid dynamics of the 
brain. The main objective of the work in this chapter was to use EVAC MRI to image and 
compare the extracellular fluid dynamics in the normal rat brain and a rat model of stroke. 
Working towards this aim, a number of validation studies were conducted including flow 
phantom experiments and some in vivo imaging of subcutaneous mouse tumours, where the 
interaction between interstitial fluid and the tissue microenvironment is relatively well-
understood. 
Parts of this chapter are contained in the paper: Imaging tumor interstitial fluid dynamics 
with MRI. Simon Walker-Samuel, Thomas Roberts, Rajiv Ramasawmy, Jake Burrell, S. 
Peter Johnson, Jack Wells, Bernard Siow, Simon Richardson, Miguel Gonçalves, Douglas 
Pendsé, Simon P. Robinson, R. Barbara Pedley, Mark F. Lythgoe (under review). 
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3.1 Introduction 
Stroke is the second largest cause of death worldwide behind heart disease [1]. In 2012, 6.7 
million people died of stroke worldwide. The primary cause of stroke is ischaemia, which 
accounts for 85% of cases [2], where the blood supply to the brain is blocked by a thrombus. 
A series of cellular and molecular processes following ischaemia (see section 1.2.2), known 
as the ischaemic cascade [3], leads to neuronal death and ultimately brain damage. 
Currently, MRI is widely used for the assessment of the ischaemic penumbra [4] using dual 
diffusion weighted imaging (DWI) [5] and perfusion weighted imaging (PWI) [6] scans, 
which generate contrast based on the movement of water molecules and the perfusion state 
of brain tissue, respectively (section 1.2.3). 
Recently in CABI, Dr Simon Walker-Samuel created an MRI pulse sequence for measuring 
extracellular fluid dynamics [7], known as extravascular convectography (EVAC) MRI. In 
this sequence, signal generation in phase contrast images comes from the flow of interstitial 
fluid molecules through the tissue microenvironment. The original application of the 
sequence was to image interstitial fluid flow in subcutaneous mouse tumours for the purpose 
of assessing the efficacy of anti-cancer drug delivery techniques. Walker-Samuel et al. 
showed that interstitial fluid pressure (IFP) maps – derived from interstitial fluid velocity 
measurements using EVAC – were strongly correlated with gold-standard, invasive, wick-
in-needle measures. This demonstrated the potential of EVAC as a non-invasive method for 
examining IFP, which is a highly important parameter in tumour microbiology. 
In stroke, oedema causes severe alterations in brain interstitial fluid and cerebrospinal fluid 
dynamics. Therefore, the overarching aim of the work in this chapter was to apply EVAC to 
stroke, to establish whether quantification of brain fluid dynamics could offer some 
interesting and useful pathological information, potentially beyond the information 
attainable using well-established DWI/PWI mismatch paradigms. 
It should be noted that some of the work by Walker-Samuel et al. fed into this chapter, and 
conversely some of the work in this chapter contributes to the wider development of the 
EVAC technique. Where work is not my own, but necessary for discussion, credit will be 
given to the appropriate author. 
In order to follow the experiments in this chapter, an understanding of the EVAC sequence 
is needed, which is discussed in the next section, 3.1.1. Section 3.2 discusses the aims and 
objectives of the experiments in this chapter, including a number of preliminary experiments 
carried out to validate and ensure the robustness of the EVAC sequence. Finally, the results 
are presented in section 3.4 and discussed in section 3.5. 
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3.1.1 The EVAC sequence 
The EVAC pulse sequence is designed to eliminate any MR signal contributions from blood, 
while velocity-encoding gradients sensitise moving water molecules. Therefore, the acquired 
signal comes from only tissue and interstitial fluid, and the resulting phase contrast 
difference images are proportional to interstitial fluid flow. 
 
Figure 3.1: The EVAC pulse sequence. The sequence is based on a gradient echo readout containing 
velocity-encoding bipolar gradients. A double inversion preparation precedes the readout. The 
double inversion nulls any signal contribution from blood within the slice. The velocity-encoding 
bipolar gradients are sensitive to any moving nuclei. Therefore, any phase contrast signal caused by 
flow should originate from interstitial fluid, if imaging tissue. 
 
The pulse sequence (Figure 3.1) combines two MRI concepts discussed in chapter 2, 
specifically bipolar velocity-encoding gradients and a double inversion recovery (DIR) RF 
pulse preparation. The double inversion preparation consists of two 180° hyperbolic secant 
RF pulses. The first RF pulse is applied globally and causes inversion of the entire sample. 
The second RF pulse is slice selective and reverses the spins within the slice back to 
equilibrium magnetisation. After a recovery delay, trec, blood which experienced only the 
global inversion pulse recovers following T1 recovery to the blood null point. During this 
time, inverted blood also flows into the imaging slice while unsaturated blood flows out of 
the slice. In theory, the slice only contains saturated blood which does not contribute to the 
signal in the final image.  
At time, trec, the gradient echo readout is applied with the additional bipolar velocity-
encoding gradients played in either the readout, phase-encode or slice-select direction. The 
sequence is then repeated with the velocity-encoding gradients inverted. Stationary spins 
acquire zero net phase from the bipolar gradients. However, if the spins are moving in the 
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direction of the bipolar gradients while they play, the spins accumulate additional phase, 
linearly proportional to their velocity. In total, four scans are acquired to construct a single 
2D velocity-encoded image: one per spatial encoding direction and one per bipolar gradient 
polarity. 
 
3.2 Individual study outlines and aims 
The main objective of the work in this chapter was to use EVAC for imaging brain fluid 
dynamics in a rat stroke model. To this end, a number of preliminary studies were carried 
out to further validate the EVAC technique. This section provides background to each study 
and details the aim of each one. 
 
3.2.1 Phantom study 1 – establishing the slowest measureable fluid velocity in 
a flow phantom 
The vast majority of MRI phase contrast sequences are applied to imaging fast, bulk blood 
flow through vasculature, such as the great vessels of the heart [8-11] and the 
cerebrovascular arteries [12, 13]. Blood flow velocity in these vessels is typically anywhere 
between 1-150 cm/s. By comparison, interstitial fluid velocity is believed to be several 
orders of magnitude lower, on the order of microns per second [14]. As a consequence, the 
magnitude of the velocity-encoding gradients used in a phase contrast MRI sequence must 
be greatly increased for sensitivity to the slowest flows, according to equation 3.1: 
𝑉𝐸𝑁𝐶 =
𝜋
𝛾𝐺𝑇2
       EQ 3.1 
where VENC is maximum resolvable velocity, γ is the gyromagnetic ratio and G and T are 
the velocity-encoding gradient magnitude and duration, respectively. However, the 
magnitude of the velocity-encoding gradients is limited by the scanner hardware, hence they 
can only be increased to a certain strength. Furthermore, the maximum duration of the 
velocity-encoding gradients is also limited, as gradient duration is proportional to signal loss 
(due to spin dephasing). Therefore, using a water flow phantom, the aims of this study were 
to establish an optimum VENC for measuring slow flow and to infer the slowest 
measureable speed using the 9.4T MRI scanner in CABI. 
 
61 
 
3.2.2 Phantom study 2 – measuring and correcting the phase offset caused by 
electrical eddy currents 
The magnetic fields generated by the Gx, Gy and Gz imaging gradients in an MRI scanner 
induce electrical eddy currents within the magnet, the imaging gradients themselves and the 
RF coil, which in turn create small, unwanted magnetic fields that act to degrade image 
quality [15]. Electrical eddy currents arise according to Faraday’s law: 
𝜀 = −
𝑑𝛷𝑚
𝑑𝑡
        EQ 3.2 
where ε is the electromotive force, Φm is the magnetic flux and t is time. Equation 3.2 
implies that an electric field is generated whenever there is a change in magnetic flux. 
Gradient waveforms in an MRI pulse sequence require a finite ramp-up time, defined by the 
gradient slew rate, and it is during this period of changing magnetic field that electrical eddy 
currents are generated, as illustrated in Figure 3.2. A rising ramp generates a negative eddy 
current magnetic field, and vice versa. The net effect is that the shape of the gradient 
waveforms is imperfect. Phase contrast velocimetry measurements are particularly prone to 
electrical eddy current distortion, which leads to phase offset errors causing non-zero 
quantification of stationary substances and inaccurate measurement of flowing substances 
[16]. 
 
Figure 3.2: The effects of electrical eddy currents on distorting gradient waveforms in an MRI pulse 
sequence. 
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Previous vasculature blood flow studies using phase contrast MRI showed improved 
quantification following phase offset correction [16-18]. It was anticipated that electrical 
eddy currents may affect our measurements of extracellular fluid flow, therefore, a phantom 
experiment was performed to assess the effects of electrical eddy currents on our 9.4T MRI 
scanner. A previous study [17] demonstrated that the phase offset resulting from electrical 
eddy currents can be estimated by measuring the phase of a stationary sample. Thus, the aim 
of this study was to measure the phase offset caused by the velocity-encoding bipolar 
gradients within the EVAC sequence using an agar phantom and use this information to 
correct inaccuracies in MR measurements of a flow phantom. 
 
3.2.3 Mouse tumour study – Establishing the repeatability and reproducibility 
of EVAC in vivo and applying the phase offset correction method in vivo 
Prior to stroke imaging, mouse tumour imaging was carried out with EVAC to examine the 
in vivo repeatability and reproducibility of the EVAC sequence, which had not been carried 
out in previous developmental work by Walker-Samuel et al [7]. Subcutaneous tumours 
were chosen as a logical starting point for examining the robustness of the sequence in vivo 
because the interstitial fluid dynamics of the tumour microenvironment have been studied 
extensively [19-25]. Further to this, tumour imaging allowed the opportunity to investigate 
the effect of applying the eddy current correction method in vivo, which had also not been 
carried out previously. 
Therefore, the aims of this study were 1) to examine the within- and between-session 
variability of interstitial fluid measurements using EVAC and 2) to see how improvements 
in velocity measurements using the eddy current correction method compared with the 
inherent in vivo variability of the EVAC sequence. 
 
3.2.4 Stroke rat study – Imaging extracellular fluid dynamics in an 
experimental rat stroke model 
Finally EVAC was applied to imaging extracellular fluid dynamics (brain interstitial fluid 
and cerebrospinal fluid) in an experimental rat stroke model. Compared to our knowledge of 
tumour interstitial fluid dynamics, brain fluid dynamics remain relatively poorly understood 
despite more than 100 years of research [26, 27]. It is well-established that stroke induces 
cytotoxic oedema causing brain water content to increase rapidly, resulting in a significant 
elevation in intracranial pressure (ICP) [28, 29]. Based on this knowledge, it was 
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hypothesised that brain fluid pressure gradients would form in the ipsilateral hemisphere of 
the stroke brain, potentially altering the brain fluid dynamics, as illustrated in Figure 3.3. 
Therefore, the aim of this experiment was to test this hypothesis by visualising the fluid 
dynamics in stroke rat brains using EVAC and compare with normal, healthily functioning 
brains. 
 
Figure 3.3: Illustration showing hypothesised fluid pressure gradients following stroke in a rat brain. 
Oedema (light blue) in the ipsilateral hemisphere of the brain causes an increase in intracranial 
pressure leading to the formation of pressure gradients which disrupt the flow of extravascular fluid 
in the brain.  
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3.3 Methods 
3.3.1 EVAC velocity map pipeline 
All EVAC velocity maps contained in the results section of this chapter were generated 
using the phase contrast reconstruction pipeline outlined below.  
Velocity-encoding in a single dimension requires two repetitions of the EVAC sequence, 
one per bipolar gradient polarity. Thus, two magnitude and two phase images are generated. 
Fluid velocity in one dimension, v, is proportional to the difference in the phase shift, Δϕ, 
induced in the spins by the two bipolar gradients given by: 
𝑣 =
∆𝜙
𝛾∆𝑀1
 EQ 3.3 
where γ is the proton gyromagnetic ratio (267.513 × 106 rad s-1 T-1) and ΔM1 is the 
difference in first order velocity gradient moments, as described in section 2.2. For in-plane 
2D measurements, x- and y-velocity components were encoded by the readout and phase 
encoding imaging gradients. Therefore, four phase contrast images were required to generate 
a single velocity map. Phase difference maps (Δϕ) were calculated according to Bernstein et 
al. (2004) [15]: 
∆𝜙 = 𝐴𝑇𝐴𝑁2 (𝐼𝑚 ∑
𝑍+𝑗𝑍−𝑗
∗
𝜎𝑗
2
𝑗
, 𝑅𝑒 ∑
𝑍+𝑗𝑍−𝑗
∗
𝜎𝑗
2
𝑗
) EQ 3.4 
where ATAN2 is the arctangent2 operator, Z+ is the complex image acquired with a positive-
negative polarity bipolar gradient (Z- is negative-positive polarity), index j corresponds to 
the jth receiver channel (if using a multichannel phased-array) and σj
2
 is the measured noise 
variance in the jth receiver. 
In practice, the measureable range of velocities is determined by the operator by tuning the 
change in first order gradient moment, ΔM1, according to the equation:  
𝑉𝐸𝑁𝐶 =
𝜋
𝛾∆𝑀1
 EQ 3.5 
The VENC value represents the maximum encodable speed before aliasing occurs. Speeds 
greater than VENC cause phase wrapping, therefore a trade-off is required: lowering the 
VENC increases the sensitivity of the velocity-encoding to slower flows, but increases the 
prospect of wrapping. Any flows that cause a phase change greater than ±2π cannot be 
unwrapped using the ATAN2 operator. 
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Figure 3.4: Schematic illustrating the pipeline for generating EVAC velocity maps. Data from flow 
phantom experiments are shown. Four phase contrast images are required for 2-dimensional 
velocity-encoding: one per bipolar gradient and one per gradient direction. Phase wrapping – 
regions that suddenly change from black to white, or vice versa – can be observed in the raw phase 
contrast images. The ATAN2 operator unwraps any phase wrapping. The Δϕ maps are combined and 
scaled to produce an EVAC velocity vector map. 
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3.3.2 In vivo MRI setup 
All in vivo studies were performed in accordance with the local ethical review panel, the UK 
Home Office Animals Scientific Procedures Act, 1986 and UKCCCR guidelines. For all in 
vivo experiments, mice and rats were monitored and imaged using the MRI equipment 
described in Chapter 2. Briefly, animals were anesthetised with 1.5-2.0% isoflurane in 2 
l/min O2 and positioned in a cradle which could be positioned in the middle of the scanner 
bore. Temperature was monitored and maintained at physiological temperature. Respiration 
was monitored using a neonatal apnea pad. Mouse imaging was conducted using 1000mT/m 
gradient inserts and a 39mm volume RF coil (RAPID). Rat imaging was conducted using 
400 mT/m gradients and a 72mm volume RF coil (RAPID) for transmission with a 4-
channel rat head phased-array coil (RAPID) for reception. 
 
3.3.3 Phantom study 1 – establishing the slowest measureable fluid velocity in 
a flow phantom 
In this study, a custom-built flow phantom was constructed out of a 5ml syringe (internal 
diameter 12.06mm) and rubber tubing connected to a PHD 2000 Syringe Pump (Harvard 
Apparatus, UK). Water was pumped through the phantom at a range of pre-determined 
inflow rates (0.069 to 3.43 ml/min, equivalent to theoretical peak fluid velocities in the 
range: 10µm/s to 500µm/s) according to: 
𝐹 =
𝐴𝑣𝑝
2
 EQ 3.6 
where F is in the inflow rate on the syringe pump, A is the cross-sectional area of the 
phantom and vp is the peak velocity assuming laminar flow. For each flow rate, EVAC was 
used to measure the fluid velocity inside the phantom. The double inversion recovery 
preparation in the EVAC sequence was switched off to save time since nulling was not 
required. Surfactant was used to minimise the formation of air bubbles inside the phantom 
which could cause susceptibility artefacts.  
Imaging was carried out using a 26mm volume RF coil (Rapid MR International, Ohio, US). 
The phantom was positioned in the isocentre of the scanner and was encased in paper towel 
to minimise any bulk motion caused by imaging gradients. 
EVAC scans: The double inversion preparation was switched-off. Therefore, the single-slice 
gradient echo readout was acquired with the following parameters: TR = 250 ms, TE = 3ms, 
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flip angle = 30°, averages = 1, slice thickness = 1 mm, FOV = 30mm
2
, matrix size = 128
2
. 
The gradient amplitude, G0, and gradient duration, Δt, were varied to establish the optimum 
VENC for maximum flow sensitivity whilst retaining sufficient signal for imaging. 
Statistics: Regression analysis was performed to assess the relationship between pump 
inflow rate and measuring velocity. Statistical significance was assigned at p < 0.05. 
 
3.3.4 Phantom study 2 – measuring and correcting the phase offset caused by 
electrical eddy currents 
In this study, the effects of electrical eddy currents on phase measurements were 
investigated. An agar phantom was created using 1% agarose powder dissolved in distilled 
water, which was left to set within a 50ml centrifuge tube. A 39mm volume RF coil (Rapid 
MR International, Ohio, US) was used for imaging. The agar phantom was imaged using the 
EVAC sequence. Immediately after this, the agar phantom was removed and replaced with 
the flow phantom described in the previous section (3.3.3). The flow phantom was driven at 
a range of inflow rates (0.069 to 1.71 ml/min) using the syringe pump and imaged with 
EVAC, maintaining exactly the same pulse sequence parameters that were used to image the 
agar phantom, to ensure consistent gradient waveform shapes. 
EVAC scans: The double inversion preparation was switched-off. Therefore, the single-slice 
gradient echo readout was acquired with the following parameters: TR = 250 ms, TE = 3ms, 
flip angle = 30°, averages = 1, slice thickness = 1 mm, FOV = 30mm
2
, matrix size = 128
2
. 
The VENC was set to 0.2cm/s (gradient amplitude, G0 = 30 G/cm; gradient duration, Δt = 3 
ms). 
Image analysis: All images were reconstructed according to the velocity map pipeline 
outlined in section 3.3.1, with one additional step. To estimate the phase offset due to 
electrical eddy currents in the EVAC sequence, the phase data in the agar phantom image 
was subtracted on a pixel-wise basis from the phase data in the flow phantom images [17, 
30, 31] according to the following equation: 
𝜙𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 = 𝜙𝑓𝑙𝑜𝑤 𝑝ℎ𝑎𝑛𝑡𝑜𝑚 − 𝜙𝑎𝑔𝑎𝑟 𝑝ℎ𝑎𝑛𝑡𝑜𝑚  EQ 3.7 
where ϕ represents the phase of a pixel in the flow phantom and agar phantom images. 
Repeatability and reproducibility study: To establish how much within-session and between-
session variability there was in the EVAC measurements, both with and without the phase 
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offset correct, the flow phantom was imaged multiple times. For repeatability analysis, the 
flow phantom was imaged three times at each inflow rate on the same day. For 
reproducibility analysis, a single trial of the flow phantom experiment was repeated five 
times over the course of six months. 
Statistics: Regression analysis was performed to assess the relationship between pump 
inflow rate and measuring velocity. The coefficient of determination (r
2
) was used to 
compare the accuracy of phase corrected and phase uncorrected velocity measurements. 
 
3.3.5 Mouse tumour study – Imaging interstitial fluid dynamics in an 
experimental mouse tumour model 
Following the flow phantom studies, a cohort of mice with subcutaneous tumours was 
imaged to establish the in vivo repeatability and reproducibility of the EVAC sequence. As 
part of the study, the electrical eddy current phase offset correction method described in the 
previous section (3.3.4) was also applied in vivo to examine how it affected measures of 
interstitial fluid flow. 
Animal preparation: Female MF1 nu/nu mice (n = 4) were injected subcutaneously into the 
right flank with 5×10
6
 LS174T human colorectal carcinoma cells. Injections were carried out 
by Dr Sean Peter Johnson. 
Imaging preparation: Following a minimum 10 days of tumour growth, mice were ready for 
imaging. All mice were anaesthetised and animal physiology was monitored and maintained. 
Imaging was conducted using a 39mm volume RF coil. Manual shimming of the magnetic 
field was conducted using a local shim voxel located in the subcutaneous tumour. Typical 
linewidths achieved following shimming were between 30 and 70Hz. 
A set of multi-slice fast spin echo images, which covered the entire tumour volume, were 
used to pilot to the correct location and orientation within the tumour. The final, ideal slice 
projection through the tumour was a coronal slice which covered the largest possible extent 
of the tumour. This slice was used for positioning of the subsequent EVAC scans. 
EVAC scans: The double inversion recovery preparation consisted of two hyperbolic secant 
pulses with thicknesses of 200mm (global) and 3mm (slice-selective). The T1 of blood was 
taken to be 1900ms at 9.4T, based on measurements in a previous study [32]. Hence, trec was 
set to 1317ms according to the relationship trec = ln(2)× T1,blood. The VENC was set to 
0.2cm/s (gradient amplitude, G0 = 30 G/cm; gradient duration, Δt = 3 ms). The single-slice 
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gradient echo readout was acquired with the following parameters: TR = 3000 ms, TE = 3ms, 
flip angle = 30°, averages = 1, slice thickness = 1 mm, FOV = 30mm
2
, matrix size = 128
2
. 
EVAC blood nulling scan: To investigate the blood nulling capability of the EVAC sequence 
in the tumours, a further scan was acquired with the double inversion preparation switched 
off, while keeping all other parameters identical. The difference between two images with 
and without the double inversion preparation gave an estimate of the fractional blood 
volume within the tumour, according to the following equation: 
𝑉𝐵 =
𝑆𝑛𝑜𝑛−𝑛𝑢𝑙𝑙𝑒𝑑 − 𝑆𝑛𝑢𝑙𝑙𝑒𝑑
𝑆𝑛𝑜𝑛−𝑛𝑢𝑙𝑙𝑒𝑑
 EQ 3.8 
where VB is the fractional blood volume and S is the magnitude signal in the non-nulled (no 
DIR) and nulled (with DIR) images. 
Repeatability and reproducibility study design: The tumour mice were studied over the 
course of two days, for the purposes of repeatability and reproducibility analysis. Therefore, 
all animals were imaged with the following protocol: 
Day 1: 
– Animal setup and scanner calibration (10-15 minutes) 
– Tumour piloting using multi-slice fast spin echo scans (10 minutes) 
– 3 × consecutive EVAC scans (60 minutes) 
– 1 × non-nulled EVAC scan (20 minutes) 
– Remove and recover animal (5 minutes) 
Day 2: 
– Animal setup and scanner calibration (10-15 minutes) 
– Tumour piloting using multi-slice fast spin echo scans (10 minutes) 
– 3 × consecutive EVAC scans (60 minutes) 
– 1 × non-nulled EVAC scan (20 minutes) 
– Remove and recover animal (5 minutes) 
Phase offset correction study design: The phase offset correction method devised during the 
flow phantom experiments was applied in vivo. A separate cohort of female MF1 nu/nu mice 
(n = 6) with subcutaneous tumours were imaged with the following protocol:  
– Animal setup and scanner calibration (10-15 minutes) 
– Tumour piloting using multi-slice fast spin echo scans (10 minutes) 
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– 1 × EVAC scan (20 minutes) 
– 1 × non-nulled EVAC scan (20 minutes) 
– Remove and recover animal (5 minutes) 
– Replace animal with agar phantom (5 minutes) 
– 1 × EVAC scan using identical parameters and slice profile (20 minutes) 
Statistics: Box-whisker and Bland-Altman plots were used to assess repeatability and 
reproducibility of EVAC velocity measurements in the tumours; Mann-Whitney-U tests 
were used to test for statistical significance. A Wilcoxon paired rank test was used to test the 
statistical significance of velocity measurements before and after phase offset correction. In 
all cases, statistical significance was assigned at p < 0.05. 
 
3.3.6 Stroke rat study – Imaging extracellular fluid dynamics in an 
experimental rat stroke model 
In this study, 3 normal rats and 3 stroke rats (male, Sprague-Dawley) were scanned using 
EVAC to study extracellular fluid dynamics in the brain, along with a host of other common 
stroke imaging sequences for comparison. 
Animal preparation: Surgeries were carried out by Mrs. Valerie Taylor. Ischaemic strokes 
were induced in three rats as described in section 1.2.4. In brief, stroke rats were 
anaesthetised using 2-2.5% isoflurane in oxygen. Core body temperature was monitored 
with a rectal temperature probe and maintained with a heating pad. Ischaemic stroke was 
induced by simultaneous surgical occlusion of the middle cerebral artery using a silicone 
rubber-coated monofilament nylon suture (Doccol) and clamped ligation of the contralateral 
common carotid artery. After 30 minutes, the clamp on the contralateral common carotid 
artery was released. After a further 30 minutes, the filament occluding the middle cerebral 
artery occlusion was removed to permit reperfusion. 
Imaging preparation: Stroke rats were imaged 24 hours post-surgery. All rats were 
anaesthetised and animal physiology was monitored and maintained. Ear bars were used to 
minimise any bulk motion due to respiration. Imaging was conducted using a 72mm volume 
RF coil with a 4-channel rat head phased-array coil. Manual shimming of the magnetic field 
was conducted using a local shim voxel located in the rat brain. Typical linewidths achieved 
following manual shimming were between 30 and 50Hz. A multi-slice axial pilot scan was 
used to define the slice of interest for EVAC. A mid-brain slice with minimally-sized air 
pockets below the brain was chosen to lessen susceptibility artefacts. 
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EVAC scans: The double inversion recovery preparation consisted of two hyperbolic secant 
pulses with thicknesses of 200mm (global) and 3mm (slice-selective). The T1 of blood was 
taken to be 1900ms at 9.4T, based on measurements in a previous study [32]. Hence, trec was 
set to 1317ms according to the relationship trec = ln(2)× T1,blood. The VENC was set to 
0.2cm/s (gradient amplitude, G0 = 30 G/cm; gradient duration, Δt = 3 ms). The single-slice 
gradient echo readout was acquired with the following parameters: TR = 3000 ms, TE = 3ms, 
flip angle = 30°, averages = 1, slice thickness = 1 mm, FOV = 30mm
2
, matrix size = 128
2
. 
EVAC blood nulling scan: To investigate the blood nulling capability of the EVAC sequence 
in the rat brain, a further scan was acquired with the double inversion preparation switched 
off, while keeping all other parameters identical. The difference between two images with 
and without the double inversion preparation gave an estimate of nulling efficiency, as 
described in the previous section (3.3.5), according to equation 3.8. 
T2-weighted fast spin echo scans: A multi-slice T2-weighted FSEMS sequence was acquired 
with the following parameters: TR = 4000 ms, ETE/ESP/ETL = 48/12/8 ms, k0 = 4, averages 
= 3, slice thickness = 1mm, FOV = 30 mm
2
, data matrix = 256
2
. 
Perfusion weighted imaging: A multi-slice echo planar imaging flow-sensitive alternating 
inversion recovery arterial spin labelling (EPI FAIR ASL) sequence was acquired with the 
following parameters: TR = 4500ms, TE = 13.5ms, k0 = 8, shots = 4, repetitions = 10, slices 
= 5, slice thickness = 1mm, FOV = 30 mm
2
, data matrix = 64
2
, slice selective inversion pulse 
width = 12mm, TI = 1500ms. Repetitions were averaged together to generate the final 
perfusion weighted images. The middle slice was aligned to match the EVAC slice. 
Diffusion weighted scans: A multi-slice spin echo EPI DTI sequence was acquired with the 
following parameters: TR = 4000ms, TE = 25ms, k0 = 8, shots = 4, averages = 3, slices = 20, 
slice thickness = 1mm, FOV = 30 mm
2
, data matrix = 64
2
. Diffusion gradients were applied 
in 3 directions with the following parameters: amplitude = 19.7 G/cm, duration = 6 ms, 
Separation = 12 ms, b-value = 1030.5 s/mm
2
. In addition, a single unweighted B0 image was 
acquired. 
Histology: Following imaging, rats were sacrificed. Whole brains were extracted and 
sectioned into 10-14 1mm coronal slices using a McIlwain tissue cutter. Slices were 
immersed in 2,3,5-triphenylterazoliumchloride (TTC) at 37°C for staining. TTC was drained 
and slices were immersed in 4% paraformaldehyde (PFA) for 30 minutes. Excess PFA was 
removed and then slices were scanned at 300 DPI resolution using a desktop scanner (Canon 
Pixma MX700). 
  
72 
 
Statistics: Mann-Whitney-U tests were used to test for statistical significance between 
measurements of the nulling ratio and mean interstitial fluid velocity in normal and stroke 
brains. Statistical significance was assigned at p < 0.05. 
 
3.4 Results 
3.4.1 Phantom study 1 – establishing the slowest measureable fluid velocity in 
a flow phantom 
The main aim of this study was to establish the slowest measureable fluid velocity in a flow 
phantom using the 9.4T MRI scanner in CABI. Figure 3.5 shows the central component of 
the custom-built flow phantom, which was placed inside the RF coil and MRI scanner. The 
flow phantom was constructed using a 5ml syringe connected via rubber tubing to a tuneable 
pump. Distilled water was driven through the flow phantom into a water bath situated at the 
rear of the scanner bore. 
 
Figure 3.5: Photograph of the custom-built flow phantom. The phantom was constructed using a 5ml 
syringe. Water was driven (in the direction of the black arrow) by a syringe pump via rubber tubing 
through the phantom and into a water reservoir at the rear of the MRI scanner. The dotted line 
represents the approximate location of the imaging slice. 
 
First, the flow phantom was imaged at a range of VENC values to examine the effects of 
increasing the magnitude and duration of the bipolar gradients on the signal loss. Figure 3.6 
shows coronal slices through the flow phantom, where the hyperintense signal comes from 
the water. A small collection of hypointense air bubbles can be seen along the left edge of 
the flow phantom. 
The duration, T, of the bipolar gradients had a greater effect on signal loss than the size of 
the bipolar gradients, as expected, due to the inverse-square relationship between VENC and 
T (Equation 3.1). Scanner hardware constraints meant that the magnitude of the bipolar 
gradients, G, could not be increased beyond approximately 60 G/cm. The water signal in the 
flow phantom was markedly noisier with bipolar gradient values greater than G = 30 G/cm 
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and T = 3ms. This was determined to be the optimum combination of parameters 
corresponding to VENC = 0.2cm/s. Averaging multiple EVAC acquisitions was investigated 
as a method for recovering signal loss, thereby permitting a lower VENC, however, the 
increased scan duration was prohibitive for in vivo imaging (> 20 minutes for a single slice). 
 
 
Figure 3.6: Schematic illustrating the effects of changing the magnitude (G) and duration (T) of the 
velocity-encoding bipolar gradients in the EVAC sequence. Numbers in brackets indicate (G, T). The 
velocity-encoding parameter, VENC, is inversely proportional to G and T. Hence, increasing the size 
of the bipolar gradients makes the sequence more sensitive to slower flow velocities. But, signal loss 
increases with increasing VENC. 
 
Water was passed through the flow phantom at a range of flow rates from 0 to 3.43 ml/min 
and imaged using EVAC (with the double inversion preparation switched off to save time). 
The velocity maps are shown in Figure 3.7. Every pixel in each plot contains a vector 
corresponding to the greatest component of fluid flow within that region. Streamlines (red) 
were generated and overlaid using the “streamslice” function in MATLAB, which connects 
the underlying velocity vectors to show bulk flow directionality. In Figure 3.7a, the air space 
outside the flow phantom has been retained in the image to demonstrate the appearance of 
noise in a velocity map. For clarity, this region has been segmented from subsequent images 
At flow rates higher than 0.069 ml/min, water flowed from the point of inflow towards the 
point of outflow (a-d). At 3.43ml/min water flow exhibited a laminar profile with the 
greatest flow in a central channel through the flow phantom (a). Towards the periphery of 
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the flow phantom the streamlines curl towards the plastic boundary indicating the effects of 
friction and turbulent flow. This effect was more pronounced at increasingly slow flow rates 
(b-d). At the slowest flow rate of 0.069 ml/min, the greatest component of flow was 
backwards (e). A similar flow pattern was observed when the syringe pump driving the 
water was switched off, suggesting the possibility of a systemic suction effect which 
overcame very slow flows, or that the noise floor had been reached. 
 
Figure 3.7: EVAC velocity maps showing measurements of water velocity through the flow phantom 
at variable flow rates. All maps were measured with the same VENC (=0.2cm/s). The streamlines in 
red connect the underlying velocity vectors showing the macroscopic flow patterns. The black box in 
(a) shows the region used for calculations of peak velocity, Vp. At faster flow rates, the flow profiles 
are laminar (a, b, c). As the fluid velocity decreased, turbulent effects became more apparent (c, d). 
At the slowest flow rate (e), 0.069 ml/min, the fluid appear to flow in the reverse direction. A similar 
pattern of backwards flow was also observed even with the pump switched off (f). 
 
Figure 3.8a shows 1-dimensional flow profiles taken across a central line in the flow 
phantom. Again, at the highest inflow rates the water exhibits a laminar flow profile. The 
peak flow velocity through the water phantom was determined at each flow rate by 
averaging the velocities in a central 6x6 pixel region within the centre of each image, as 
demonstrated by the black box in Figure 3.7a. A strong linear correlation (r
2
 = 0.98, p = 
0.0002) was observed between the inflow rate and measured peak velocity, as shown in 
Figure 3.8b. However, at the slowest inflow rate of 0.069 ml/min, or with the pump switched 
off, the peak velocity was higher than that measured with a faster flow rate of 0.34 ml/min, 
reflecting that the noise floor had been approached. 
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The slowest measureable velocity on the scanner was determined to be 44 ± 5 µm/s based on 
the velocity map of the slowest inflow rate which exhibited a forward flowing velocity 
pattern (0.34 ml/min, Figure 3.7d). 
 
Figure 3.8: (a) 1-dimensional laminar flow profiles across the flow phantom. (b) Flow rate plotted 
against the peak velocity, Vp, in the flow phantom measured using EVAC. Vp was calculated using a 
small 6x6 voxel region in the centre of each velocity map. Error bars corresponding to the standard 
deviation across the 6x6 voxel are too small for visualisation. There was a significant linear 
correlation between the inflow rate and measured peak velocities (r
2
 = 0.98, p = 0.0002). 
 
3.4.2 Phantom study 2 – measuring and correcting the phase offset caused by 
electrical eddy currents 
Electrical eddy currents created during a pulse sequence result in additional magnetic fields 
which alter the shape of the gradient waveforms, ultimately affecting the phase of the MRI 
signals. The aim of this study was to measure the phase offset resulting from these magnetic 
fields in a static agar phantom and then use this information to correct the phase offset in 
velocity-encoded MRI phase contrast data of a flow phantom. 
The EVAC velocity map phase offset correction process is demonstrated in Figure 3.9. All 
images were obtained using identical scan parameters (except for alternating the bipolar 
gradients) and slice locations to ensure eddy current effects were consistent between flow 
phantom and agar scans. The top row shows images from the flow phantom including the 
raw magnitude image (a) and two maps showing the difference in phase, Δϕ, between the 
bipolar gradients for each velocity-encoding direction (b, c). The bottom row shows the 
equivalent images taken in an agar phantom (d, e, f). Note, the agar phantom was 
deliberately made larger than the flow phantom and large enough to fill the majority of the 
RF coil so that the agar phantom always spatially overlapped with the flow phantom. All 
images are from a trial with a flow rate of 1.71 ml/min. With the bipolar gradients orientated 
in the readout direction (RO), a laminar gradient of phase change can be observed in the 
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phase difference image of the flow phantom (b). This is caused by the flowing water which 
accumulates phase as the bipolar gradients play out. The same profile is not observed in the 
agar phantom (e) as there is no flow. With the bipolar gradients orientated in the phase 
encode direction (PE), a subtle linear change in phase difference can be observed in the flow 
phantom (c), changing from negative phase on the left edge to positive phase on the right 
edge. This linear gradient represents a phase offset, which is not flow related as it is also 
observed in the static agar phantom (f). Combining the flow phantom phase difference maps 
according to Equation 3.1 produces a raw, uncorrected EVAC velocity map (g). By 
subtracting the agar phase difference images from the flow phantom phase difference images 
before combining the phase difference maps results in a corrected EVAC velocity map (h). 
 
Figure 3.9: Phase offset determination in an agar phantom and application to correcting flow 
measurements in a flow phantom. The top row shows (a) magnitude and (b,c) phase difference images 
from a flow phantom. The bottom row shows (d) magnitude and (e,f) phase difference images from a 
an agar phantom. The uncorrected EVAC velocity map (g) is created by combining the two raw phase 
difference maps. The corrected EVAC velocity map (h) is created by subtracting the phase difference 
contributions measured in the agar phantom from the flow phantom measurements. 
 
The phase offset correction method was applied to a range of inflow rates from 0 to 1.71 
ml/min. The uncorrected and corrected EVAC velocity maps are shown in Figure 3.10. At 
the highest flow rate of 1.71 ml/min (a), the uncorrected velocity map exhibits a broadly 
laminar profile with distinct edge effects along the edges of the flow phantom. In the 
corrected image (e) the streamlines become more parallel with the edge of the flow phantom. 
At a flow rate of 0.34 ml/min, the flow pattern in the uncorrected image (b) is mostly 
forwards, however, at the outflow end of the image the streamlines have a larger component 
orientated backwards. In the corrected version (f) the streamlines flow forwards through the 
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entirety of the flow phantom. At the slowest flow rate of 0.069 ml/min (c), halfway through 
the phantom the streamlines flow backwards. In the corrected image (g), the largest 
component of flow is forwards, although, the streamlines are not parallel to the edge of the 
flow phantom. With the flow phantom switched off, the uncorrected image (d) shows 
apparent backwards flow, however, in the corrected image (h) the streamlines are not 
connected and there is no clear directionality to the flow pattern.  
 
Figure 3.10: Representative EVAC velocity maps of the flow before (uncorrected) and after 
(corrected) the electrical eddy current phase offset correction was applied. All maps were measured 
with the same VENC (=0.2cm/s). The streamlines in red connect the underlying velocity vectors 
showing the macroscopic flow patterns. At the faster flow rates, the electrical eddy current correction 
has the effect of straightening the streamlines towards the edge of the flow phantom (a,b), producing 
a more laminar flow profile than in the uncorrected images (e,f). At the slowest flow rate of 0.069 
ml/min, applying the eddy current correction produces a turbulent, but broadly forward flowing 
velocity pattern (g), unlike the uncorrected velocity map which has components of apparent 
backwards flow (c). With the pump switched off, the flow pattern in the corrected image is 
heterogeneous, with no clear component of flow (h), unlike the uncorrected image which appears to 
show backwards flow (d). 
 
To examine the stability of flow quantification using the phase offset correction method, 
repeatability and reproducibility experiments were undertaken. Figure 3.11a shows the 
repeatability of three consecutive flow phantom trials using multiple flow rates conducted on 
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the same day (within-session). Figure 3.11b shows the reproducibility of five separate flow 
phantom experiments conducted over the course of six months (between-session). In both 
plots, the dashed grey line represents the theoretical peak velocity in the centre of the flow 
phantom assuming a laminar flow profile (calculated according to equation 3.6). 
Repeatability of the EVAC sequence was very strong in both the uncorrected data and 
corrected data: both showed a strong, significant correlation between the inflow rate and the 
measured peak velocities (uncorrected: r
2
 = 0.98, p = < 0.0001 and corrected: r
2
 = 0.99, p 
< 0.0001). Reproducibility of the EVAC sequence showed greater variation, as evidenced by 
the much larger error bars in Figure 3.11. There was a marked difference between the 
measured peak velocities with and without the phase offset correction. The corrected data 
demonstrated a stronger, significant correlation (r
2
 = 0.87, p < 0.0001) than the uncorrected 
data (r
2
 = 0.61, p < 0.0001). Furthermore, the corrected data (blue curve) was more closely 
aligned to the theoretical data (dashed grey curve) compared to the uncorrected data (red 
curve). 
 
Figure 3.11: Repeatability and reproducibility of slow flow velocity measurements in a flow phantom 
using the EVAC sequence. (a) Repeatability values consist of three consecutive within-session 
measurements of the flow phantom. (b) Reproducibility values consist of five between-session 
measurements of the flow phantom on different days. The accuracy of velocity measurements was 
improved with the electrical eddy current phase offset correction (blue curve, r
2
 = 0.87) compared to 
the raw, uncorrected velocity data (red curve, r
2
 = 0.61). Dashed grey line represents the theoretical 
water flow velocity through the phantom. 
 
Overall, the phase offset correction had the effect of raising the measured peak velocity 
values at higher flow rates (≥ 0.34 ml/min) and lowering them at slower flow rates. The 
average peak velocity measured at a flow rate of 0.069 ml/min was 48 ± 29µm/s with the 
phase offset correction, compared to 78 ± 13µm/s without the phase offset correction. 
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3.4.3 Mouse tumour study – Imaging interstitial fluid dynamics in an 
experimental mouse tumour model 
The aim of this study was to examine the repeatability and reproducibility of the EVAC 
sequence in vivo, using an experimental subcutaneous mouse tumour model. Four mice were 
imaged across two days with three consecutive repeats of the EVAC sequence. 
 
 
Figure 3.12: Evaluating the blood nulling ratio in a subcutaneous mouse tumour. (a) Axial 
anatomical image showing the tumour imaging plane (red line). (b) Non-nulled image acquired with 
the double-inversion preparation in the EVAC sequence switched-off. (c) Blood nulled image 
acquired using the full EVAC sequence. The two magnitude images appear broadly the same. (d) The 
nulling ratio image reveals the difference in signal between the nulled and non-nulled images. A 
localised region of high nulling is visible on the left of the tumour, potentially corresponding to a 
large tumour blood vessel (red arrow). 
 
Firstly, the efficiency of the blood nulling double inversion preparation was investigated. 
Taking the ratio of a slice acquired with the double inversion preparation to a slice with the 
nulling preparation switched off gave the nulling ratio (Equation 3.8), which is a first order 
estimate of the fractional blood volume. Figure 3.12 shows this process applied to a tumour. 
The signal in the non-nulled magnitude image (b) is heterogeneous, typical of a tumour 
image, which could feature regions of necrosis alongside viable tissue. The EVAC, or 
nulled, magnitude image (c) shows a similar, albeit subtly reduced signal distribution. 
Calculation of the blood nulling ratio (d) revealed further information on the heterogeneous 
blood content within the tumour. The nulling ratio ranged from 0 to 80%. Pixels with the 
highest nulling ratio (yellow) containing the largest volume of blood corresponded to 
regions in which vasculature is known to be most dense such as at the periphery of the 
tumour (red arrow). The mean nulling ratio based on a single slice measurement in each of 
the tumours across the two days (n = 8) was 9.4 ± 3.7 %, which is in agreement with 
previous data on microvascular density in LS147T tumours [33]. 
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When EVAC was applied to the mouse tumours, three different types of interstitial fluid 
flow pattern were broadly observed, as shown in Figure 3.13. These included a radial pattern 
where interstitial fluid flowed from the centre of the tumour towards the periphery (a), a 
laminar flow profile where fluid travelled laterally across the tumour and (c) a combination 
of both.  
 
Figure 3.13: EVAC velocity maps in three different mouse tumours showing three different types of 
interstitial fluid flow pattern. (a) Radial flow from the centre of the tumour, outwards. (b) Laminar 
flow, where the largest component of flow is laterally across the tumour. (c) A combination of both 
radial and laminar flow. 
 
The in vivo repeatability of the EVAC sequence was investigated by imaging the cohort of 
mice three times consecutively in the same imaging session. Reproducibility was examined 
by repeating the experiment on the following day. Repeatability was strong as EVAC 
velocity maps showed similar interstitial fluid flow patterns within-session, as illustrated in 
Figure 3.14a. On the left edge of the tumour, there was a small region of high, randomly-
orientated velocity vectors (red arrow). This corresponded to tumour vasculature (also 
visualised in the blood nulling ratio map in Figure 3.12d) containing fast-flowing blood, 
above the VENC, hence the random orientation of vectors due to phase wrapping. The 
interstitial fluid emanated from this region, flowing across the tumour towards the periphery. 
This pattern was broadly consistent across within-session scans. Reproducibility was also 
strong, as shown in Figure 3.14b. Once again, the small region of blood flow was visible on 
the left edge of the tumour (red arrow), from which the interstitial fluid flowed across the 
tumour towards the periphery. 
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Figure 3.14: Repeatability and reproducibility of EVAC in a mouse tumour. (a) On day 1, the three 
trials show similar interstitial fluid flow patterns. (b) Reproducibility is also strong, as on day 2 the 
interstitial fluid flow patterns are broadly consistent with those on day 1. In this tumour, much of the 
interstitial fluid appears to emanate from a large blood vessel on the left edge of tumour (see Figure 
3.12), which then flows from left-to-right across the tumour towards the periphery. 
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Quantitative repeatability and reproducibility analysis of the EVAC sequence was also 
conducted. Box plots of the mean interstitial fluid velocity measured across all tumours in all 
trials is shown in Figure 3.15a, as well as Bland-Altman plots of repeatability (b) and 
reproducibility (c). The mean interstitial fluid velocity on Day 1 was 206 ± 126 µm/s. On 
Day 2 the mean interstitial fluid velocity decreased to 188 ± 126 µm/s. Within-session 
repeatability, calculated by comparing all data from trials 1 and trial 2, was non-significantly 
different (p = 0.2, Mann-Whitney-U) with a SDrepeat = 17.9%. Between-session 
reproducibility, calculated by comparing all trials between days, was also non-significantly 
different (p = 0.34, Mann-Whitney-U) with a SDreprod = 26.6%. Note, the two outliers seen 
on Day 2 were caused by scanner instability which partially corrupted the magnitude and 
phase images. 
 
Figure 3.15: Repeatability and reproducibility of in vivo EVAC velocity measurements of interstitial 
fluid flow in subcutaneous tumours. (a) In the box plots, each point represents the mean velocity 
across a single slice EVAC velocity map during one of the trials. Mean tumour velocities were lower 
on Day 2, however, the overall between-session difference was non-significant (p = 0.34, Mann-
Whitney-U). Similarly, the within-session difference was also non-significant (p = 0.2, Mann-
Whitney-U). (b) Bland-Altman plots of within-session repeatability, SDrepeat = 17.9%, and (c) 
between-session reproducibility, SDreprod = 26.6%. 
 
In a separate cohort of subcutaneous tumour mice (n = 6), the phase offset correction method 
developed in the flow phantom was applied to examine its effect on imaging tumour 
interstitial fluid dynamics. Firstly, the mouse tumour was imaged using EVAC, as shown in 
Figure 3.16b. Following this, the mouse was removed and replaced with an agar phantom 
which filled the majority of the RF coil. The agar phantom was imaged again using exactly 
the same EVAC sequence and scan parameters that were used for in vivo imaging. Figure 
3.16c shows an axial view of the agar phantom, where the red line corresponds to the slice 
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location of the EVAC scan. The corresponding in-plane image is shown in Figure 3.16d, 
showing where the tumour was located (dashed blue line). 
 
Figure 3.16: Schematic illustrating how the phase offset region within an agar phantom is delineated. 
(a) Axial anatomical image showing the tumour imaging plane (red line). (b) Coronal slice (FOV = 
25.6mm
2
) through the tumour, in the same orientation used for the EVAC velocity maps. A region of 
interest (blue) was drawn around the tumour boundary. (c) Axial image of the agar phantom (FOV = 
50mm
2
), placed in the scanner following tumour imaging. The red line indicates the slice orientation 
used for tumour imaging. (d) The agar phantom imaged using exactly the same slice orientation as 
the tumour slice. The blue dashed line now represents the location of where the tumour occupied the 
scanner. The phase data within the blue region of interest is used in the electrical eddy current 
correction procedure. 
 
As before, the phase signals measured in agar were subtracted from the EVAC tumour data 
to produce phase offset corrected velocity maps. Uncorrected and corrected EVAC velocity 
maps from two subcutaneous tumours are shown in Figure 3.17. In both mice, the 
uncorrected and corrected velocity maps demonstrated similar interstitial fluid flow patterns. 
Mouse 1 appeared to have a large region of potential necrosis (a), which had randomly 
orientated velocity vectors in the corresponding EVAC velocity maps (b,c). Outside of this 
region the interstitial fluid appeared to flow towards the tumour periphery. In the 
uncorrected image, the major component of flow was towards the right edge of the tumour 
(b), whereas in the corrected image the flow was towards the upper edge of the tumour (c). 
In mouse 2, the flow patterns within the uncorrected and corrected EVAC velocity maps 
were even more similar, suggesting that the phase offset correction had little effect on the 
tumour EVAC velocity maps. 
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Figure 3.17: Applying the electrical eddy current correction in vivo to mouse tumours. Data from two 
animals are shown. (a) The tumour in Mouse 1 has a large area of signal hypointensity covering the 
left hand side of the tumour, possibly corresponding to necrotic tissue. (d) By comparison, the tumour 
in Mouse 2 has a smaller area of potential necrosis towards the top of the tumour. (e, f) The corrected 
EVAC velocity maps show some differences in vector directionality compared to the uncorrected 
maps (b, c), however, the overall interstitial fluid flow patterns remain very similar. 
 
The difference in measured mean velocities across the tumours, before and after phase offset 
correction, is shown in Figure 3.18. The mean velocity of the corrected data (235 ± 45 µm/s) 
was marginally lower than the uncorrected data (259 ± 58 µm/s), however, this difference 
was non-significant (p = 0.44, Mann-Whitney-U). 
Overall, the phase offset correction method did not show any definitive improvements to the 
data over the standard EVAC protocol. There was no notable difference in vector 
directionality or significant difference in velocity magnitude, therefore, the phase offset 
correction method was not implemented in the stroke imaging study, described in the 
following section. 
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Figure 3.18: Mean velocities across six tumours before (uncorrected) and after (corrected) 
application of the phase offset correction method. There was no significant difference between 
velocity values before or after the correction was applied (p = 0.44, Wilcoxon paired rank test). 
 
 
3.4.4 Stroke rat study – Imaging extracellular fluid dynamics in an 
experimental rat stroke model 
The aim of this study was to image the extracellular brain fluid dynamics in normal rats and 
a rat model of stroke using the EVAC sequence. A multi-parametric protocol of sequences 
commonly used in stroke imaging, including T2-weighted imaging, perfusion weighted 
imaging (PWI) and diffusion weighted imaging (DWI) was acquired for comparison with 
the EVAC results. Representative images from each of these modalities are shown in Figure 
3.19. The T2-weighted images showed hyperintensity in the ipsilateral hemispheres of the 
stroke rats (e), whereas in normal rats signal intensity was uniform across hemispheres (a). 
PW images showed a distinct region of perfusion deficit in stroke rats (f) and similarly there 
was a marked reduction in ADC in stroke rats (g). These results were consistent with 
histology where TTC-staining showed a significant infarct region, which covered the 
majority of the ipsilateral hemisphere (g). 
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Figure 3.19: Representative images from conventional multi-parametric MRI sequences used in 
stroke imaging. The top row shows images from a normal rat. The bottom row shows images from a 
stroke rat imaged 24 hours post-surgery. (a,e) T2-weighted imaging sensitises oedema, which is 
hyperintense in the stroke animal. (b,f) Perfusion weighted imaging shows perfusion deficits, which 
are marked by dark blue regions in the stroke animal. (c,g) Diffusion weighted imaging is a marker of 
infarcted tissue, which is hypointense on ADC maps corresponding to the restricted motion of water 
molecules. (d,h) TTC-stained histology confirmed that the stroke rats had extensive infarct lesions. 
 
Prior to EVAC imaging, the efficiency of the blood nulling double inversion preparation was 
investigated in the rat brains, as shown in Figure 3.20. Taking the ratio of a slice acquired 
with the double inversion preparation to the same slice with the nulling preparation switched 
off gave the nulling ratio (Equation 3.8), which is a first order estimate of the fractional 
blood volume. As in the tumour study, the non-nulled and nulled images had similar, but 
subtly different contrast (a, b, d, e). The blood nulling ratio maps in the normal rat brains (c) 
were largely homogenous across both hemispheres. Small regions of high intensity (yellow) 
corresponded to the carotid arteries (red arrows). In the stroke rats, there was a clear 
difference between the two hemispheres (f). The ipsilateral hemisphere had a markedly 
lower nulling ratio corresponding to lower fractional blood volume in the infarcted tissue, 
which agreed with the perfusion deficit seen in the earlier PWI images (Figure 3.19). Across 
all pixels the nulling ratio ranged from 0 to 85%. The mean nulling ratio across the slice for 
the normal rats was 12.5 ± 4.6%. In the stroke rats, the mean nulling ratio decreased by more 
than half to 5.4 ± 3.7%, although this difference was insignificant (p = 0.2, Mann-Whitney-
U). The nulling ratio in the normal rats was higher than similar measurements of cerebral 
blood volume reported in the literature (5%) [34], but values were of the same order. 
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Figure 3.20: Evaluating the blood nulling ratio in normal and stroke rat brains. The top row shows 
images from a normal rat. The bottom row shows images from a stroke rat. (a, d) Non-nulled images 
acquired with the double-inversion preparation in the EVAC sequence switched off. (b, e) Blood 
nulled images acquired using the full EVAC sequence. (c, f) Nulling ratio maps showing the 
difference in signal between the non-nulled and nulled scans due to fractional blood volume. 
 
Next, the cohort of rats was imaged with EVAC. The magnitude, phase and phase difference 
images generated during the EVAC velocity map image processing pipeline are shown in 
Figure 3.21. Only data with the velocity encoding bipolar gradients applied in the readout 
direction are shown. Two phase images were generated to measure one velocity component, 
one with a negative bipolar gradient (b) and one with a positive bipolar gradient (c). Both 
images contain phase wrapping where the phase suddenly jumps from π to –π, however, the 
discontinuities were successfully unwrapped by the ATAN2 operator used in the calculation 
of the phase difference maps (d). The phase difference map is smooth across the brain tissue. 
The carotid arteries show a large change in phase, consistent with phase wrapping due to 
high velocity blood flow.  
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Figure 3.21: Image processing schematic illustrating the steps involved in generating an EVAC 
velocity map in a rat brain. All images are from a scan acquired with bipolar gradients orientated in 
the readout direction. (a) Magnitude image, (b) negative bipolar gradient polarity phase image, (c) 
positive bipolar gradient polarity phase image and (d) phase difference image. The phase wrap 
present in the phase maps is unwrapped in the phase difference data. 
 
Representative EVAC velocity maps from a normal and a stroke rat are shown in Figure 
3.22. The interstitial fluid flow patterns were unexpectedly uniform and broadly 
unidirectional. In both the normal and stroke rats, the velocity vectors were directed laterally 
across the brain, from the left hemisphere to the right, ipsilateral hemisphere. This 
directionality, or vice versa (right to left), was observed in the rest of the cohort.  
Measured velocities ranged from 300 to 1000 µm/s, which was much higher than tumour 
measurements of interstitial fluid flow. Average velocity magnitude across the entire brain 
region was reduced in stroke rats (507 ± 160 µm/s) compared to normal rats (897 ± 90 
µm/s), however this difference was non-significant (p = 0.10), as shown in Figure 3.23. The 
induced strokes were clearly extensive based on the multi-parametric imaging and histology 
(Figure 3.19), so it was unexpected to observe no obvious hemispheric differences in the 
EVAC velocity maps of the stroke animals. There was no obvious change in vector 
directionality or vector magnitude between the two hemispheres. In the region of the carotid 
arteries, the magnitude of the velocity vectors was very different to the surrounding tissue, 
reflecting the phase wrapping due to fast blood flow. 
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Figure 3.22: Representative EVAC velocity maps in a (a) normal rat brain and a (b) stroke rat brain. 
Each voxel contains an individual vector, which is supposed to represent interstitial fluid flow within 
that region. In both the normal and stroke brains, the vast majority of the vectors point laterally 
across the brain, from left to right. Across the entire brain, the mean velocity magnitude is higher in 
the normal brain than the stroke brain, which was observed across the entire cohort. 
 
90 
 
 
Figure 3.23: Mean interstitial fluid velocity measured across the brains of the normal and stroke rats. 
Velocities were lower in the stroke rats, however, the difference was insignificant (p = 0.10, Mann-
Whitney-U). 
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3.5 Discussion 
In this chapter, further development was conducted on an in-house MRI sequence known as 
EVAC, designed to image the flow of extracellular fluid. The primary objective of the work 
in this chapter was to image the flow of extracellular fluid in a rat brain following stroke. To 
this end, a number of preliminary experiments were undertaken for the purpose of validating 
the measurements obtained with EVAC. Flow phantom experiments were conducted to 
establish the slowest measureable flow velocity on the CABI 9.4T MRI scanner and to study 
the effects of electrical eddy currents on phase measurements. For in vivo validation, 
interstitial fluid flow in mouse tumours was imaged as the underlying physiology is 
relatively well understood compared to brain fluid dynamics. Finally, the EVAC sequence 
was applied to rat brains. 
Velocity-encoded phase contrast MRI has been predominantly applied to measuring blood 
flow in major vasculature such as the great vessels [8-11] and the carotid arteries [12, 13] 
where the flow is constrained and fast. Aortic blood flow in mice can be greater than 100 
cm/s [35], while carotid blood flow in mice can reach almost 50cm/s [13]. Measuring very 
slow flows with MRI is novel in itself, hence a flow phantom experiment was conceived to 
measure the slowest measurable speed on our 9.4T scanner. The flow resolution was 
ultimately limited by the size of the velocity encoding gradients. It was demonstrated how 
smaller VENC values, which require increasingly large gradients, crush out the signal. 
Averaging and other SNR boosting methods could be used to recover the lost signal, but the 
increase in sequence duration would be prohibitive for in vivo studies. 
Fluid speeds lower than 50µm/s were determined to be resolvable while retaining accurate 
directionality. The flow phantom study was partially limited by the design of the flow 
phantom because at very slow inflow rates (0.34 ml/min) – and even with the inflow turned 
off – the direction of flow appeared to be backwards. This was possibly a real effect caused 
by some form of low-level suction, but more likely it was an artefact related to reaching the 
noise floor of the phase contrast measurements. Another limitation of the flow phantom was 
its simplicity compared to interstitial fluid flow in real biological systems: the flow phantom 
contained only water and fluid motion was broadly unidirectional and non-pulsatile. 
Nonetheless, the study was important for establishing a baseline measurement under 
idealised conditions. 
Gradient interference due to electrical eddy currents was anticipated to potentially affect the 
phase contrast measurements in the EVAC sequence [15, 36]. The phase data subtraction 
process used to create EVAC plots could not compensate for electrical eddy currents 
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because alternating the polarity of the bipolar gradients also alternates the sign of the eddy 
currents, hence they become additive in the phase difference image during the image 
processing pipeline [15]. Previous studies have described two main electrical eddy current 
correction methods for phase contrast measurements. One common technique is to measure 
phase in a ‘static’ region of an image and use this information to correct phase offsets in 
measures of high speed vascular flow [37]. However, this technique is difficult to implement 
with EVAC because the sequence is intended to image very slow flows within tissues that 
would be regarded as “static” for phase correction purposes in vascular flow studies. Instead, 
the phase offset was measured in a stationary agar phantom after flow imaging, similar to 
the study by Chernobelsky et al. [17]. 
When the phase offset correction was applied to the flow phantom, the accuracy of the flow 
measurements appeared to improve. At higher flow rates, the streamlines representing the 
underlying velocity vectors became straighter in the direction of flow. At slower flow rates, 
vector directionality also appeared to improve. Notably, at a flow rate of 0.34 ml/min – 
where the direction of flow was backwards in the uncorrected EVAC velocity maps – the 
phase offset correction resulted in the velocity vectors pointing in the correct direction of 
flow. Furthermore, with the pump switched off, the flow pattern had no clear directionality, 
instead appearing static, thus resembling stationary water. The reproducibility experiment 
demonstrated that the phase offset correction method resulted in more accurate measures of 
fluid velocity in the flow phantom, compared to the standard, uncorrected approach. 
However, as the correlation plot of repeatability showed (Figure 3.11a), sometimes EVAC 
yielded accurate velocity measurements, in line with theoretical values, without the need for 
phase offset correction. In general, however, applying the phase offset correction appeared 
to be beneficial, especially at the slowest flow rate (0.069 ml/min) where the average 
measured velocity was approximately 48 µm/s compared to 78 µm/s without the correction. 
The first in vivo application of EVAC was in subcutaneous mouse tumours, as the fluid 
dynamics within the tumour microenvironment have been studied widely [22, 23, 25]. The 
experiments in this chapter and work previously conducted by Simon Walker Samuel et al. 
[7] imply that EVAC velocity maps accurately and reproducibly reflect interstitial fluid flow 
patterns in tumours. Tumour blood nulling percentages agreed with previous reports on 
microvascular density, suggesting that the double inversion preparation functioned correctly. 
EVAC velocity maps showed a range of interstitial fluid patterns broadly demonstrating 
either outward, radial flow towards the tumour periphery; laminar flow across the tumour; or 
a combination of both. These patterns were consistent with interstitial fluid flow from 
regions of high pressure, such as tumour vasculature, to regions of low pressure, such as the 
tumour boundary at the intersection with normal tissue. The repeatability and reproducibility 
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studies demonstrated that EVAC velocity maps showed both low within- and between-
session variability. This was further reflected in the mean tumour velocities, where there was 
no significant difference between trials or days. 
One issue apparent in the tumour results was that the magnitudes of the measured interstitial 
fluid velocity vectors were much higher than reports of interstitial fluid flow in the literature. 
Interstitial fluid velocity is typically reported between 0.1 and 10 µm/s. These reports 
include mathematical models of tumour interstitial fluid dynamics [38-41], fluorescence 
recovery measurements after photobleaching [42], in vitro studies of interstitial fluid flow in 
glioma cell invasion [43] and dynamic contrast-enhanced MRI-based experiments [44]. One 
more recent report suggested interstitial fluid velocity could be up to 55 µm/s [14]. The 
measurements in tumours using EVAC averaged approximately 200 µm/s, an order of 
magnitude, or more, higher than the aforementioned reports. The phase offset correction 
method was applied to the EVAC tumour measurements to examine whether this velocity 
disparity might be caused by the effects of electrical eddy currents. Despite having a clear 
effect in the flow phantom experiments, the phase offset correction appeared to make little 
difference to the tumour data. The EVAC velocity maps looked very similar between the 
corrected and uncorrected data, and although there was an average decrease in the velocities 
when the phase offset correction method was applied, the difference was non-significant. 
Another reason for the velocity disparity could be the incorrect assumption that data 
acquired with EVAC was completely blood nulled. Simulations carried out by Simon 
Walker-Samuel (unpublished) suggest that non-nulled blood could contribute to elevating 
measured interstitial fluid velocity values (Figure 3.24). If this is true, then it is likely that 
the tumour nulling ratio measurements include some percentage of interstitial fluid or tissue 
nulling, rather than solely blood nulling. 
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Figure 3.24: Simulations showing the effect of imperfect blood nulling on EVAC measurements of 
interstitial fluid velocity (figure created and supplied by Simon Walker-Samuel). Measured interstitial 
fluid velocities become increasingly large as the blood nulling efficiency decreases (100, 95, 80 and 
50%). Error bars show the standard error in the mean. 
 
Although it is difficult to definitively account for the disparity in velocities between EVAC 
measurements and literature values, the robustness of the interstitial fluid flow patterns 
observed in the repeatability and reproducibility studies offer compelling evidence that the 
EVAC velocity maps reflect the underlying tumour fluid dynamics. Furthermore, 
gadolinium infusion studies conducted by Simon Walker-Samuel (unpublished) showed that 
the contrast agent collected in regions downstream of the EVAC velocity vectors (Figure 
3.25), reinforcing the notion that the directionality of the vectors in EVAC tumour 
measurements appears to be accurate, even if the absolute values are overestimated. 
 
Figure 3.25: Comparison between a subcutaneous mouse tumour (a) infused with a gadolinium 
contrast agent and an (b) EVAC velocity map (images created and supplied by Simon Walker-
Samuel). The gadolinium collects in regions downstream of the velocity vectors in the EVAC map. 
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Following tumour imaging, EVAC was applied to a rat model of stroke to examine the 
alterations in brain fluid dynamics post-infarction. The blood nulling percentage in the 
normal rat brains was 12.5%, higher than the tumour values and previously reported values 
of cerebral blood volume [34], perhaps reflecting that more than just blood was nulled. In 
the stroke rats, this value decreased to 5.4% reflecting the infarcted region devoid of 
perfused tissue.  
The multi-parametric imaging sequences all performed as expected. T2-weighting, PWI and 
DWI were all consistent with histology in showing a large infarcted region in the ipsilateral 
hemisphere of the stroke animals. Hence, it was very surprising to see no immediate 
differences between the hemispheres of the stroke animals with EVAC. In normal brains, 
fluid flow was expected to be approximately random or drain into the ventricles. In stroke 
brains, extracellular fluid was expected to flow away from the infarcted region due to the 
build-up of oedema, or at the very least, some form of disruption to vector directionality was 
expected compared to the healthy hemisphere. Instead, EVAC maps of both normal and 
stroke brains demonstrated unidirectional flow patterns directed laterally across the brain 
from one hemisphere to the other. However, this does not make physiological sense as it is 
impossible for fluid to cross the brain in this way because of the longitudinal fissure which 
separates the hemispheres. The mean measured extracellular fluid velocities were higher in 
the brains than the tumours, especially in the normal rats which were more than four times 
higher, averaging approximately 897 µm/s. Clearly these values were not physiologically 
accurate, neither was the directionality of the velocity vectors. 
The exact cause of the errors in the stroke EVAC data is difficult to determine with 
certainty. The main hardware differences between the rat brain imaging and the tumour 
imaging were the use of a larger gradient set (1000mT/m compared to 400mT/m in the 
mice), a larger RF coil and a 4-channel rat head phased array receiver. A further test was 
carried out to examine whether the image processing pipeline (section 3.3.1) was correctly 
reconstructing the 4-channel phased array data, by imaging the flow phantom consecutively 
in volume receive mode, as in the tumour studies, and then with the same hardware 
configuration used in the rat studies. The EVAC velocity maps were comparable showing 
forward flow, both in volume receive mode and 4-channel receive mode (Figure 3.26), 
indicating that the image processing pipeline was working as intended. 
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Figure 3.26: Comparing the accuracy of EVAC velocity map reconstruction between a volume receive 
and a 4-channel receive hardware configuration. (a) The flow phantom imaged using the 72mm 
diameter RF coil in volume-receive mode. (b) The flow phantom imaged using the 72 mm diameter 
RF coil in transmit mode and the 4-channel rat head phased array as the receiver. An inflow rate of 
1.71 ml/min and a VENC of 0.5cm/s were used in both scans. 
 
Another potential source of error in the measurements may have been motion caused by 
respiration or scanner vibrations, which masked the very slow interstitial fluid speeds. This 
may explain why the velocity vectors in the brain images (Figure 3.22) were directed 
laterally across the brain, reflecting bulk motion of the animal’s entire head, although no 
obvious signs of such motion were observed in the magnitude images. Furthermore, small 
ear bars were used to tightly secure the heads of the animals to minimise such motion and 
this exact setup (see section 2.8.1) is routinely used for similarly, motion-susceptible 
diffusion MRI, without issue. 
It is only possible to speculate on the exact cause of the unexpected EVAC velocity maps in 
the rat brains. Applying EVAC to brains was a natural extension to the tumour imaging 
work – where the sequence has been more thoroughly validated – however, at present EVAC 
does not produce physiologically sensible results in brains. More work is required to 
understand the issues underlying EVAC in the brain, which was not possible to carry out in 
time for completion of this thesis. 
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3.6 Summary 
In this chapter, further development was conducted of a novel technique for in vivo imaging 
of extracellular fluid flow known as extravascular convectography (EVAC) MRI. A number 
of validation studies were carried out in a flow phantom and an in vivo mouse tumour model 
to ensure the robustness of the sequence. EVAC was applied to imaging the brain fluid 
dynamics in a rat model of stroke, however, the results did not reflect the underlying 
physiology of the brain. EVAC was successful at imaging interstitial fluid dynamics in 
subcutaneous mouse tumours, but further work is required in the rat brain to establish the 
sources of error masking the phase contrast extracellular fluid signal. 
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CHAPTER 4: ASSESSMENT OF CARDIAC STRUCTURE & 
FUNCTION USING ADVANCED MRI TECHNIQUES 
 
A breadth of sequences exist for assessing many different aspects of cardiac physiology 
including morphology, function, myocardial status and the great vessels. This chapter 
focuses on a pair of studies conducted with cardiac MRI. Firstly, CINE and late gadolinium-
enhanced MRI are applied to studying a Prox-1 deficient mouse model of dilated 
cardiomyopathy, and secondly, the feasibility of using multi-parametric MRI, including T2-
mapping, arterial spin labelling and late gadolinium-enhanced MRI, is assessed for 
quantifying the extent of area-at-risk following myocardial infarction. 
Parts of this chapter are contained in the paper: Loss of Prox1 in striated muscle causes slow 
to fast skeletal muscle fiber conversion and dilated cardiomyopathy Louise K. Petchey, 
Catherine A. Risebro, Joaquim M. Vieira, Tom Roberts, John B. Bryson, Linda Greensmith, 
Mark F. Lythgoe, Paul R. Riley. PNAS (2014) 111 (26) 9515-9520. 
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4.1 Introduction 
Cardiac MR studies were first carried out in the 1970s as a method for assessing myocardial 
metabolism using phosphorus spectroscopy in isolated, perfused rat hearts [1, 2]. In the 
1980s, cardiac MR progressed into clinical imaging where, nowadays, it is routinely carried 
out. In the past three decades [3], advanced MRI techniques have revolutionised biomedical 
research by providing novel insights into disease pathophysiology and therapies for treating 
disease. With cardiac MRI, it is now possible to assess myocardial structure, function, 
perfusion, metabolism, tissue-status, great vessel blood flow and much more. 
In the pre-clinical setting, many surgical and genetic animal models exist which attempt to 
recreate the pathologies found in humans. Rigorous in vivo testing of the pathology 
underlying these models is crucially important, not only to validate how closely they reflect 
human conditions, but also to monitor the efficacy of novel therapies and to determine the 
mechanisms through which such treatments benefit the heart. Imaging plays a significant 
role in this testing process, as imaging biomarkers can be developed to both characterise 
these diseases and examine the effects of therapies.  
In this chapter, two studies are presented where cardiac MRI is used to assess two different 
animal models of heart disease. In the first study, a genetic mouse model of dilated 
cardiomyopathy is assessed using CINE and late gadolinium enhanced MRI. In the second 
study, multi-parametric cardiac MRI – including T2-mapping and arterial spin labelling 
(ASL) – is applied to delineate and quantify the size of the area-at-risk following myocardial 
ischaemia. 
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4.2 Study 1 – Imaging dilated cardiomyopathy and intracardiac 
thrombi with MRI 
4.2.1 Introduction 
Dilated cardiomyopathy (DCM) is a common form of heart disease characterised by an 
increase in both myocardial mass (hypertrophy) and chamber volume (dilation) [4, 5]. The 
myocardial walls become stretched, enlarged, or a combination of both, leading to reduced 
contractility and poor left ventricular function. Key indicators of DCM include reduced 
ejection fraction (below 40%), increased end diastolic volume and increased left ventricular 
mass. DCM may occur at any age, but is most common between the ages of 20 and 50 years 
old. 25-35% of patients that present with DCM have a genetically inherited form of the 
disease, but there is also a host of non-genetic causes including myocardial ischaemia, viral 
infections, excessive alcohol consumption, valvular heart disease and hypertension. 
At least 50 genes have been linked to causing familial DCM, including numerous mutations 
in sarcomere genes [6]. Sarcomeres are the basic unit of all muscles. In striated muscle 
tissue, such as skeletal and cardiac muscle, long myofibrils are formed from repeating 
sarcomeres. The myofibrils are composed of myosin and actin protein filaments which slide 
past one another during muscle contraction. Muscle fibres can be categorised based on their 
‘twitch’ capabilities: they are classified as either slow- or fast-twitch fibres depending on 
their speed of contraction [7]. Fast-twitch fibres contract quickly, but fatigue more easily, 
whereas slow-twitch fibres have slower contractility but greater endurance. In all muscles, 
there is a balance between the number of fast- and slow- twitch muscle fibres required for 
normal function. In the heart, an imbalance in the proportions of these muscle fibres can lead 
to cardiomyopathy. 
Recently, Risebro et al. (2009) demonstrated that the protein Prospero-related homeobox 
factor 1 (Prox1) is essential for healthy cardiac function and that Prox1 inactivation leads to 
irregular sarcomere formation and myofibril disarray [8]. Following this study, the same 
group wanted to probe the exact mechanisms of sarcomere disruption underlying loss of 
Prox1. In 2014, Petchey et al. demonstrated that Prox1 represses troponin T3, troponin I2 
and myosin light chain 1 gene expression, and that the absence of Prox1 causes a switch 
from the formation of slow- to fast-twitch myofibrils in the heart, which ultimately results in 
a DCM phenotype [9]. 
As part of the Petchey et al. (2014) study [9], I imaged adult Prox1-deficient mutant mice in 
vivo to provide functional evidence of a DCM phenotype and to investigate whether it was 
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caused by myocardial deficiencies associated with the gene knockout rather than structural 
abnormalities such as aortic stenosis. Preliminary studies had also shown the possibility of 
intracardiac thrombus formation, which were also visualised using MRI. Three cohorts of 
mice, including a control cohort, Prox1-deficient mutants at 6-weeks old and Prox1-deficient 
mutants at 8-weeks old were imaged using CINE imaging for assessment of cardiac function 
and late gadolinium-enhanced inversion recovery (LGE IR) for thrombus detection. 
  
4.2.2 Methods 
Animal strains and cohorts: The mouse strains used for generating mutant mice are 
described fully in [10, 11]. In short, three cohorts of adult mice were imaged: a six-week old 
control group (n = 6), a six-week old Prox1-deficient mutant group (n = 6) and an eight-
week old Prox1-deficient mutant group (n = 2). 
Imaging preparation: All imaging was performed according to the mouse imaging protocol 
described in section 2.8.1. Briefly, mice were induced and anesthetised with 4% and 1.5-
2.0% isoflurane in 2 l/min O2, respectively. Mice were positioned supine in a cradle which 
could be positioned in the middle of the scanner bore. Temperature was monitored and 
maintained at physiological temperature. Respiration was monitored using a neonatal apnea 
pad and ECG was monitored using three ECG electrodes inserted subcutaneously. For 
thrombus visualisation experiments, an infusion line was inserted intraperitoneally for 
injection of gadolinium contrast agent. All imaging was conducted using 1000mT/m 
gradient inserts and a 39mm volume RF coil (RAPID). 
CINE imaging: CINE imaging was conducted according to the protocol outlined in section 
2.7.1. Long-axis and short-axis images of the heart were obtained, including full short-axis 
CINE stacks (9-12 slices). Imaging parameters for all CINE scans were: TR = 5 ms, TE = 
1.21 ms, FA = 15°, data matrix = 128
2
 (zerofilled to 256
2
), FOV = 25.6mm
2
, slice thickness 
= 1mm. Cardiac functional and structural parameters (EF, EDV, ESV, SV, LVM) were 
analysed using Segment, as described in section 2.7.2. LVM measurements were normalised 
to mouse mass. The degree of left ventricular remodelling was assessed by calculation of 
relative wall mass (LVM/EDV), according to Nahrendorf et al.[12]. 
Late-gadolinium inversion recovery imaging: Long-axis and short-axis images of the heart 
were obtained using LGE IR imaging, which was conducted according to the protocol 
outlined in section 2.7.3 [13]. In brief, 0.6 mmol/kg Gd‐DTPA was injected 
intraperitoneally. After an 8 minute delay to allow contrast agent to wash out of healthy 
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tissue, an IR gradient echo sequence was used for high SNR between the blood pool and 
thrombi. Imaging parameters were: TR = 3.1ms, TE = 1.21ms, FA = 90°, TI = ~4 x RR‐
interval (~400ms), data matrix = 128
2
 (zerofilled to 256
2
), FOV = 25.6mm
2
, slice thickness = 
1mm. 
Aortic stenosis analysis: Four measurements of aortic diameter (in pixels) were made using 
short-axis CINE images located at the base of the aorta for consistency. Pixel measurements 
were converted to mm based on a resolution of 100µm/px. The mean aortic diameter was 
calculated from the average of the four measurements for cohort comparisons. 
Statistics: Mann-Whitney-U tests were performed to test for significance between 
measurements of cardiac parameters in control and mutant mice. Statistical significance was 
assigned at p < 0.05. 
 
4.2.3 Results 
CINE imaging: Visual inspection of Prox1-deficient mutant mice showed marked 
ventricular dilation and atrial dilation in both the 6-week old (Figure 4.1c and Figure 4.1d) 
and 8-week old cohorts (Figure 4.1e and Figure 4.1f) compared to control mice. Mutant 
mouse hearts grew progressively larger with time. CINE movies showed abnormal blood 
flow patterns – particularly in the left ventricle – in the mutant mice visualised as distinct 
regions of turbulent hypointensity (red arrows, Figure 4.1d). 
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Figure 4.1: Short axis and long axis CINE frames at end diastole from (a-b) a control mouse, (c-d) a 
6-week old Prox1 mutant mouse and (e-f) an 8-week old Prox1 mutant mouse. At 6 weeks, the mutant 
mice exhibit atrial and ventricular dilatation. At 8 weeks, the hearts have grown even further. 
Abnormal flow patterns can be observed in the mutant hearts, particularly in the long-axis views (red 
arrows). 
 
Cardiac parameters including EF, EDV, ESV, SV, LVM and LVM/EDV were assessed by 
segmentation of the CINE images (Figure 4.2 and Table 4.2). EF and SV were significantly 
reduced in the 6-week old cohort of mutant mice (p = 0.002 and p = 0.02, respectively) 
indicating marked impairment of cardiac contractility. Mean EF in the mutant 6-week old 
cohort was 27.8 ± 6.2%, well below the 40% threshold of DCM. Both EDV and ESV were 
significantly increased in the mutants compared to control animals (p = 0.009 and p = 0.002, 
respectively), reflecting ventricular dilation. LVM was also significantly larger in mutants 
than control animals reflecting myocardial hypertrophy (p = 0.004). LVM/EDV was 
significantly lower in the mutant animals, decreasing from 1.44 ± 0.05 mg/µl in the control 
animals to 1.11 ± 0.08 mg/µl in the mutants (p = 0.008), in keeping with both left ventricle 
dilatation and hypertrophy. 
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Figure 4.2: Measurements of cardiac function and structure in control mice and the 6-week old 
cohort determined by CINE segmentation of the left ventricle. All differences tested using Mann-
Whitney-U statistics: *p < 0.05, **p< 0.01. 
 
 Control Mutant – 6 weeks 
n 6 6 
EDV (µl) 53.5 ± 2.7 99.0 ± 15.6 
ESV (µl) 17.8 ± 1.0 75.0 ± 16.7 
SV (µl) 35.7 ± 2.1 24.0 ± 2.6 
EF (%) 66.6 ± 1.5 27.8 ± 6.2 
LVM (g) 0.095 ± 0.004 0.133 ± 0.010 
LVM/EDV (mg/µl) 1.44 ± 0.05 1.11 ± 0.08 
Table 4.2: Measurements of cardiac function and structure determined by CINE segmentation of the 
left ventricle in the control and 6-week old mutant cohorts. Values represent mean ± SEM. 
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Late gadolinium-enhanced imaging: LGE IR imaging improved visualisation of left 
ventricular dilation in the mutant mice compared to CINE images because of superior 
contrast between the nulled myocardium and hyperintense blood pool (Figure 4.3b and 
Figure 4.3c). Short-axis LGE IR images (not shown) were inspected for signs of diffuse 
signal hyperintensity indicative of mid wall fibrosis, however, little evidence was observed 
in either the control or mutant cohorts. The primary purpose for running the LGE IR 
sequence was thrombus visualisation. Thrombi were not detected in control mice or 6-week 
old mutant mice. However, a region of hypointensity corresponding to a large thrombus was 
observed in the right atrium of one 8-week old mutant mouse, pictured in Figure 4.3c. The 
thrombus was not readily visible with CINE imaging in the same mouse, with the same slice 
orientation (Figure 4.1f). 
 
 
Figure 4.3: Long axis late gadolinium-enhanced inversion recovery images from (a) a control mouse, 
(b) a 6-week old mutant mouse and (c) an 8-week old Prox1 mutant mouse. The addition of contrast 
agent enables the visualisation of a large thrombus in the right atrium of the 8-week old mutant, 
which was not previously visible using a standard CINE sequence. 
 
Aortic stenosis analysis: To determine whether aortic stenosis, rather than the genetic 
ablation, may have caused the reduction in cardiac function, the diameter of the aorta was 
examined in the 6-week old cohort. There was no significant difference in the aortic 
diameter of the control and 6-week old Prox1 mutant mice (p = 0.31) based on analysis of 
short-axis CINE slices located at the base of the aorta (Figure 4.4). 
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Figure 4.4: Measuring aortic diameter for evidence of aortic stenosis. (a) Diameter was measured at 
four locations in the aorta (red arrows) of every mouse using a short axis view of the heart. (b) The 
mean aortic diameter (+ SEM) was non-significantly different between the control and mutant mouse 
groups (p = 0.31, MWU), indicating no evidence of aortic stenosis. 
 
4.2.4 Discussion 
Prox1 plays an essential role in the development of a normal heart by regulating fast-twitch 
gene expression within the sarcomeres of the cardiac muscle. In the absence of Prox1, 
normal cardiac muscle structure and growth is severely disrupted. The primary aim of this 
study was to measure in vivo cardiac function in a Prox1 mutant mouse model and to 
demonstrate the presentation of a DCM phenotype. 
CINE and LGE IR imaging of the mutant mice indicated severe left ventricular chamber 
dilation and increased myocardial mass, consistent with eccentric hypertrophy. This 
observation was validated by assessment of cardiac function in control, 6-week and 8-week 
old mutant mice. 6-week old mutant mice exhibited severe cardiac impairment in the form of 
greatly reduced EF, well below the 40% threshold indicative of DCM. EDV increased by 
85% indicating severe left ventricle dilation and LVM increased by 40% indicating LV 
hypertrophy. Although only two mutant mice were observed at the 8-week timepoint (due to 
phenotype lethality and death upon anaesthetic inducement), it was clear from visual 
inspection of the images that the degree of eccentric hypertrophy was even more 
pronounced. 
LGE IR imaging of one mutant mouse from the 8-week old cohort revealed the presence of a 
very large atrial thrombus, once again consistent with DCM [4]. The thrombus was dark 
against the hyperintense, gadolinium-enhanced blood pool. This pattern of contrast was 
likely caused by the inability of gadolinium to accumulate in the avascular thrombus, which 
has also been observed in images from patients [14]. Considering the size of the thrombus, it 
110 
 
is perhaps surprising that detection was not possible in the standard CINE images. This may 
be due to a combination of flow artefacts masking the presence of the thrombus and similar 
T2* times between the blood pool and thrombus. Whereas, the T1 times between the regions 
are much different in the presence of gadolinium, hence there is contrast in the inversion 
recovery image, but not the CINE image. This experiment demonstrated the added utility of 
administering gadolinium contrast agent beyond its most conventional use of visualising 
scarring following myocardial infarction. Unfortunately, histology was not performed on the 
thrombotic heart, however, separate histological experiments carried out in 8-week, 12-week 
and 14-week old Prox1-deficient mutant mice also revealed thrombi in the left ventricle and 
the atria [9], reinforcing the MRI finding. Thrombi were not detected using LGE IR MRI in 
the 6-week old cohort, either because the blood clots had not formed at this timepoint, or 
because only small mural thrombi were present, which were isointense with the 
myocardium. 
Finally, the aortic diameter was measured in all control and 6-week old mutant mice. No 
significant difference was measured, providing supporting evidence that the DCM 
phenotype was caused by muscular abnormalities rather than aortic stenosis, which is also 
known to cause DCM. 
In summary, the Prox1 knockout mouse model used in this study has a clear and very severe 
DCM phenotype, as demonstrated by CINE and LGE IR MRI. The onset of DCM and 
manifestation of DCM in this mouse model shares many hallmarks with the human 
condition including dilated cardiac chambers, myocardial hypertrophy, thrombus and 
impaired cardiac function. This mouse model may be of significant value in future 
prognostic studies of DCM. Furthermore, the imaging carried out in this study demonstrates 
the validity of using these techniques to follow disease progression and response to therapy.  
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4.3 Study 2 – Imaging the area-at-risk in myocardial infarction 
with multi-parametric MRI 
4.3.1 Introduction 
Coronary heart disease (CHD) is the leading cause of death worldwide. In 2012, 7.4 million 
deaths were associated with CHD across the globe [15]. In ischaemic CHD, atherosclerosis 
leads to the blockage of the coronary arteries resulting in myocardial infarction. The region 
of myocardial tissue normally perfused by the affected coronary artery, known as the area-
at-risk (AAR), experiences hypoxia, ATP generation falls and gradually cell death sweeps 
through the cells of the myocardium [16]. 
The extent of irreversible cell death within the AAR is determined by the duration of 
ischaemia in a process known as the “wavefront concept” [16]. In the absence of 
reperfusion, the entire AAR will evolve into necrotic tissue. However, with reperfusion – 
following therapeutic intervention, for example – blood flow is restored to the occluded 
vessel and a proportion of the AAR may be salvaged. The extent of myocardial salvage 
depends on a host of factors including the duration of ischaemia to reperfusion, amount of 
tissue perfusion from collateral vessels and reperfusion injury following restoration of blood 
flow [17]. 
Accurate visualisation and quantification of AAR size in patients is an ongoing area of 
research [18-21]. The extent of myocardial salvage is an important determinant of final 
infarct size, therefore, quantitative assessment of AAR offers great potential for the 
development of therapeutics targeted at reducing ischaemic damage [22, 23]. 
Currently, the most widely used method for assessing AAR in the clinic is single-photon 
emission tomography (SPECT) imaging of technetium (Tc99m) [18, 19, 24]. However, 
SPECT requires the injection of a radiotracer before reperfusion therapy can be performed, 
which is suboptimal for patient recovery, as reperfusion therapy needs to be conducted as 
quickly as possible. An alternative method for measuring AAR is by calculating the Bypass 
Angioplasty Revascularization Investigation Myocardial Jeopardy Index (BARI score) using 
angiography [25, 26]. However, this method does not directly measure the size of the AAR, 
instead, the lengths and calibre of the coronary arteries are scored and a percentage is 
calculated as a proxy for AAR size [27]. More recently, T2-weighted (T2w) MRI has 
emerged as a viable alternative [28-30] for assessing AAR in patients who have already 
undergone reperfusion therapy. During the acute phase of myocardial infarction, cellular 
oedema causes increased T2 signal, which can be used to retrospectively quantify the size of 
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the AAR several days after reperfusion therapy. T2w-imaging has been carried out in mouse 
models of myocardial ischaemia [31], but it is an inherently low SNR technique requiring 
long echo times to produce oedema contrast. T2-mapping has emerged as an alternative to 
T2w-imaging in clinical studies [32, 33], as it circumvents issues of low signal through 
quantification of absolute T2 values. But, currently only one small T2-mapping study exists 
in an animal model of myocardial infarction [34]. 
In this study, a T2-mapping sequence was used to assess the size of the AAR in the 
myocardium of mice which underwent myocardial ischaemia reperfusion surgery 72 hours 
prior to imaging. Infarct size (IS) was also assessed using the late-gadolinium enhanced 
inversion recovery (LGE IR) sequence [13] described in section 2.7.3. Together, these two 
measures were used to quantify the volumetric extent of irreversibly damaged myocardium 
and potentially salvageable tissue. In addition, myocardial perfusion in the AAR was also 
quantified for comparison using a multi-slice arterial spin labelling (ASL) technique recently 
developed in CABI [35, 36]. To establish the accuracy of the multi-parametric MRI, images 
were compared with gold-standard histological assessment of AAR and infarct size.  
The work in this study was highly collaborative, conducted in partnership with Dr. Rachel 
Dongworth, who carried out the animal surgery, histology and histological analysis, and Dr 
Adrienne Campbell-Washburn, who created the T2-mapping and ASL sequences [35, 36], as 
well as carrying out some of the imaging and much of the data analysis. I contributed to the 
study by carrying out large amounts of imaging, parts of the data analysis, as well as 
presenting the work at various conferences. 
In summary, the aim of the present study was to assess and quantify AAR in a reperfused 
experimental mouse model of myocardial infarction using multi-parametric MRI, including 
T2-mapping, ASL and LGE IR and compare with gold-standard histological staining of 
excised hearts. 
 
4.3.2 Methods 
Study design: B6Sv129 mice (n = 6) underwent myocardial ischaemia reperfusion surgery, 
as described in section 1.2.9. All surgery was carried out by Dr Rachel Dongworth. In brief, 
mice were anaesthetised with 2% isoflurane in 1.5 l/min oxygen. Animals were positioned 
supine on a heated operating table to maintain physiological body temperature. ECG was 
monitored with subcutaneous electrodes. Artificial respiration was provided by a ventilator. 
Open-chest surgery was performed to gain access to the heart. The lower anterior descending 
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(LAD) artery was identified and a suture was placed under the vessel approximately 2mm 
below the tip of the left atrium. A custom-made snare system was used to occlude the LAD 
for 30 minutes, after which the snare was released to allow for reperfusion of the 
myocardium. The snare system was removed, but the suture was left in place for re-
occlusion later on during histology. The chest cavity was closed and the animal was 
recovered. 72 hours after surgery, mice were imaged using the following MRI sequences, 
before histology was performed: 
- CINE MRI for slice localisation (20 minutes) 
- T2-mapping for assessment of oedema (40 minutes) 
- ASL for assessment of perfusion (30 minutes) 
- LGE IR for assessment of infarct size (20 minutes) 
Imaging preparation: All imaging was performed according to the mouse imaging protocol 
described in section 2.8.1. Briefly, mice were induced and anesthetised with 4% and 1.5-
2.0% isoflurane in 2 l/min O2, respectively. Mice were positioned supine in a cradle which 
could be positioned in the middle of the scanner bore. Temperature was monitored and 
maintained at physiological temperature. Respiration was monitored using a neonatal apnea 
pad and ECG was monitored using three ECG electrodes inserted subcutaneously. For late 
gadolinium enhancement experiments, an infusion line was inserted intraperitoneally for 
injection of contrast agent. All imaging was conducted using 1000mT/m gradient inserts and 
a 35mm volume RF coil (RAPID). 
T2-mapping: The T2-mapping protocol was designed by Dr. Adrienne Campbell-Washburn. 
A standard spin echo sequence was modified to be both cardiac- and respiration-gated, as 
illustrated in Figure 4.5. For each respiration trigger, the sequence acquired one line of k-
space per ECG event in a total of 7 different slices. Therefore, the respiration of the animal 
was maintained below 60 bpm to ensure there was enough time to acquire one phase 
encoding line for each slice. The sequence was run with 8 different TE values ranging from 
3.5 to 30ms. The sequence parameters were: TR = respiration interval, TE = 3.5, 7, 10, 12, 
15, 17, 20, 25 and 30ms, matrix size = 128mm
2
, slice thickness = 1mm, FOV = 25.6mm
2
. 
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Figure 4.5: Doubled-gated T2-mapping pulse sequence diagram. The T2-mapping sequence is based 
on a spin echo readout. When the respiration window opens, the pulse sequence is triggered by the 
next seven ECG R-waves. For each R-wave, a single line of k-space for each slice is obtained at the 
current TE value. The sequence is repeated for multiple TE values to construct a T2-map. 
 
T2 maps were generated by fitting the signal in each pixel from each of the 8 TE images to 
the following model of T2 decay: 
𝑆(𝑡) = 𝑆0𝑒
−𝑇𝐸/𝑇2
 EQ 4.1 
where S(t) is the signal at time t, S0 is the signal at equilibrium, TE is the echo time and T2 is 
the T2 value of the pixel. 
To determine which pixels in the T2 maps of the myocardium corresponded to oedematous 
tissue, a threshold was determined to classify tissue with elevated T2, as in [34]. The T2 
value of normal tissue was calculated by averaging over an ROI drawn in the septal region 
of the myocardium in the most basal slice, as this region of the heart was assumed to be 
unaffected following surgery. Based on this, the threshold for elevated T2 values, T2e, was 
defined as: 
𝑇2𝑒 = 𝑚𝑒𝑎𝑛(𝑇2𝑠𝑒𝑝𝑡𝑎𝑙) + (1 × 𝑆𝐷) EQ 4.2 
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Finally, the total size of the AAR as a percentage of LV volume was calculated according to: 
𝑇2𝑒/𝐿𝑉(%) =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑇2𝑒  𝑝𝑖𝑥𝑒𝑙𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑖𝑛 𝐿𝑉
 EQ 4.3 
Perfusion mapping: Perfusion mapping was performed using a multi-slice ASL sequence 
designed by Adrienne Campbell-Washburn [35, 36], as illustrated in Figure 4.6. The 
sequence uses a doubled-gated Look-Locker T1 mapping technique [37] following a 180° 
inversion pulse to gradually build up a series of images at different inversion times during 
the course of T1 recovery. T1 mapping begins with a 180° inversion pulse triggered to occur 
at the start of the first quiescent respiration phase. Following this, T1 recovery is sampled in 
the following 50 heart beats. With each ECG trigger, 4 lines of k-space are acquired in 3 
different slices using gradient echo readouts. The entire sequence is repeated (or segmented) 
32 times to produce an entire dataset consisting of 50 images throughout the course of T1 
recovery. 
To measure perfusion in a single slice, the sequence is run twice using a flow alternating 
inversion recovery (FAIR) technique [38], first with a global 180° inversion pulse and then 
with a slice selective 180° inversion pulse centred on, but slightly wider than the imaging 
plane (Figure 4.7). With the global inversion pulse, both the in-plane myocardium and 
inflowing blood are inverted, and both recover according to T1 relaxation. With the slice 
selective inversion pulse, the in-plane myocardium is inverted, but any inflowing blood 
which originated from outside of the inversion slab is assumed to be completely relaxed. 
This has the net effect of causing accelerated T1 relaxation of myocardium in the imaging 
plane. Hence, the difference between the global and slice selective T1 recovery curves gives 
an estimation of perfusion.  
For multi-slice acquisition, the sequence is modified to include a larger slice-selective 
inversion slab, which is required to measure T1 in each slice. However, moving to a larger 
slice-selective pulse causes more of the blood in the heart and lungs to be inverted. As a 
result, some of the blood pumped through the coronary arteries into the myocardium now 
retains a significant amount of magnetisation – compared to single-slice ASL – such that 
there is an underestimation in T1 relaxation times. To correct for this, the magnetisation of 
the LV blood pool is measured and accounted for in a method known as the bpMBF 
quantification method, described in [36]. 
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Figure 4.6: Multi-slice perfusion mapping ASL pulse sequence diagram. A 180° inversion pulse is 
triggered to occur on the first R-wave after a breath. The myocardium recovers with T1 relaxation 
during which time a multi-slice, ECG-gated Look-Locker readout is acquired. 12 lines of k-space are 
acquired for each heart beat, 4 per slice. The sequence runs for 50 heart beats, approximately 5-6 
seconds, allowing time for T1 recovery. The 180° inversion pulse is repeated for each k-space 
segment. In total, 32 segments are acquired for full k-space coverage at every timepoint in the T1 
recovery curve. 
 
 
Figure 4.7: Single-slice FAIR ASL in the mouse heart. (a) A global inversion pulse (blue) inverts all 
blood in the heart. Blood entering the in-plane myocardium (grey) relaxes according to the T1 of 
blood. (b) A slice-selective pulse inverts the in-plane myocardium, but not the inflowing blood which 
remains at equilibrium magnetisation. (c) Therefore, the non-inverted blood accelerates T1 recovery. 
The difference between the two T1 recovery curves gives an estimate of myocardial tissue perfusion. 
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The ASL sequence was performed with the following parameters: TR(180°) = 13.5s, 
recovery delay = 8s, TR(RF) = 3ms, TE = 1.18ms, flip angle = 5°, matrix size = 128mm
2
, 
slice thickness = 1mm, FOV = 25.6mm
2
, global inversion slab thickness = 100 × slice 
thickness, slice selective slab thickness = 3 × slice thickness, timepoints on inversion 
recovery curve = 50. 
Perfusion maps were generated based on the Belle model of myocardial perfusion given in 
equation 4.4. The full quantification method is described in [36]. In brief, global and slice-
selective T1 maps were generated by fitting the signal in each pixel from each of the 50 
inversion images to a mono-exponential model of T1 recovery. T1 values were derived from 
curve fitting to generate an estimate of perfusion based on:   
𝑀𝐵𝐹 =
𝜆
𝑇1𝑏𝑙𝑜𝑜𝑑
(
𝑇1𝑔𝑙𝑜𝑏𝑎𝑙
𝑇1𝑠𝑙𝑖𝑐𝑒−𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑒
− 1) EQ 4.4 
where 𝜆 (the blood-tissue partition coefficient of water) = 0.95 ml/g. To determine the 
perfusion state of pixels in the myocardium a threshold was determined, below which pixels 
were classified as having a perfusion deficit. Variation in baseline perfusion between 
animals precluded perfusion deficit calculation using absolute values. The perfusion value of 
normal tissue was calculated, once again, by averaging over an ROI drawn in the septal 
region of the myocardium in the most basal slice. Based on this, the threshold for perfusion 
deficit, MBFd, was defined as: 
𝑀𝐵𝐹𝑑 = 𝑚𝑒𝑎𝑛(𝑀𝐵𝐹𝑠𝑒𝑝𝑡𝑎𝑙) − (1 × 𝑆𝐷) EQ 4.5 
Finally, the total size of the perfusion deficit region as a percentage of LV volume was 
calculated according to: 
𝑀𝐵𝐹𝑑/𝐿𝑉(%) =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑀𝐵𝐹𝑑  𝑝𝑖𝑥𝑒𝑙𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑖𝑛 𝐿𝑉
 EQ 4.6 
Infarct imaging: Infarct imaging was performed using the LGE IR pulse sequence protocol 
outlined in section 2.7.3 [13]. In brief, 0.6 mmol/kg Gd‐DTPA was injected 
intraperitoneally. After an 8 minute delay to allow contrast agent to circulate, an IR gradient 
echo sequence was used for high SNR between the blood pool and infarct tissue. Imaging 
parameters were: TR = 3.1ms, TE = 1.21ms, FA = 90°, TI = ~4 x RR‐interval (~400ms), 
data matrix = 128
2
, FOV = 25.6mm
2
, slice thickness = 1mm. 9-11 short-axis images of the 
heart were obtained. 
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To determine infarct size, manual segmentation was performed using Segment to delineate 
the hyperintense scar tissue within the myocardium. The region of late gadolinium 
enhancement (LGE) as a percentage of LV volume was calculated according to: 
𝐿𝐺𝐸/𝐿𝑉(%) =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑑 𝑝𝑖𝑥𝑒𝑙𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑖𝑛 𝐿𝑉
 EQ 4.7 
Histology: Immediately after imaging, animals were anaesthetised with a mixture of 
ketamine (100mg/kg), xylazine (20 mg/kg) and atropine (0.6 mg/kg) and the heart was 
excised. The aorta was cannulated and first it was washed with 1 ml saline to remove the 
residual blood from the coronary system. Next, the heart was stained with 2,3,5-
triphenylterazoliumchloride (TTC) to delineate the infarct region. The LAD suture retained 
during the previous surgery session was tightened to re-occlude the vessel and Evans Blue 
dye was perfused while the heart was submerged in water (to prevent myocardial surface 
staining) to delineate the healthy tissue and AAR. Following staining, hearts were stored at -
20°C for 1 to 2 days. Frozen hearts were then sliced free-hand through to produce short axis 
views of the heart. Seven or eight slices were taken from the apex towards the base of the 
heart. Slices were fixed in 10% formalin for 2 hours, then the right ventricle myocardium 
was removed and all slices were scanned (Epson Scanner, 1200 dpi). 
Histology volume analysis: Quantification of infarct size and AAR was performed using 
ImageJ. Raw images were split into separate colour channels. The AAR region was 
delineated by choosing a threshold of pixel intensity within the red channel image which 
matched the AAR in the raw image. The infarct size (IS) was delineated by choosing a 
threshold of pixel intensity within the blue channel image which matched the infarcted tissue 
in the raw image. Excised hearts were sliced to match the MR images as closely as possible, 
including removing right ventricle myocardium. The number of pixels contained in both the 
AAR and the infarct region were calculated as a percentage of total the pixels in the slice, 
across all slices. Hence, final values of AAR/LV(%) and IS/LV(%) are presented in the 
results section (4.3.3). 
Statistics: Mann-Whitney-U tests were performed to test for significance between 
histological and MRI-based measurements of volume. Statistical significance was assigned 
at p < 0.05. Bland-Altman analysis was used to examine the spread the spread of the data.  
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4.3.3 Results 
A complete representative multi-parametric MRI dataset from a single mouse, alongside the 
corresponding histological slices is shown in Figure 4.8. Seven slices are shown for each 
modality, apart from ASL where six slices were obtained. Slice 1 represents the most apical 
slice in the heart. Slice 7 corresponds to a basal slice 6mm higher than slice 1, located 
approximately below the mitral valve. Slice locations were maintained between MRI 
sequences. 
 
Figure 4.8: Representative multi-parametric MRI and histology dataset of AAR quantification from 
an infarcted mouse. 7 histology, late gadolinium-enhanced inversion recovery and T2-mapping slices 
were used for volumetric analysis of AAR and IS. 6 ASL slices were used. TTC and Evans Blue 
staining of histology shows: dark blue = perfused tissue, red = viable tissue, white = infarcted tissue. 
Hyperintense regions of myocardium in LGE images show infarcted tissue. Elevated T2-values in T2 
maps show the AAR. Perfusion deficit in ASL maps shows another measure of AAR. 
 
The first row in Figure 4.8 shows the histology. The dark blue tissue is stained with Evans 
Blue, which represents healthy perfused tissue. The red staining corresponds to TTC, which 
represents ischaemic, but viable tissue within the AAR. The white, unstained tissue is 
infarcted myocardium. The most basal slices consistently contained the largest proportion of 
Evans Blue stained, perfused tissue whereas the more apical slices tended to have large 
regions of infarcted and at-risk tissue. This pattern of infarction was observed through the 
entire cohort indicating that surgery was successful and consistent. Mean AAR/LV assessed 
across 7 histology slices was 64.3 ± 6.1%. Mean IS/LV was 32.3 ± 3.7%. On average, the 
area of salvageable myocardium (100% – IS/AAR) occupied 49.4 ± 6.9% of the area-at-risk. 
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Infarct regions assessed by LGE IR (Figure 4.8, second row) showed excellent spatial 
agreement with histology. Hyperintensity in the myocardium closely matched the white, 
unstained infarct tissue in the histological slices. Mean LGE/LV across 7 slices was 31.7 ± 
5.8%, which closely matched IS/LV determined by histology (Figure 4.9a, p = 0.79, Mann-
Whitney-U). 
T2-mapping showed distinct regions of elevated T2 (T2e > mean septal T2 + 1 SD) which 
matched the AAR in the histology images. Infarcted tissue was not distinguishable from 
salvageable tissue using T2 mapping. The mean T2 value of tissue in the ‘normal’, septal 
region was 17.9 ± 2.8ms. Regions of elevated T2 increased by approximately 31% to a mean 
value of 25.8 ± 4.3ms. Mean T2e/LV was 60.4 ± 5.9%, which closely matched AAR/LV 
determined by histology (Figure 4.9b, p = 0.24, Mann-Whitney-U). Based on T2 mapping 
across 7 slices, the average area of salvageable myocardium (100% – IS/AAR) was 
determined to be 47.1 ± 11.2% of the area-at-risk, which agreed with histology. 
ASL showed very distinct regions of perfusion deficit (MBPd < mean septal MBF – 1 SD) 
which also showed excellent spatial agreement with the AAR in histology images. Again, 
infarcted tissue was not distinguishable from salvageable tissue using perfusion mapping. 
Mean perfusion in the septal region was 18.2 ± 4.9 ml/g/min. Regions of perfusion deficit 
decreased by approximately 70% to 5.6 ± 1.5 ml/g/min. Mean MBPd/LV across 6 slices 
(rather than 7) was 63.3 ± 9.2%, which closely matched AAR/LV determined by histology 
(Figure 4.9c, p = 0.68, Mann-Whitney-U). Based on perfusion mapping, the average area of 
salvageable myocardium (100% – IS/AAR) was determined to be 55.1 ± 13.7% of the area-
at-risk, which compared to 50.8 ± 5.8% for histology (both analysed across 6 slices). 
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Figure 4.9: Bar charts showing mean infarct size as a percentage of left-ventricle volume (%IS/LV) 
and area-at-risk values as a percentage of left-ventricle volume (%AAR/LV), and corresponding 
Bland-Altman plots comparing each MRI sequence with gold-standard histology measurements. (a) 
Infarct volume assessed by LGE agreed with histology. (b) Elevated regions of T2 matched TTC-
stained histological volumes. (c) Perfusion deficit also agreed with TTC-stained histological volumes. 
All comparisons show no statistical differences (Mann-Whitney-U). 
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4.3.4 Discussion 
There is a clinical need for accurate in vivo visualisation and assessment of the AAR 
following myocardial infarction as the extent of salvageable tissue is an important indicator 
of final infarct size and it represents a target for therapeutics aimed at reducing ischaemic 
injury. In this study, the size of the AAR was assessed and quantified in a mouse model of 
reperfused myocardial infarction, 72 hours post-surgery, using a multi-parametric MRI 
protocol. The primary aim was to determine how well T2 mapping quantified the size of the 
AAR, however, perfusion imaging with ASL was also performed. To determine the accuracy 
of MR-derived regions, gold-standard histology was used for comparison. 
Elevated T2 has previously been shown to correspond to myocardial oedema [38-40]. T2-
weighted imaging has been used widely in the clinic to measure oedema, but T2-mapping 
has had little pre-clinical application and potentially offers a more robust alternative, as it is 
less susceptible to problems of signal variation [33]. The results from this study suggest that 
T2-mapping can accurately measure the size of the AAR in a reperfused model of 
myocardial infarction. The average size of the AAR measured using T2-mapping closely 
matched the AAR using histology. Volumetric subtraction of infarct regions determined the 
extent of salvageable tissue within the myocardium, which was also in agreement with 
histology. 
Despite the agreement with histology, there were some limitations to the T2-mapping in this 
study. Firstly, the T2 maps were reconstructed from images up to 30ms after the R-wave. 
This corresponds to almost one third of a cardiac cycle, meaning that T2 maps were 
comprised of images at various stages of myocardial contraction. As a result, it is likely that 
the T2 fits were biased, although across the entire myocardium the fits were still sufficiently 
accurate that elevated regions of T2 matched the AAR using histology. Another limitation 
was the necessity for an internal reference point in the septum to determine elevated T2 
values. Ideally, absolute T2 values would have been used to determine AAR, however, inter-
animal T2 variation meant that normalisation to septal tissue improved comparisons to 
histology. Intra-animal thresholding is not a definitive solution either though: in this cohort, 
the mice did not demonstrate elevated T2 in the septum suggesting the tissue was still 
normal, however, in animals with more extensive infarcts the septum may be damaged too. 
Furthermore, studies in humans suggest that the remote region in myocardial infarction 
patients has a slightly higher T2 value than the myocardium in a normal, healthy patient 
[41]. The uniformity of T2 elevation between the infarct region and AAR was also perhaps 
surprising. T2 is thought to increase linearly with oedema and water content within infarcted 
tissue can be as much as 88% compared to 10% in salvageable tissue [42]. Yet, as in many 
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other studies [31, 34, 39, 40], there was no clear difference in T2 values between infarcted 
and salvageable tissue in this study – the infarct region was only distinguishable using LGE 
IR MRI. In fact, this disparity represents a controversial topic within the field as to whether 
increased T2 represents acute infarction or the AAR [42]. The present study suggests the 
latter.  
Measurements of AAR based on perfusion deficit in the myocardium using ASL also closely 
matched histological measurements of AAR. This result was surprising because the AAR 
was not expected to show such extensive perfusion deficit given that a reperfused 
myocardial infarction mouse model was used. It was expected that the AAR may have 
reduced perfusion compared to remote tissue, but not reduced to the extent of the infarcted 
tissue. Instead the perfusion deficit was indistinguishable between salvageable and infarcted 
tissue. Two possible explanations for this observation are that some of the myocardium 
within the AAR may have entered a hibernating state [43] resulting in reduced demand for 
oxygen, or that some of the blood vessels within the AAR – and not just the infarct region – 
were damaged following ischaemia, enhancing the perfusion reduction. There is also the 
possibility that surgery was simply incorrect and reperfusion did not occur, however, this 
seems unlikely as previous surgeries where permanent coronary occlusions were carried out 
by Dr Rachel Dongworth demonstrated extensive transmural infarction, with minimal viable 
tissue within the AAR, following TTC staining. 
Overall, the results in this study show that both T2 mapping and ASL can be used to 
measure the extent of AAR in a mouse model of reperfused myocardial infarction and, when 
used in conjunction with LGE IR MRI, the area of salvageable tissue can be quantified. This 
multi-parametric approach has the potential to be highly valuable for developing and 
assessing the efficacy of therapies targeted at reducing ischaemic injury. 
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4.4 Overall Discussion 
This chapter has demonstrated the broad utility of cardiac MRI and the wealth of 
information that can be obtained using a selection of different pulse sequences. A Prox1-
deficient mouse model was imaged using CINE MRI for functional analysis and LGE IR 
MRI for thrombus visualisation, and shown to exhibit a severe DCM phenotype, which may 
offer significant value for future prognostic studies of DCM. In the second study, LGE IR 
MRI, T2-mapping and ASL, were used for the in vivo assessment of area-at-risk following 
myocardial infarction, which compared favourably with gold-standard histological staining. 
The imaging methods applied in this chapter enable thorough characterisation of animal 
models of human CVD and enable the efficacy of novel cardioprotective therapies to be 
assessed. 
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CHAPTER 5: HIGH TEMPORAL RESOLUTION 
RETROSPECTIVE CINE MRI FOR ASSESSING DIASTOLIC 
FUNCTION IN HEALTHY AND INFARCTED MOUSE HEARTS: 
COMPARISON WITH ULTRASOUND 
 
Cardiac function is widely assessed in the clinic using quantitative measures of systolic 
function, however, assessment of diastolic function may offer a more sensitive early 
indicator of heart failure. This chapter is focussed on the development of a retrospective 
high-temporal resolution (HTR) CINE sequence for the assessment of diastolic function in 
mouse hearts. The chapter describes the creation and optimisation of the sequence, 
development of algorithms to reconstruct the imaging data, repeatability studies to assess the 
variability of the technique and comparisons with Doppler ultrasound, which is currently the 
preferred method for in vivo assessment of diastolic function. Finally, the sequence is 
applied to a mouse model of myocardial infarction. 
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5.1 Introduction 
In the clinic, cardiac function is most commonly assessed using measures of systolic 
parameters such as ejection fraction and stroke volume. Reduced ejection fraction (< 50%) is 
a primary indicator of global systolic dysfunction. However, approximately 50% of heart 
failure patients have normal ejection fraction [1], but present with diastolic dysfunction. This 
complicates diagnosis of heart failure and has led to the creation of new terminology to 
categorise these patients: they are said to have heart failure with preserved ejection fraction 
(HFpEF). A vast body of literature now exists focused on HFpEF [2-8], as it is recognised as 
a major international public health problem, and one which is growing [4]. While outcomes 
in heart failure with reduced ejection fraction (HFrEF) have improved in recent years, 
HFpEF outcomes have not improved [5], underlining the need for further research in this 
field. 
The cardiac cycle is divided into two main phases: systole and diastole. During systole left 
ventricular contraction pumps blood out of the heart. Contraction is activated by an influx of 
calcium (Ca
2+
) ions into the cardiomyocytes [9]. The diastolic phase involves left ventricular 
filling, which is characterised by two main stages: the early-filling phase (E) where the 
myocardium actively relaxes by pumping of Ca
2+
 ions into the sarcoplasmic reticulum via 
energy-dependent SERCA (sarcoplasmic reticulum calcium ATPase) pumps and the atrial-
filling phase (A) where the left atrium contracts to push through more blood. Diastolic 
performance can be quantified by measuring the blood flow velocity across the mitral valve 
during these two phases to give the E/A ratio [10]. Two main mechanisms contribute to 
diastolic heart failure, which can be detected by alterations in the E/A ratio. Firstly, 
abnormalities in calcium homeostasis, such as decreased SERCA function, can cause 
impaired active relaxation [11]. This results in a mild form of diastolic heart failure where 
LV relaxation is slowed and atrial contraction is increased to compensate, known as 
impaired diastolic dysfunction. In this case, E/A is less than 1 (Figure 5.1). The second 
mechanism is increased myocardial stiffening which causes elevated blood pressure 
resulting in the early opening of the mitral valve and a faster inflow of blood into the LV 
[12]. This is a more severe form of diastolic heart failure known as restrictive filling, which 
results in an E/A ratio greater than 1.7. For healthy individuals, an E/A value between 1.0 
and 1.7 is considered normal, however, patients that fall within this range are considered to 
be transitioning from impaired to restrictive filling [13]. 
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Figure 5.1: Schematic showing different patterns of left ventricular filling by measurement of 
transmitral valve blood flow. E corresponds to the early-filling phase of diastole and A corresponds 
to the atrial-filling phase of diastole. 
 
Ultrasound is the "method of choice" for diagnosing heart failure [2, 14] in the clinic and can 
be used for assessment of both systolic and diastolic dysfunction. It has also been 
successfully applied to mouse and rat models of heart disease [15-17], however, measures of 
diastolic dysfunction in particular are limited by difficulties with transducer positioning, the 
small acoustic window, 1-dimensional acquisition and high heart rates which can lead to the 
early and atrial filling phases merging together. 
MRI is widely recognised as a viable and potentially better alternative for measuring 
diastolic function [18-20] because of its ability to image the heart in 3D with excellent 
spatial resolution and tissue contrast. In patients, MRI has been shown to correlate closely 
with ultrasound measurements of diastolic function [21]. In rodents, where conventional 
CINE imaging generates 15-30 frames throughout the cardiac cycle, the temporal resolution 
is only sufficient for analysis of systolic parameters. Assessment of diastolic function 
requires higher temporal resolution to resolve the subtle filling patterns. Measurements in 
mice are further complicated by high heart rates and the merging of the E- and A-filling 
phases, which is not exhibited in human hearts. Ultrasound has the requisite temporal 
resolution for murine studies, but measurements are often imperfect due to hardware 
limitations such as those outlined in the previous paragraph. More recently, high temporal 
resolution, pre-clinical MRI techniques have emerged including a prospective CINE method 
[22] and a self-gated retrospective method [23] for measuring the E/A ratio in rodents, 
however none have been directly compared and validated against ultrasound measurements. 
Therefore, the aim of this chapter was to develop an ECG-gated retrospective high-temporal 
resolution (HTR-) CINE sequence for assessing diastolic function in mice by measurement 
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of E/A ratios and compare the results with ultrasound. The theory behind the retrospective 
HTR-CINE sequence is discussed in the next section (section 5.1.1). The methods and 
results begin with some preliminary experiments including phantom scans, early in vivo tests 
and simulations, which all contributed to the optimisation of the sequence. Then, the final 
image reconstruction pipeline is outlined. Following development of the sequence, an 
ultrasound versus retrospective HTR-CINE MRI repeatability and variability study is 
described. Finally, a study applying the HTR-CINE sequence to an experimental mouse 
model of myocardial infaction (MI) is presented. 
 
5.1.1 Retrospective HTR-CINE sequence theory 
The retrospective HTR-CINE sequence developed in this chapter extends the basic idea of a 
standard retrospective CINE sequence, as described in section 2.7. In a standard 
retrospective CINE acquisition (Figure 2.10), the sequence is run continuously (~1 minute 
per slice) with a fixed TR, k-space is sorted depending on ECG and respiration events and 
then reconstructed offline once all phase encode lines have been acquired. For high temporal 
resolution, the same sequence is run except the acquisition duration is extended (typically 
>10 minutes) so that the cardiac cycle is effectively sampled with a high frame rate. Natural 
fluctuations in heart rate ensure that the cardiac cycle is sampled approximately randomly. 
Figure 5.2 shows how the retrospective HTR-CINE sequence samples the cardiac cycle at 
slightly different phases throughout the course of an entire scan. 
 
 
Figure 5.2: Cardiac cycle sampling with a retrospectively-gated HTR-CINE sequence. The red lines 
show the timing of each k-line acquisition throughout the R-R interval. In this schematic, TR = 5ms 
for simplicity. The first line acquired in R-R interval (A) coincides with end diastole at 0ms. Later on 
in the acquisition, the coupling between the sequence and the ECG trace has changed such that the 
lines acquired in R-R interval (B) are shifted by 3ms through the course of the cardiac cycle.  
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5.2 Methods 
5.2.1 Retrospective HTR-CINE sequence reconstruction 
For retrospective reconstruction of the HTR-CINE sequence, a datalogger (see section 2.8) 
was used to record the exact timings of all RF, ECG and respiration events. These data – 
along with the raw imaging data – were exported for offline reconstruction of the sequence, 
as the vendor software on the MRI scanner was incapable of reconstructing retrospectively 
acquired images. 
A reconstruction pipeline was developed in MATLAB to sort the RF events depending on 
their location within the cardiac cycle and the respiration state of the animal. Data was 
passed through the pipeline below (see Figure 5.3 for an illustration of this process): 
1. All RF events were identified as k1 to k128 depending on their position in the k-space 
phase encoding table. 
2. The period of every cardiac R-R interval was calculated based on the ECG 
recordings. The ECG trace was passed through the arrthymia correction algorithm 
described in the next section (5.2.2). 
3. Using the corrected ECG trace, every R-R interval was divided into NF frames – as 
defined by the user – of equal duration. For example, an R-R interval of 100ms 
divided into 20 frames gave a binwidth of 5ms. 
4. All RF events were assigned a second number f1 to fNF depending on where they 
occurred during each cardiac cycle. 
5. Any RF events which occurred during a breath were discarded. 
6. k-space for each frame was compiled using the corresponding k-lines k1 to k128. 
7. Lastly, each k-space frame was Fourier transformed to produce a real image. 
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Figure 5.3: Schematic showing RF assignment for retrospective HTR-CINE reconstruction. All k-
lines acquired during respiration breaths (grey) are discarded. Each k-line is assigned a number 
between 1 and 128 (ki) depending on its location in k-space. The k-lines are also assigned a frame 
number (fNF) from 1 to NF (= 50 in this diagram) depending on its location in the R-R interval. k-
space is reconstructed by sorting the k-lines according to their assigned values. 
 
5.2.2 ECG arrhytmia correction algorithm 
There were two main sources of QRS timing error in the ECG recording equipment that 
were corrected to ensure retrospective reconstruction was as robust as possible (Figure 5.4). 
Firstly, the SA Instruments software occasionally missed QRS events (a) causing the 
apparent duration of the R-R interval to double. Secondly, the software sometimes 
mistakenly recorded spikes of noise in the ECG trace as QRS events causing a shortening of 
one R-R interval followed by lengthening of the subsequent interval (b). 
 
Figure 5.4: Sources of error in ECG recordings. (a) Fluctuating ECG signal would sometimes lead to 
missed QRS peaks which caused recorded R-R intervals to double in duration. (b) Noise in the ECG 
signal would also lead to false QRS detection which caused the dual effect of shortening the duration 
of one interval followed by increasing the duration of the subsequent R-R interval. 
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Both sources of error caused incorrect assignment of RF events during reconstruction. To 
account for this, an ECG correction algorithm was developed as part of the reconstruction 
pipeline in section 5.2.1. The duration of every R-R interval was calculated and the average 
R-R duration was determined. For missed QRS events, with an R-R interval greater than 
175% of the mean R-R duration, a new QRS event was inserted. To account for false QRS 
detection, all R-R intervals shorter than the mean R-R duration by 2 SD or more were 
detected and shifted in time to the median R-R duration of the surrounding 10 ECG 
intervals. 
 
5.2.3 Phantom experiment – retrospective HTR-CINE block acquisition 
correction 
Preliminary in vivo images using the retrospective HTR-CINE sequence contained 
significant flickering artefacts (see Results, Figure 5.8) which needed to be corrected before 
continuing with the main studies. Therefore, a number of experiments (described in the 
Results section) in agar phantoms were carried out to determine the source of the artefact. 
Phantoms were imaged using the retrospective HTR-CINE sequence with the following 
parameters: TR = 3.15 ms, TE = 1.21 ms, NR = 2500, FA = 15°, data matrix = 128
2
, FOV = 
20mm
2
, slice thickness = 2mm. 
 
5.2.4 In vivo simulations 
The majority of preliminary experiments were conducted with NR = 2500, which equated to 
20 minutes for a single slice. Therefore, prior to carrying out the main experiments, 
simulations of typical in vivo mouse physiology were programmed and run in MATLAB to 
determine the optimum scan duration for characterising diastolic function. 
Two parameters were varied in the simulations: heart rate and respiration rate. Temperature 
and isoflurane concentration were assumed constant. An ECG trace was simulated with an 
R-R interval based on the input heart rate. Gaussian noise was applied to the trace so that 
ECG events were distributed around the mean R-R interval with a 1ms standard deviation. 
Similarly, a respiration trace was simulated with a quiescent interval based on the input 
respiration rate. Breath duration was held constant at 0.25s, based on previous in vivo 
experience, therefore only the quiescent phase was varied in duration. Respiration events 
were also modelled as a Gaussian distribution with a 0.1s standard deviation. TR was set to 
be 3.15 ms, in keeping with the minimum duration achievable in vivo on the laboratory MRI 
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scanner. The number of repeats, NR, was set to 2500, equivalent to 320,000 RF events. For 
analysis, heart rate and respiration rate were varied between 400–650 bpm and 30–90 bpm, 
respectively, which were rates consistent with previous in vivo mouse experiments. All 
simulations were repeated five times (n = 5) and error bars represent standard error in the 
mean (SEM). 
Previous studies by Coolen et al. (2013) showed that retrospective HTR-CINEs generated 
from only partially filled k-f spaces were adequate for diastolic function analysis [23]. Thus, 
the simulations were run to determine the time needed 99% completion of k-f space, and for 
comparison, 95% and 100% completion of k-f space. 
 
5.2.5 In vivo MRI setup 
For all in vivo experiments, mice were imaged using the standard cardiac MRI setup 
described in section 2.8.1. Briefly, mice were anesthetised with 1.5-2.0% isoflurane in 2 
l/min O2 and positioned supine in a cradle which could be positioned in the middle of the 
scanner bore. Temperature was monitored and maintained at physiological temperature. 
Respiration was monitored using a neonatal apnea pad and ECG was monitored using three 
ECG electrodes inserted subcutaneously. For myocardial infarction experiments, an infusion 
line was inserted intraperitoneally for injection of gadolinium contrast agent. All imaging 
was conducted using 1000mT/m gradient inserts and a 35mm volume RF coil (RAPID). 
 
5.2.6 Study 1: Repeatability of diastolic function measurements using 
retrospective HTR-CINE MRI vs ultrasound 
The aim of this experiment was to establish the repeatability of the retrospective HTR-CINE 
sequence and validate the results using ultrasound. To this end, (n = 8) naïve mice were 
scanned twice using both ultrasound and MRI for intra- and inter-modality comparisons. 
Pulse wave Dopper mode ultrasound was used as a gold-standard estimate of E/A ratios. The 
retrospective HTR-CINE sequence was performed at three different slice locations within 
the heart: apical, mid-ventricular and basal, to examine variability due to slice location. A 
conventional CINE stack was also acquired to serve as a basis for localising the 
retrospective planes, for estimation of systolic functional parameters and to compare 
variation in established parameters such as ejection fraction and stroke volume with 
variation in the diastolic function parameters. Total imaging time was approximately 2.5 
hours per animal. All animals were imaged with the following protocol: 
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1. Ultrasound scan 1 (15 minutes) 
2. MRI session 1 
– Animal setup and scanner calibration (15-20 minutes) 
– Prospective CINE stack (10 minutes) 
– Retrospective HTR-CINE 
 – single apical slice (11 minutes) 
 – single mid-ventricle slice (11 minutes) 
 – single basal slice (11 minutes) 
3. MRI session 2 
– Remove and reposition the animal cradle within the scanner 
– Scanner calibration (5 minutes) 
– Prospective CINE stack (10 minutes) 
– Retrospective HTR-CINE 
 – single apical slice (11 minutes) 
 – single mid-ventricle slice (11 minutes) 
 – single basal slice (11 minutes) 
4. Ultrasound scan 2 (15 minutes) 
In vivo ultrasound setup: Ultrasound imaging was carried out on a VisualSonics Vevo 2100 
(CA, USA) system using a VisualSonics 550D 30 MHz transducer. Mice were anesthetised 
with 1.5-2.0% isoflurene in 2 l/min O2 and positioned supine on a physiological monitoring 
platform which simultaneously regulated body temperature and measured respiration and 
ECG traces. Prior to imaging, hair removal cream (Veet, UK) was applied to the chest to 
reduce attenuation of ultrasound signal. 
For the assessment of diastolic function, pulse wave Doppler mode ultrasound was used to 
measure mitral inflow in an apical four-chamber view of the heart. Early-filling (E) and 
atrial-filling (A) peaks were measured in three separate heart beats, from which the mean 
E/A ratio was calculated for each animal. 
In vivo MRI setup: Mice were positioned in the scanner as described in section 5.2.5. Global 
shimming was performed followed by a series of pilot scans to correctly orientate the short 
axis CINE stack within the heart. The main MRI sequences were acquired with the 
following imaging parameters: 
Prospective CINE imaging: To quantify standard cardiac functional parameters, a standard 
CINE stack was acquired with the following parameters. TR = 5 ms, TE = 1.21 ms, FA = 
15°, data matrix = 128
2
, FOV = 25.6mm
2
, slice thickness = 1mm, number of slices = 9-12 
depending on animal. 
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Retrospective HTR-CINE imaging: For quantifying diastolic function, the retrospective 
HTR-CINE sequence was run with the following parameters: TR = 3.15 ms, TE = 1.21 ms, 
NR = 1400, FA = 15°, data matrix = 128
2
, FOV = 25.6mm
2
, slice thickness = 1mm. Images 
were reconstructed according to the pipeline described in section 5.2.1. 
Statistics: Bland-Altman analysis was used to assess the repeatability of systolic parameters 
measured using CINE imaging and the repeatability of E/A parameters. Variability of E/A 
measurements were compared between imaging modalities using the standard deviation 
(SD) derived from Bland-Altman plots. Spearman’s correlation (ρs) was also performed to 
compare measurements of E/A between MRI and ultrasound. Statistical significance was 
assigned at p < 0.05. 
 
5.2.7 Study 2: Application of HTR-CINE MRI to imaging myocardial 
infarction 
The aim of this study was to examine the performance of the retrospective HTR-CINE 
sequence in a mouse model of myocardial infarction (n = 14) and compare this to 
ultrasound. In addition to running prospective and retrospective CINE sequences, a late 
gadolinium enhanced inversion recovery sequence was performed to characterise infarct 
volume for comparison.  
CINE imaging: The prospective and retrospective HTR-CINE sequences were acquired with 
the same parameters as described in the previous section. 
Late-gadolinium inversion recovery imaging: Long-axis and short-axis images of the heart 
were obtained using LGE IR imaging, which was conducted according to the protocol 
outlined in section 2.7.3 [24]. In brief, 0.6 mmol/kg Gd‐DTPA was injected 
intraperitoneally. After an 8 minute delay to allow contrast agent to wash out of healthy 
tissue, an IR gradient echo sequence was used for high SNR between the infarcted and 
healthy tissue. Imaging parameters were: TR = 3.1ms, TE = 1.21ms, FA = 90°, TI = ~4 x 
RR‐interval (~400ms), data matrix = 1282 (zerofilled to 2562), FOV = 25.6mm2, slice 
thickness = 1mm. Note, one mouse died before LGE IR imaging could be performed, hence 
this data point is omitted from some plots in the Results section. 
Statistics: Mann-Whitney-U tests were performed to test for significance between 
measurements of systolic cardiac parameters. Spearman’s correlation (ρs) was performed to 
examine the relationship between infarct size assessed by LGE imaging and measurements 
138 
 
of EF. Mann-Whitney-U tests were also used to compare measurements of mean E/A in 
naïve and infarcted animals. In all cases, statistical significance was assigned at p < 0.05. 
 
5.2.8 Image analysis for determining E/A ratios 
Following reconstruction, retrospective HTR-CINE images were exported to Segment 
(http://segment.heiberg.se/) for segmentation. The endocardial border was semi-
automatically delineated in all frames to produce a chamber volume curve. A filling rate 
curve was calculated from the derivative of the volume curve. Moving average statistics 
(span = 5: N-2 … N+2) were applied to filling curves to filter noise. From the filling rate 
curve, E and A peaks were determined and the E/A ratio calculated. 
 
5.3 Results 
5.3.1 Preliminary pulse sequence development, reconstruction and 
implementation 
The vendor software on the Agilent MRI scanner did not contain a retrospective CINE 
sequence, so a custom retrospective CINE sequence was programmed. The sequence was 
based on a conventional FLASH CINE sequence, but modified to run for a user-defined 
number of repetitions, NR. TR was set to its minimum of 3.15ms to ensure maximal 
temporal resolution through the cardiac cycle. In vivo scans required retrospective sorting 
according to animal physiological traces. Figure 5.5 shows RF, ECG and respiration events 
recorded using the datalogger. 
 
Figure 5.5: Screenshot from the datalogger software, Spike2, showing recordings of mouse 
respiration, ECG and the k-line RF timestamps. 
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The imaging data and the traces from the datalogger were passed through the reconstruction 
pipeline described in the methods (section 5.2.1). Based on recordings of 8 naïve mice, the 
mean percentage of k-space lines discarded from a scan due to respiration events was 43.3 ± 
1.3% and the average R-R interval duration was 100.5 ± 2.5ms. 
As discussed in section 5.2.2, there were two main sources of timing error in the datalogger 
ECG recordings, which caused miscalculated R-R intervals. Figure 5.6a shows a plot of all 
R-R interval durations from a mouse. The spikes in the plot correspond to missed or 
incorrectly timed ECG events. On average, there were 6936 ± 165 heart beats during a scan. 
The mean percentage of incorrectly recorded QRS events in a mouse was 1.5 ± 0.4%. The 
arrhythmia correction algorithm was effective at detecting and correcting any missed or 
erroneous ECG timestamps recorded by datalogger (Figure 5.6b). 
 
 
Figure 5.6: Arrhythmia correction in a mouse ECG trace. (a) The raw ECG trace shown has a mean 
R-R duration of 0.11 ms, however, noise in the ECG traces caused incorrect measurement of QRS 
events or QRS events to be missed completely. (b) The same ECG trace passed through the 
arrhythmia correction algorithm shows steady R-R intervals. 
 
Following respiration and arrhythmia correction, the imaging data were retrospectively 
reconstructed into HTR-CINE movies. Figure 5.7 shows typical k-f space filling patterns in 
a single mouse. In each plot, the x-axis corresponds to the phase encode lines (or k-lines) in 
a single image and the y-axis corresponds to the different frames of the cardiac cycle. Every 
nonzero pixel in the image corresponds to a successfully assigned RF event. The diagrams 
feature repeating diagonal streaks through k-f space indicative of the animal physiology. The 
widest regions of unfilled bins correspond to respiration events, during which lines of k-
space are discarded.  As the number of repeats, NR, increases many bins are filled more than 
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once before the entirety of k-f space is completely filled. By NR = 1400, the entire 
acquisition has been completed: the target number of k-lines per bin for the HTR-CINE 
acquisition was 3 (dark red), which has clearly been achieved in the majority of bins. Any 
bins which were filled more than three times were automatically reduced to three k-lines, to 
minimise artefacts in the reconstructed images. 
 
 
Figure 5.7: Plots showing k-f space filling over the course of an entire acquisition. After 10 repeats 
(NR = 10), the vast majority of k-f space remains unfilled. The ‘zig-zag’ pattern reflects animal 
physiology. The widest sections of unfilled k-f space reflect respiration events. As k-f space filling 
proceeds, some bins are filled two or three times (yellow and red), while other bins remain unfilled 
(dark blue). By NR = 500, the majority of bins have been filled at least once. By NR = 1400, most bins 
have been filled at least three or more times. 
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Once k-f space was constructed, each frame was fast Fourier transformed to create the HTR-
CINE images. Figure 5.8 shows end diastolic frames from a preliminary retrospective HTR-
CINE scan, reconstructed using the full pipeline, alongside the equivalent frame from a 
prospective CINE. The retrospective HTR-CINE images contained flickering artefacts 
(Figure 5.8a) that were present throughout the entire cardiac cycle, which significantly 
compromised image quality. The artefacts appeared similar to respiration artefacts 
manifesting as streaks across the images, however, they were not present in prospective 
CINE images acquired during the same session (Figure 5.8c) suggesting the problem was 
isolated to the retrospective HTR-CINE sequence. Closer examination of k-space revealed 
streaking patterns (Figure 5.8b), which were not present in k-space of the prospective CINE 
images (Figure 5.8d). This effect was investigated further, and is discussed in the next 
section. 
 
Figure 5.8: Preliminary retrospective HTR-CINE images compared to prospective CINE images. (a) 
The retrospective HTR-CINE images contained 'flickering' artefacts across the image in the phase 
encode direction, severely compromising image quality. (b) In k-space, these artefacts appeared as 
streaks. (c) Prospective CINE images acquired were free from artefacts and (d) k-space was smooth, 
as expected. 
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5.3.2 Phantom experiment – retrospective HTR-CINE block acquisition 
correction 
To investigate whether the artefacts observed in the in vivo retrospective HTR-CINE images 
were due to animal physiology or caused by errors in the reconstruction algorithms, the 
retrospective HTR-CINE sequence was applied to an agar phantom. 
Images reconstructed using a block of 128 consecutive lines of k-space, from anywhere 
during the entire acquisition, resulted in an accurate representation of the phantom (Figure 
5.9a). Reconstructing k-space using phase encode lines randomly selected from different 
repetitions of the sequence resulted in images containing significant artefacts (Figure 5.9b). 
As observed in the preliminary in vivo scans, the artefacts manifested as streaks across the 
images in the phase encode direction. This suggested that the artefacts observed earlier in 
vivo were not caused by physiological effects. 
 
Figure 5.9: Retrospective HTR-CINE images of an agar phantom. (a) Image generated using 128 
consecutive lines of k-space. (b) Image generated using phase encode lines selected randomly 
throughout the entire acquisition. This experiment determined that the cause of the artefact was not 
physiological. 
 
Further investigation of k-space in the agar phantom experiments demonstrated that a k-
space “phase roll” effect was causing the artefacts in the retrospective HTR-CINE images. 
That is, the signals recorded in k-space would invert – then reinvert – as an increasing 
number of repetitions (NR) were acquired, as shown in Figure 5.10a. The plot shows the 
maximum signal intensity measured in a 1D profile through the centre of k-space (Figure 
5.10b and Figure 5.10c) for every repetition, NR, in a single run of the retrospective HTR-
CINE sequence. The signal in the centre of k-space (Figure 5.10d) was initially high (> 6000 
au) for the first 4 repetitions while the magnetisation reaches a steady state. From NR #5 to 
approximately NR #250 the signal in the centre of k-space was approximately constant at 
~5800 au (red points). After this point, the signal drops sharply, plateauing at ~1200 au (blue 
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points). A 1D profile through k-space of the blue repetitions showed a negative signal 
(Figure 5.10e). The signal from the central line of k-space proceeded to oscillate for the 
duration of the scan, increasing in frequency with NR. 
 
 
Figure 5.10: k-space phase roll during the retrospective HTR-CINE sequence. (a) The phase of k-
space oscillates as the number of sequence repetitions increases. Red points correspond to repetitions 
where the central line of k-space (b) has positive signal (d).Blue points correspond to repetitions 
where the central line of k-space (c) has negative signal (e). Corrupt image reconstructed using 
random phase encode lines from black and blue repetitions only. (f) Image reconstructed using 
random phase encode lines from red repetitions only. 
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Images reconstructed using randomly sampled phase encode lines from red repetitions only, 
(i.e, those with a positive signal in the centre of k-space) produced artefact-free images of 
the agar phantom (Figure 5.10g). Whereas, images reconstructed using phase encode lines 
randomly sampled from both blue and black repetitions contained artefacts (Figure 5.10f). 
Similarly, images reconstructed using only blue repetitions – or only black – also contained 
artefacts (not shown, but looked very similar to Figure 5.10f).  
In an attempt to remedy this issue, large spoiler gradients were implemented into the 
sequence to test whether it was caused by any residual transverse phase accumulation, but 
the oscillating phase roll remained. In the end, the issue was circumvented by acquiring 
consecutive repetitions of shortened acquisitions. The retrospective HTR-CINE sequence 
was shortened to NR = 200 and immediately restarted once the sequence had finished 
acquiring. To test the correction method, 5 blocks of 200 repetitions were run for a total NR 
= 1000. The block-acquisition strategy was carried out in a mouse heart, using the 
datalogger as normal to record the RF and physiological events. The signal in k-space 
remained approximately constant throughout the duration of the scan (Figure 5.11). The 
resultant HTR-CINE images were artefact-free throughout the entire cardiac cycle. This 
block acquisition approach was implemented in all subsequent studies. 
 
 
Figure 5.11: The block acquisition strategy for artefact-free retrospective HTR-CINE images. In this 
example, the full acquisition comprises five blocks of 200 sequence repetitions. The scanner is 
momentarily stopped in between blocks before resuming. The maximum signal in k-space remains 
positive throughout the entire duration of the acquisition. Image quality was greatly improved, as 
shown in an end diastolic frame acquired using the block acquisition strategy. 
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5.3.3 In vivo simulations 
Prior to the main animal studies, simulations of in vivo mouse physiology were conducted to 
determine the optimum scan duration required to satisfactorily fill k-f space so that image 
quality was good enough for reliable segmentation. Simulations were run to determine the 
time needed for 99% completion of k-f space, and for comparison, 95% and 100% 
completion of k-f space. 
The simulations showed (Figure 5.12a) that the acquisition time required for one complete 
transient (NT = 1) with 100% filling of k-f space was 11 minutes, with a heart rate of 450 
bpm and a respiration rate of 50 bpm, typical of an anesthetised mouse. This equated to three 
complete transients with 99% filling. Acquisition time was halved for one 99% completed 
transients of k-f space, which took just over 5 minutes. 95% completion took just under 4 
minutes. As k-f filling was a stochastic process, the time taken to acquire transients after 
completely filling k-f space once was greatly reduced as many phase encode lines had 
already been acquired multiple times (as shown in Figure 5.7). 
Heart rate had little effect on k-f space filling completion times (Figure 5.12b), with 
respiration set constant at 50 bpm. The time taken to complete one transient with 100% 
filling (blue curve) was approximately 11 minutes with heart rates between 450 and 650 
bpm. However, respiration rate was directly proportional to k-f space completion times 
(Figure 5.12c), with ECG set constant at 450 bpm. As outlined above, the time taken to 
complete one transient with 100% filling (blue curve) was approximately 11 minutes. This 
decreased to less than 9 minutes with a respiration rate of 30 bpm and increased to 14 
minutes with a respiration rate of 90 bpm. This result reflects the fact that with faster 
breathing rates, the duration of the quiescent phase decreases, therefore more lines of k-
space must be discarded. 
Testing during preliminary experiments determined that creating HTR-CINEs from averages 
of three 99% complete k-f spaces would be sufficient for determining E/A ratios in the main 
diastolic function studies. As determined by the simulations, this required imaging for 
approximately 10 minutes. Therefore, with the addition of a small buffer to allow for some 
additional respiration variation between animals and imperfect QRS detection in vivo, an 
imaging time of 11 minutes (NR = 1400, 7 blocks) was chosen for subsequent studies to 
generate retrospective HTR-CINEs with 90 frames per cardiac cycle. 
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Figure 5.12: In vivo simulations of the retrospective HTR-CINE sequence. (a) The three curves 
represent the times taken to fill a 90 frame k-f space to 100%, 99% and 95% completion. Each point 
on a curve represents one 'complete' transient. In this simulation, the mouse heart rate was set to 450 
bpm and the respiration rate was set to 50 bpm. (b) The effect of heart rate and (c) the effect of 
respiration rate on k-f space completion times. The blue curves represent the time taken to complete 
one transient (NT = 1) with 100% filling. The red curves represent the take taken to complete 3 
transients (NT = 3) with 99% filling. Different heart rates have little effect on completion times, 
whereas completion times take longer with increasing respiration rate.  
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5.4 Study 1 – Retrospective HTR-CINE MRI vs. ultrasound: 
repeatability of diastolic function measurements in normal 
mice 
5.4.1 Systolic assessment with retrospective HTR-CINE MRI 
Prior to assessment of diastolic function, the repeatability of systolic parameters was 
determined to examine the variability in the measurements. EF and SV had the lowest 
variability (Figure 5.13 and Table 5.3) as they depend on two values: EDV and ESV. 
Measurements of ESV were more variable than EDV because the left ventricle chamber is 
smaller at end systole making segmentation more difficult. These measurements of systolic 
variation are discussed further in comparison with variation in diastolic parameters later in 
the chapter (see section 5.4.4). 
 
Figure 5.13: Bland-Altman plots showing the repeatability of systolic parameters assessed by 
segmentation of standard CINE stacks. Solid lines show mean bias, dotted lines show 95% confidence 
intervals (= 1.96 × SD). EF is highly repeatable with SD = 6.0%. Variability in SV measurements is 
greater, but still low with SD = 10.4%. 
 
Cardiac 
Parameter 
Bland-Altman SD of %Difference 
between Trial 1 and Trial 2 
EF 6.0 % 
EDV 13.6 % 
ESV 28.5 % 
SV 10.4 % 
Table 5.3: Table showing the standard deviation of the percentage difference between two 
measurements of various cardiac systolic parameters. 
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5.4.2 Slice selection for diastolic function assessment 
Retrospective HTR-CINEs were generated at three separate slice locations in the heart based 
on standard CINE stacks (Figure 5.14) acquired within the same session. The three separate 
slice locations were acquired to establish which slice was most closely correlated with 
ultrasound measurements of E/A ratios. ‘Basal’ slices were defined as the slices closest to 
the atria, just below the mitral valve. ‘Apical’ slices were defined as the most apical slice 
which still contained papillary muscles. ‘Mid-ventricle’ slices were defined as a slice in 
between the Basal and Apical slices. The slices chosen were often contiguous, as shown in 
Figure 5.14, but in some animals there was a gap equivalent to one slice between the Apical 
and Mid-Ventricle slices. 
 
Figure 5.14: Prospective CINE stack showing slices selected for use in retrospective HTR-CINE 
scans (red boxes). ‘Basal’ slices were defined as slices closest to – but not including – the atria. 
‘Apical’ slices were defined as the most apical slice which still clearly contained papillary muscles. 
‘Mid-ventricle’ slices were defined as a slice inbetween the Basal and Apical slices. 
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5.4.3 Diastolic function image analysis – determining E/A ratios from HTR-
CINE MRI and ultrasound 
Figure 5.15 shows every third image through the cardiac cycle of a naïve mouse from a 90 
frames retrospective HTR-CINE acquisition. For comparison, images from a pulsed wave 
Doppler ultrasound scan are shown in Figure 5.16a. Retrospective HTR-CINEs were 
exported to Segment for left ventricular segmentation (Figure 5.16c). Every frame in the 
cardiac cycle was segmented to generate a left ventricular volume curve (blue) (Figure 
5.16d). Filling curves (red) were calculated by differentiation of the volume curve. For 
ultrasound, one filling curve (Figure 5.16b) was acquired for every heartbeat – the average 
of three consecutive filling curves was taken for final E/A values. Distinct early- and atrial- 
filling peaks could be resolved using both modalities. 
 
Figure 5.15: 30 images through the cardiac cycle from a 90 frame retrospective HTR-CINE 
acquisition. Temporal resolution is approximately 1.1-1.3ms depending on heart rate. 
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Figure 5.16: Measuring E/A ratios using pulsed wave Doppler ultrasound and retrospective HTR-
CINE MRI in naïve mice. (a) Typical ultrasound image of mitral blood flow showing Doppler 
measurements overlaid. (b) Corresponding ultrasound filling curve. (c) Retrospective HTR-CINE 
image showing left ventricle blood pool segmentation (blue). (d) Corresponding left ventricle volume 
curve (blue) and filling rate curve (red). Early- and atrial-filling peaks can be seen clearly with both 
modalities. 
 
5.4.4 MRI vs. ultrasound – repeatability and correlations 
Naïve mice (n = 8) were scanned twice for repeatability using both MRI and ultrasound. 
Figure 5.17 shows raw measurements of E/A ratios using both modalities. Ultrasound 
showed no significant difference between measurements in both trials. Similarly, there was 
no significant difference between any repeated MRI measurements, regardless of slice 
location. 
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Figure 5.17: Raw data from repeat measurements of E/A ratios using ultrasound and MRI at three 
different slice locations: Apical, Mid-ventricle and Basal. There were no significant differences 
observed in any repeat measurements (p > 0.05, Mann-Whitney-U test). 
 
Figure 5.18a presents the mean E/A ratios measured using both modalities. The mean E/A 
ratio (± SEM) measured across all ultrasound scans was 1.42 ± 0.07. The mean E/A ratios 
measured using MRI were 1.41 ± 0.10 in the Mid-ventricle slices and 1.42 ± 0.07 in the 
Basal slices, which agreed with ultrasound. These measurements were also within the range 
(1.0–1.7) of values corresponding to normal heart function. However, the mean E/A ratio 
measured using Apical slices was 1.84 ± 0.08, which was significantly higher than 
ultrasound measurements (p < 0.05). The coefficient of variation was greatest in MRI 
measures using Mid-ventricle slices (Figure 5.18b). Apical and Basal slices (16.9% and 
16.0%, respectively) were comparable to ultrasound (17.1%). 
 
 
Figure 5.18: (a) Mean E/A ratios and (b) coefficient of variation measured using ultrasound and MRI 
at three different slice locations in the heart. MRI measures of E/A using Apical slices were 
significantly different to ultrasound values (p < 0.05), whereas Mid-ventricle and Basal slices showed 
the closest correspondence to ultrasound values. There was most variation in Mid-ventricle measures 
of E/A, whereas variation in the other two slice positions was comparable to ultrasound. 
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Bland-Altman analysis of ultrasound and MRI filling ratio measurements was carried out to 
establish the repeatability of the two modalities and to determine which MRI slice most 
closely reflected the ultrasound measurements (Figure 5.19). Ultrasound had the smallest 
standard deviation: SDUS = 16.1%. Basal positioning of MRI slices produced the best 
repeatability in MRI measurements where the standard deviation was comparable to 
ultrasound at SDBASAL = 16.5%. Variability was much greater in Apical and Mid-Ventricle 
slice MRI measurements, which had standard deviations of SDAPICAL = 29.3% and SDMID-VEN 
= 48.1%, respectively. 
 
Figure 5.19: Bland-Altman plots of E/A ratios measured using ultrasound and MRI. All plots show 
the mean difference and percentage differences between two trials within the same mouse. Solid 
horizontal lines show mean bias, dotted lines show 95% confidence intervals (= 1.96 × SD). Apical 
and Mid-ventricle MRI measurements showed poor repeatability with standard deviations SDAPICAL = 
29.3% and SDMID-VEN = 48.1%, respectively. Repeatability in Basal MRI slices was best: SDBASAL = 
16.5%. This was comparable to ultrasound: SDUS = 16.1%. 
 
The repeatability measurements of E/A using either ultrasound or Basal MRI were 
reasonably comparable with repeatability measurements of systolic parameters (previously 
determined in section 5.4.1). The standard deviations of EF and SV measurements were 
SDEF = 6.0% and SDEF = 10.4%, respectively. Variability in the Apical and Mid-Ventricle 
MRI measurements was vastly higher, however, ultrasound and Basal MRI measurements of 
E/A had much lower and more reasonable standard deviations of 16.1% and 16.5%, 
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respectively. The increased standard deviation in the E/A measurements reflects the 
difficulty in measuring subtle diastolic filling patterns compared to systolic function. 
Furthermore, the MRI measurements of E/A are derived from a single-slice acquisition 
whereas EF and SV were determined using a CINE stack with whole heart coverage. 
Correlation plots between the two modalities in naïve mice (Figure 5.20) showed that only 
MRI measurements using Basal slices were significantly correlated with ultrasound 
measurements of E/A ratios (Spearman’s correlation coefficient, ρs = 0.54, p = 0.04). Apical 
and Mid-ventricle MRI measurements were not correlated with ultrasound (p > 0.05). Based 
on the results in this section, Basal slices were chosen for future MRI scans as E/A ratios 
determined at this location showed the greatest agreement with ultrasound and the variability 
was smallest compared to Apical and Mid-ventricle locations. 
 
 
Figure 5.20: Correlations between ultrasound and MRI measurements of E/A ratios. Apical (a) and 
Mid-ventricle (b) measures of E/A ratios showed no correlation with ultrasound, whereas Basal slice 
MRI measurements were significantly correlated with ultrasound (Spearman’s correlation, ρs = 0.54, 
p = 0.04).  
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5.5 Study 2 – Retrospective HTR-CINE MRI vs. ultrasound: 
assessing diastolic function in a mouse model of myocardial 
infarction 
5.5.1 Systolic function assessment 
Cardiac function was assessed in the infarct cohort of mice (n = 14). Figure 5.21 shows 
systolic parameters in the infarcted mice assessed by segmentation of prospective CINE 
images and compared with naïve mice from Study 1. 
 
Figure 5.21: (a) Raw data showing systolic parameters in infarcted mice. Lines on plots represent 
mean and standard deviation. (b) Comparison of systolic parameters between naïve and infarcted 
mice. Error bars represent SEM. EF was significantly reduced in infarcted mice. EDV and ESV were 
both significantly increased in infarcted mice. There was no significant difference in SV between 
groups. All p-values were generated using Mann-Whitney-U tests. 
 
The infarct cohort of mice demonstrated heart failure with varying degrees of severity. EF 
values ranged from 31.5% indicating severe heart failure to 72.1% suggesting normal 
cardiac function. Overall, mean EF in infarcted mice was 48.1 ± 3.8% (SEM), which was 
significantly reduced compared to the naïve cohort. Mean EDV was 49.4 ± 4.0 µL and mean 
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ESV was 26.8 ± 3.6 µL, both of which were significantly increased compared to the naïve 
cohort. Mean SV was 22.5 ± 1.2 µL, which was lower than the naïve cohort, but the 
difference was non-significant. 
 
5.5.2 Myocardial scar tissue volume 
Myocardial scar tissue volume was assessed using late-gadolinium enhanced MRI. Figure 
5.22a shows a representative stack of images acquired in an infarcted mouse. Normal 
myocardial tissue is dark. Segmentation of the hyperintense myocardial scar tissue enabled 
calculation of total infarct volume as a percentage of left ventricle volume (LGE/LV%). 
Mean total infarct volume across all infarcted mice was 19.4 ± 3.6% (SEM). As expected, 
ejection fraction decreased with increasing scar volume (Figure 5.22b), showing a 
significant correlation (Spearman’s correlation coefficient, ρs = -0.88, p = 0.04). A broad 
range of infarct volumes was measured, from 2.8% to 43.3%, reflecting the varying severity 
of the myocardial impairment.  
Due to the wide range of ejection fractions and infarct volumes observed in the cohort, a 
criterion was devised to create a subset of mice which had marked heart failure, where 
surgery definitely resulted in ischaemic infarction, rather than just mild damage resulting 
from the process of undergoing surgery. Infarct mice with EF < 50% and LGE/LV > 10% 
were included in the group (n = 9), which was used for all subsequent analysis. 
 
Figure 5.22: Late gadolinium enhanced MRI in an infarcted mouse heart. (a) Stack of slices from the 
apex (1) towards the base (9) of the heart. Hyperintensity in the myocardium corresponds to 
accumulation of gadolinium within scar tissue. (b) Correlation of ejection fraction versus scar tissue 
volume using MRI. EF is reduced with more severe scarring, as expected. The red outline indicates 
animals with mild cardiac impairment, which were not included in subsequent analysis. Note, n = 13 
mice shown in this plot as one animal died before LGE IR imaging was performed. 
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5.5.3 Diastolic function assessment in infarcted mice using HTR-CINE MRI 
and ultrasound 
E/A ratios were assessed using the method outlined in the repeatability study of naïve mice 
(section 5.4.3). For infarcted mice, only Basal slices were used to calculate E/A ratios as this 
slice location was determined to most closely reflect ultrasound measurements. Infarcted 
mice demonstrated a broader variety of filling rate curves compared to naïve mice. 
Representative examples are shown in Figure 5.23. Broadly, mice with the largest infarct 
volumes demonstrated E/A ratios close to or less than 1, as in Figure 5.23a. and Figure 
5.23b. Some mice exhibited merged peaks, as in Figure 5.23c. Finally, mice with minor 
infarcts generally demonstrated filling curves with higher E peaks than A peaks. 
 
Figure 5.23: Example left ventricular filling curves in infarcted mice showing the broader range of 
patterns compared to naïve animals. (a) E lower than A, indicating impaired relaxation. (b) E 
approximately equal A. (c) Merged peaks. 
 
Raw E/A ratios (Figure 5.24a) for all (n = 14) animals in the infarct cohort indicated a 
tendency for MRI to measure lower values than ultrasound. However, statistical analysis 
showed there was no significant difference in measurements of E/A ratios between MRI and 
ultrasound (p = 0.09, Mann-Whitney-U).  
Overall, E/A values were reduced in the subset of mice with marked heart failure (n = 9, see 
section 5.5.2) compared to naïve mice according to both modalities (data taken from Pre-
MRI ultrasound scans and Trial 1 Basal MRI scans only), as shown in Figure 5.24b. With 
ultrasound, the mean E/A ratio was reduced from 1.39 ± 0.10 in naïve mice to 1.21 ± 0.11 in 
the infarct subset of mice, although this difference was non-significant. However, MRI was 
able to distinguish between the naïve mice and infarcted subset – a reduction in mean E/A 
was observed from 1.42 ± 0.07 in naïve mice to 0.94 ± 0.11 in the infarcted mice, which was 
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significantly different (p = 0.006, Mann-Whitney-U). Finally, there was significant 
difference between modalities in the infarct group (p = 0.04, Mann-Whitney-U), which was 
not observed in the naïve group. 
Linear correlation of E/A ratios between the two modalities in the entire infarct cohort was 
strongly correlated (Spearman’s correlation coefficient, ρs = 0.89, r
2
 = 0.79, p << 0.05), as 
shown in Figure 5.24c. The tendency for MRI measures of E/A to be lower than ultrasound 
can be observed in all but one animal. 
 
Figure 5.24: E/A ratios in infarcted mice. (a) Raw E/A ratios generated from ultrasound and MRI 
measurements of all mice in the infarct cohort (n = 14). MRI measures tended to be lower than 
ultrasound measurements, however the difference between groups was non-significant (p = 0.09, 
Mann-Whitney-U). (b) Mean E/A ratios in the naïve mice and the subset of mice (n = 9) with marked 
infarcts (EF < 50%, LGE/LV > 10% – see section 5.5.2), assessed using both modalities. There was a 
significant difference between naïve and infarct mice using MRI (p = 0.006, Mann-Whitney-U), 
however, this difference was not significant using ultrasound. (c) Ultrasound and MRI showed a 
strong, significant correlation across the entire infarct cohort (Spearman’s correlation, ρs = 0.89, p 
<< 0.05). E/A values tended to be lower when assessed with MRI compared to ultrasound. 
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5.6 Discussion 
In this chapter a retrospective high temporal resolution CINE MRI sequence has been 
developed, optimised and applied to mice for the assessment of diastolic function by 
determination of early- and atrial-filling peaks. The technique was compared to pulsed wave 
Doppler ultrasound measurements of mitral flow, which is currently the accepted modality 
for assessing diastolic function. The results presented in this chapter suggest that MRI is 
more sensitive than ultrasound in detecting heart failure in a mouse model of myocardial 
infarction compared to naïve animals based on assessment of diastolic function. 
The retrospective HTR-CINE sequence developed in this chapter builds upon work 
conducted by Stuckey et al. and Coolen et al [22, 23]. These studies found that high 
temporal resolution MRI is able to resolve cardiac filling peaks, however, the study 
presented here is the first to directly compare MRI with pulsed wave Doppler ultrasound for 
evaluating diastolic dysfunction in mice. A retrospective acquisition strategy was chosen 
instead of interleaving multiple prospective CINE [22] scans because there are various 
advantages to retrospective sequences. Firstly, the temporal resolution can be increased 
beyond prospective strategies enabling single millisecond resolution. Retrospective 
acquisition also allows for the entire cardiac cycle to be imaged without having to trigger 
every second R-wave, reducing acquisition redundancy. In addition, retrospective 
reconstruction permits the implementation of image artefact correction schemes, such as 
arrhythmia correction, which are not possible in prospective acquisitions. 
Initial in vivo studies using the retrospective HTR-CINE pulse sequence produced 
significant ghosting artefacts. This effect was reproduced in a phantom suggesting that the 
underlying issue was caused by a problem with the sequence rather than the in vivo setup. 
The ghosting was determined to be caused by k-space gradually changing phase as the 
sequence was played out. In one preliminary study, large spoiler gradients were inserted into 
the sequence to test whether the effect was caused by an accumulation of residual transverse 
phase, however, the phase roll remained unchanged. The cause of the ghosting remains 
unclear, however, the issue was circumvented by creating a block acquisition strategy where 
the sequence was acquired using several consecutive repeats of 200 images. 
Prior to in vivo imaging, simulations were carried out to determine the optimum scan 
duration needed to acquire a CINE movie with 90 frames. An 11 minute duration was 
deemed to be sufficient for 99% filling of k-f space with 3 averages. The datalogger used 
during in vivo scans was very good at correctly detecting the ECG events; the imaging 
gradients were anticipated to significantly interfere with the signal measured by the 
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subcutaneous electrodes, however, only 1.5% of ECG events were mistimed during a scan, 
including those discarded during respiration breaths. The arrhythmia correction algorithm 
successfully corrected these timing issues, however, even without its implementation the 
datalogger recordings were generally robust enough to produce CINEs with minimal 
artefacts.  
In study 1, repeatability experiments were carried out to test the variability in measurements 
of E/A ratios using both the retrospective HTR-CINE sequence and the pulsed wave Doppler 
ultrasound system. A basal slice location in the heart was determined to have the smallest 
variability compared to more apical slices. Basal slice measurements using HTR-CINE MRI 
showed comparable mean values and variability with ultrasound, most likely because the 
basal slices were closest to the mitral valve plane where the ultrasound probe measured 
inflowing blood. The mean E/A ratio values measured in the naïve mice using basal slices 
(1.42 ± 0.07) corresponded closely with measurements of non-diabetic control mice in MRI 
experiments by Coolen et al. [23] (1.51 ± 0.08). However, MRI measurements in non-
diabetic control mice by Stuckey et al. were [22] lower (1.06 ± 0.06). Ultrasound 
measurements of non-diabetic mice by Daniels et al. [25] measured E/A ratios (1.5 ± 0.1) 
which supported the data obtained in this chapter. 
In study 2, the retrospective HTR-CINE sequence was applied to a cohort of infarct mice 
and compared with pulsed wave Doppler ultrasound to examine the robustness of the 
sequence to pathology. First, the animals were imaged with standard CINE imaging to 
determine systolic function parameters and LGE IR to quantify infarct size. The cohort of 
mice exhibited varying infarct severity, reflected in the range of ejection fractions and infarct 
volumes observed. Consequently, a broader variety of filling curves was observed in the 
infarcted mice compared to naïve animals. Both modalities were able to successfully resolve 
the filling peaks in the majority of mice, however, in some hearts the filling peaks were 
merged. On average, infarcted mice exhibited reduced E/A ratios compared to healthy mice, 
as determined using both modalities. However, this reduction was only significant when 
measured using HTR-CINE MRI, and not with ultrasound. Furthermore, MRI measured a 
mean E/A ratio = 0.94 ± 0.11, which was below the threshold of healthy diastolic function 
(less than 1.0). This was not the case with ultrasound, which remained above the threshold 
(greater than 1.0). These results indicated that MRI was more sensitive for detecting heart 
failure in mice based on assessment of diastolic function. The reason for this difference may 
possibly be attributed to the subtly different measurements made by the two techniques: 
pulsed wave Doppler ultrasound measures blood velocity during inflow, whereas MRI 
measures volumetric change during diastole. Hence, MRI may be a more direct measure of 
myocardial relaxation than ultrasound.  
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5.7 Summary 
In this chapter a retrospective HTR-CINE MRI sequence has been developed, implemented 
and optimised for imaging diastolic function in mouse hearts. Repeatability comparisons 
between HTR-CINE MRI and pulsed wave Doppler ultrasound – the current-standard for 
assessing diastolic function – indicated that variability was similar and MRI was robust. 
Measurement of E/A ratios in infarcted mice using both techniques found that HTR-CINE 
MRI was more sensitive to detecting diastolic dysfunction compared to ultrasound.  
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CHAPTER 6: FINAL DISCUSSION 
 
Cardiovascular diseases are the number one cause of death worldwide. As the economic 
burden of CVDs continues to grow, the need to understand and treat these conditions 
becomes increasingly important. Research into CVDs must be all-encompassing: the basic 
mechanisms of these diseases must be exhaustively understood, methods of diagnosis and 
prognosis must be reliable and accurate, and therapies must be thoroughly validated and 
cost-effective before coming to market. To this end, pre-clinical imaging using animal 
models plays an extremely valuable role in medical research. Imaging experimental animal 
models allows observation of biological processes at every scale, from the cellular level to 
the interaction of whole organs. Pre-clinical imaging allows for the development of sensitive 
and specific imaging biomarkers which can be translated into the clinic, as new methods for 
the diagnosis and prognosis of disease. And, pre-clinical imaging facilitates the wider 
development of therapeutics through the longitudinal characterisation of drugs in relatively 
low-cost animal models of human disease, prior to proceeding with long and expensive 
clinical trials. The overall aim of the research in this thesis was the development of pre-
clinical MRI techniques for imaging four important areas of CVD including: stroke, dilated 
cardiomyopathy, myocardial infarction and diastolic heart failure. This chapter summarises 
the studies carried out throughout the thesis, discusses some of the successes and limitations 
of each study and outlines potential avenues for future development. 
In chapter 3, a novel method for imaging extracellular and interstitial fluid flow in vivo, 
known as extravascular convectography (EVAC) MRI, was applied to imaging brain fluid 
dynamics following a stroke in a surgical rat model. Stroke is known to cause major 
alterations to intracranial pressure and intracranial fluid dynamics. Some previous studies 
have attempted to quantify ICP using MRI [1, 2] as an alternative to highly invasive gold-
standard methods [3], however, these methods only result in a global measure of ICP. With 
EVAC, the aim of the technique was to visualise localised changes in fluid dynamics and to 
determine if any useful pathological information could be gained beyond simple measures of 
ICP or other commonly used MRI methods such as diffusion and perfusion imaging. 
In the end, the results from applying EVAC to stroke rats were physiologically inaccurate. 
The EVAC velocity maps of extracellular fluid flow showed lateral movement across the 
hemispheres, which was not physically possible. The cause of the erroneous measurements 
was difficult to ascertain. In vivo repeatability and reproducibility studies carried out in a 
subcutaneous mouse tumour model demonstrated meaningful interstitial fluid flow patterns 
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which agreed with literature descriptions [4] of pressure distribution in tumours. The 
interstitial fluid flow maps were validated by gadolinium distribution experiments carried 
out by Walker-Samuel et al., which showed contrast agent accumulation in regions of vector 
convergence, suggesting that the directionality of the vectors was accurate in the tumour 
experiments despite high absolute values of interstitial fluid velocity compared to 
measurements using other techniques [5]. Validation studies were also carried out in a flow 
phantom to determine if the high interstitial fluid velocity values could be attributed to a 
phase offset effect, possibly due to electrical eddy currents masking the bipolar gradient 
velocity-encoded phase changes. A phase offset correction technique was implemented, 
which showed promise in flow phantom experiments, however, when it was applied in vivo 
the fluid patterns showed minimal changes. This was likely caused by added complications 
when imaging in vivo, such as more complicated fluid dynamics, voxels comprised of 
flowing and static tissue and a poorer shim, which all contributed to masking the benefits of 
the phase offset correction. Conversely, the flow phantom experiments were limited because 
the setup was probably too ideal: the flow was highly coherent and the signal measured was 
very high compared to in vivo imaging. 
Establishing and correcting the cause of the error in the brain measurements using EVAC 
will be a significant challenge. Nonetheless, imaging mouse brains using the same hardware 
configuration as that used in the tumour imaging studies – to rule out the rat imaging setup 
as a confounder – may be an informative future study. However, this is likely to result in 
lower SNR due to volume coil usage rather than a 4-channel receive configuration, which 
will likely require increased scan duration as a trade-off. 
In chapter 4, a pair of studies was carried out using MRI to assess two different animal 
models of heart disease. In the first study, CINE and LGE IR imaging were used to 
characterise a novel Prox1-deficient mutant mouse model with a DCM phenotype, in order 
to investigate the importance of the Prox1 gene in the maintenance of normal cardiac muscle 
physiology and development. CINE imaging was used to quantify various parameters of 
cardiac function and to assess changes in myocardial morphology. At 6-weeks old, the 
mutant mice demonstrated significantly raised left ventricular mass, end diastolic volume 
and significantly lower ejection fraction, all indicative of DCM. By 8-weeks, the severity of 
the phenotype increased such that only two mutants survived through to imaging. Despite 
this, LGE IR MRI indicated a thrombus in the right atrium of one 8-week old mouse, 
illustrating the versatility of this technique beyond traditional scar tissue visualisation. One 
limitation of the study was that, unfortunately, the mouse which presented with a thrombus 
was not taken for histology, which may have provided additional evidence that the 
hypointensity was definitely a thrombus and not an unusual flow artefact. Despite this, 
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histology performed in other Prox1-deficient mice also showed thrombi, reinforcing the 
LGE IR MRI finding. Another limitation of the study was the severity of the animal model: 
anaesthetising the mice beyond the age of 6-weeks old often resulted in death soon after 
induction, which restricted the number of animals imaged. Further still, the mutant mice 
were very weak once anaesthetised and required prompt imaging. For future studies using 
the model, this would make extensive multi-parametric protocols challenging, although the 
animals could be imaged at earlier timepoints when the phenotype is less severe. Overall 
though, the MRI showed that the mouse model shared many of the features present in human 
DCM, illustrating its importance as a tool for understanding the biological processes 
underlying the disorder and its utility for future studies investigating prognosis in DCM 
patients. 
In the second study of chapter 4, multi-parametric cardiac MRI techniques were applied to 
visualising and quantifying the AAR in vivo following myocardial infarction. Currently, in 
the clinic SPECT imaging is most commonly used for assessing the AAR, however, this 
requires substantial radiation exposure and must take place before reperfusion therapy can be 
administered, which is detrimental to patient outcome. The most widely used MRI 
alternative is T2-weighted MRI – which can be used post-reperfusion therapy – however, 
assessment is based on small signal increases within the myocardium. Hence, in this study 
T2-mapping was applied as a quantitative alternative for assessing AAR in a reperfused 
mouse model of myocardial infarction. In addition, perfusion mapping was also carried out 
for AAR analysis and LGE IR was conducted to calculate scar tissue volume. The MRI 
images were compared with gold-standard histology to assess the accuracy of the in vivo 
data.  
Two main results arose from this study. Firstly, areas of elevated T2 matched closely with 
volumes measured by histological staining. This demonstrated the potential of T2-mapping 
as a useful marker of oedema and indicates promise for use in clinical imaging. However, 
the T2-mapping protocol used in this study was not without its limitations. The sequence 
was relatively slow, taking approximately 40 minutes to acquire a full dataset necessary for 
generating the T2 maps. Acquiring less data using fewer echo times would reduce the 
acquisition time, but at the expense of less accurate T2 fitting. Another issue was the 
threshold method for determining elevated T2, which makes direct comparison of AAR 
regions between animals difficult without absolute values. This is less of an issue for 
volumetric analysis, but absolute quantification would potentially allow for the degree of 
severity within the AAR to be assessed. This could be useful for therapeutic studies, for 
instance if there was proportionality between T2 elevation and the potential to reverse the 
tissue damage, and in conditions where T2 is altered across the whole myocardium, such as 
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aortic stenosis [6].  Further studies are needed to improve the T2-mapping protocol. A 
cohort of normal, non-infarcted animals should be studied to gain an understanding of 
baseline T2 variation in mouse hearts, which would be informative for defining AAR 
thresholds. In addition, the interplay between oedema and AAR over time would be a 
valuable area of study, especially in response to therapy, to fully understand T2-mapping as 
a useful biomarker. 
The other main interesting result from this study was more surprising: quantification of AAR 
using perfusion mapping also showed a very close correspondence to histological measures. 
Despite reperfusion of the ligated vessel, regions of distinct perfusion deficit were observed 
in the ASL maps, which corresponded closely with the AAR under histology. The 
underlying mechanisms causing this perfusion deficit are not entirely clear – the ischaemic 
injury may have caused capillary damage and impaired microvascular perfusion – and may 
be of interest in future studies. As with T2-mapping, further studies are needed to understand 
how perfusion mapping of AAR evolves with time and therapy. 
Finally, in chapter 5 a retrospectively-gated HTR-CINE sequence was developed, optimised 
and compared to pulsed wave Doppler ultrasound for assessing diastolic function in mouse 
hearts. Diastolic function is believed to be a potentially more sensitive marker for early-
stage heart failure and MRI has emerged as an alternative to ultrasound for detecting 
diastolic dysfunction. Only a few studies exist in this area [7, 8] and none have yet to 
compare the two techniques directly in mice. A retrospective CINE acquisition was used as 
it enabled very high temporal resolution sampling of the cardiac cycle. Simulations 
determined that an 11-minute acquisition was sufficient for 90 frames per cardiac cycle with 
effectively three averages. A higher frame rate could have been achieved, however, any 
longer was prohibitive for the repeatability study as a total scan duration of less than 3 hours 
was required. As MRI measurements of E/A were based on a single-slice MRI acquisition, 
positioning of the imaging plane was crucial for minimising variation. Slices located just 
below the mitral valve were determined to have the least variation. In naïve mice, MRI and 
ultrasound measurements of E/A ratios showed a close correspondence and were determined 
to have comparable variation. Following validation in naïve mice, the HTR-CINE MRI 
sequence was applied to a cohort of infarcted mice and compared with ultrasound. Both 
modalities measured an average reduction in E/A ratios compared to the naïve cohort, but 
only MRI measured a significant reduction, indicating that MRI may be the more sensitive 
technique for detecting diastolic dysfunction in mice. The difference in E/A ratios between 
the modalities is possibly due to the different quantification methods used to calculate the E- 
and A-peaks. Pulsed wave Doppler ultrasound is a 1-dimensional measurement of blood 
flow, which is highly dependent on probe positioning whereas MRI is a 2-dimensional 
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measure of volume change, which is a more direct measure of myocardial relaxation and is 
more robust to orientation misalignment. 
While the results in chapter 5 suggested that MRI may be more sensitive than ultrasound at 
detecting dysfunction due to myocardial infarction, there was not enough evidence to say 
whether diastolic function is a more sensitive marker than systolic function for detecting 
early heart failure. However, this could be a focus of future experiments. For example, one 
limitation of this study was the wide range of infarct sizes within the infarct cohort; if a more 
reproducible model of mild heart failure was used – such as caused by a short duration of 
ischaemia – then it would be possible to test whether assessment of diastolic function is 
more sensitive that systolic measures. Another limitation to the study was the use of a 
single-slice acquisition for assessing an inherently 3-dimensional problem. It would be 
worthwhile comparing the results from a single-slice HTR-CINE acquisition with a multi-
slice scan covering the whole left ventricle, which would provide insight into how well the 
single-slice acquisition represents the entire change in volume of the left ventricle chamber. 
This experiment would require a scan duration of more than 90 minutes per animal, which is 
feasible for a validation purposes, but future experiments requiring a full HTR-CINE stack 
may need to implement MRI undersampling techniques [9] to improve acquisition times. 
Alternatively, it may be beneficial to evaluate diastolic parameters based on three or four 
slices rather than an entire stack. 
To conclude, in this thesis a number of MRI techniques have been developed and applied to 
pre-clinical animal models including stroke and various forms of heart disease. These 
imaging techniques provide valuable insights into the pathological mechanisms underlying 
CVDs, facilitate the creation of improved, non-invasive biomarkers and contribute to the 
development of new therapeutic strategies, all of which are crucial in the ongoing effort to 
tackle the global burden of CVD.  
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